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6ABSTRACT
Schistosomiasis is a chronic infection by a digean trematode of the genus Schistosoma. More than
207 million people are infected with this parasite, of which 120 million are symptomatic. There are
two main species infecting humans in sub-Saharan Africa: Schistosoma haematobium and S.
mansoni, both occur in areas with similar socio-economic and environmental conditions and often
have matching distribution patterns. The principle aims of the research presented in this thesis were
to further our understanding of schistosome population genetics, associated human host morbidity
and chemotherapeutic treatment of schistosomes in relation to mixed species infections.
Structured sampling of parasites and/or host traits from school-aged children at baseline and post Mass
Drug Administration (MDA) in Niger and Kenya were performed. The results presented provided
evidence for S. haematobium - S. mansoni interactions and their impact on the human host and on the
parasite population. In Kenya coinfections had lower S. haematobium related morbidity relative to
single S. haematobium infections pre and post MDA. Additionally parasite infra-populations from
coinfected children had higher genetic diversity levels compared to single infected children in mixed
infection foci. In Niger, an impact of MDA on the population genetics of S. mansoni was detected in
one mixed infection village, characterised as a noticeable bottleneck effect, but not in the other. There
was no aapparent impact of MDA on the population genetics of S. haematobium. Conversely, in
Kenya, a significant impact of MDA on both species was detected, with a bottleneck effect occurring
on the S. haematobium population and conversely, an increase in genetic diversity in the S. mansoni
population. The results of this thesis are discussed in terms of their implications on schistosome
epidemiology and evolution, and in relation to the control of schistosomiasis in sub-Saharan Africa
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GLOSSARY
In the literature available, some of these terms are used in different context with subtle variations in
their meaning. To avoid confusion I have outlined the definitions used in this thesis below.
Antagonistic interactions: Interactions to the detriment of one or both of the interacting species
Co-endemic: Two or more parasites endemic to the same region/population (see Endemic)
Coinfection: Infection of one host by two or more parasitic species
Ectopic eggs: Eggs found in some place other than their normal site of infection/excretion
Endemic: A parasite population maintained in a particular region without the need of an external input
Haematuria: Blood in urine
Heterospecific: Between two different species
Homospecific: Between members of the same species
Heterogeneity: Diversity
Inter-specific: Between species
Intra-specific: Within species
Mass Drug Administration (MDA): Administration of chemotherapy to a large population once the
prevalence had been confirmed to be high. E.g. all children in a school or everybody in a village
Polyparasitism: Infection of a single host by more than one species of parasite
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Praziquantel (PZQ): a tremotodicide used to treat schistosome infections. Aka biltricide, 2-
(cyclohexylcarbonyl)-1, 2, 3, 6, 7, 11b-hexahydro-4H-pyrazino [2, 1-a] isoquinolin-4-one with the
molecular formula; C19H24N2O2
Refugia: proportion of population not subject to selection pressure (i.e. not affected by treatment)
which can “dilute” the resistant genotype in the population
S. haematobium and S. mansoni groups: Schistosome species are generally allocated to groups based
on their egg morphology and genera of their preferred intermediate host. Thus S. haematobium, S.
intercalatum, S. bovis etc are members of the S. haematobium groups where as S. mansoni, S.
rhodaini, S. edwardiense etc belong to the S. mansoni group. There are also two other groups; S.
japonicum and S. indicum but they are not part of the scope of this research
Sympatry: Two or more species occurring in the same region/area without inbreeding at the genetic
level
Synergistic interactions: Interactions that work together to the advantage of one or both interacting
species
15
GENERAL INTRODUCTION
Schistosomiasis
Schistosomiasis is one of the so called Neglected Tropical Diseases (NTDs) and is of profound
medical, veterinary and economic significance. Schistosomiasis is a chronic infection by a digean
trematode. Currently approximately over 206 million people are infected with this parasite, with 779
million at risk of infection (Steinmann et al., 2006). In terms of disease burden, the 2002 WHO
Technical Report Series (WHO, 2002) recognises some 4.5 million Disability-Adjusted Life Years
(DALYs) are lost due to this disease and more recently King and colleagues (King, 2010; King et al.,
2006; Utzinger et al.; Utzinger et al., 2009; WHO, 2002) proposed the figure to actually much higher,
in between 6 and 13.5 million DALYs.
Schistosoma species
Schistosomes belong to the Schistosomatidae family of the digean Trematode class of the
Platyhelminthes phylum. This family is unusual in the Trematoda class in that members are dioecious
i.e. sexes are separated into males and females. Within the Schistosomatidae family, only the genus
Schistosoma is associated with humans. There are six human schistosome species; Schistosoma
mansoni, S. haematobium, S. japonicum are responsible for the majority of disease burden, whilst S.
intercalatum, S. guineensis and S. mekongi have a more localized distribution and health importance.
S. mansoni, S. intercalatum (Fisher 1934) and S. japonicum, S. mekongi cause intestinal
schistosomiasis, the latter two restricted to Asia. S. haematobium causes urinary or urogenital
schistosomiasis. Of these, S. mansoni and S. haematobium are the most widely distributed and
prevalent schistosome species in sub-Saharan Africa (Figure 1) (Gryseels et al., 2001).
Life Cycle of African Human Schistosoma
Schistosome eggs are excreted into the environment via the intestinal or urinary tract, and, under the
appropriate environmental conditions (Figure 2), mainly water, light and temperature, a motile,
intermediate stage called a miracidium hatches out immediately demonstrating host-locating behaviour
for the species-specific intermediate host; a freshwater snail of the Bulinus or Biomphalaria genus
depending on the species of schistosome. Once the appropriate snail genus is located, the miracidium
penetrates the snail’s soft-bodied foot and undergoes several stages of asexual development. First the
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miracidium develops into a primary sporocyst from which germ cells bud off and develop into
secondary sporocysts. These break away and actively migrate to other tissues. Cercariae developfrom
secondary sporocysts and, once mature, break off to migrate through snail tissues to the surface, often
causing damage to the snail and generally resulting in the snail ‘shedding’ thousands of cercariae, the
larval stages infective to the mammalian definitive host. The cercariae through an array of host-
seeking strategies locate their mammalian host and use specific enzymes to penetrate the skin, where
they change into schistosomula. The schistosomula utilize the venous blood system to migrate to the
lungs, then to the liver sinusoids where they develop oral suckers and commence blood feeding and
sexual development. In order for the female to reach sexual maturity the male must encircle her in a
“schist” called the gynaecological canal (Figure 3). Then the coupled schistosomes migrate to their
preferred ovipositioning site; the mesenteric veins for S. mansoni and the veins of the vesicle and
pelvic plexus for S. haematobium, where, via sexual reproduction, they ‘shed’ hundreds to thousands
of eggs. The eggs travel against the flow of the blood to the wall of the intestinal or urinary tract
depending on the species, penetrate the epithelium and travel down to be released in stool or urine
(Figure 4).
Human Pathology of Schistosomiasis
Mild dermatitis is known to occur at the onset of cercarial penetration through the skin, after which a
minority of people develop an acute febrile symptom, which appears to coincide with maturation and
early egg output of worms, known as Toxaemic schistosomiasis or Katayama fever (Jaureguiberry et
al., 2010). However the majority of people living in endemic areas suffer from the chronic,
progressive consequences of the disease which is linked to the immunogenic effect of the schistosome
eggs. As mentioned in the life cycle of schistosomes, worm pairing and sexual maturation occurs in
the venous system of the liver. Once sexually mature the male worms carry the females, travelling
against the blood flow, to the species-specific ovipositioning site, where the females release numerous
eggs into the mesenteric veins or the vesicular venous plexus, the eggs then have to migrate through
the lumen of the intestine or bladder in order to be voided with stool or urine excretion. This migration
through bladder or intestinal tract tissues causes the most obvious clinical symptoms such as
haematuria or diarrhoea with or without blood. Other consequences of this egg migration are ulcers,
granulomas, polypoidal lesions and pain on micturition or abdominal pain. However, it has been
estimated that over half of the eggs produced are washed back with the blood flow and remain trapped
in various tissues. The liver is the main site of egg deposition but common sites also include the
urinary and intestinal tract, the lungs (pulmonary schistosomiasis), the reproductive organs (genital
schistosomiasis) and other parts of the body. These trapped eggs trigger a typical eosinophilic
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inflammatory and granulomatous reaction by the host’s immune system which, without treatment,
generally progresses to fibrotic deposits (Gryseels et al., 2006). Specifically in sub-Saharan Africa,
urinary schistosomiasis, resulting from infection by Schistosoma haematobium, affects over 112
million people with associated pathology of haematuria affecting an estimated 70 million individuals
and an estimated 18 and 10 million individuals respectively suffer from major bladder wall pathology
and hydronephrosis with a high risk of progression to severe disease such as kidney failure and
bladder cancer (Botelho et al., 2009a; Botelho et al., 2009b; van der Werf et al., 2003; van der Werf et
al., 2002). Intestinal schistosomiasis in sub-Saharan Africa is mainly caused by infection with S.
mansoni, estimated to be the cause of bloody diarrhoea in 4.4 million people, and
hepatosplenomegaly, a severe clinical manifestation of the disease is estimated to affect 8.5 million
people (van der Werf et al., 2003). Additional subtle morbidities (such as chronic pain, growth
stunting and anaemia which are harder to quantify as they may have other etiological causes) together
with the afore mentioned severe manifestations all contribute to the global burden of Schistosomiasis
(King, 2007).
Schistosoma Control, Genetics and Evolution
Host-parasite interactions, and thus the outcome of infection, are comprised of three main
components; the environment, the host’s genetic background and the parasites genetic background.
Interplay of these factors contributes to the antagonistic co-evolutionary dynamics characteristic of
host- parasite relationships. Coevolution is evolution in one species in response to selection imposed
by a second species, accompanied by evolution in the second species in response to reciprocal
selection imposed by the first species (Janzen, 1980). Coevolution may be regarded as particularly
important in host-parasite systems because of the intimate nature of the association and the strong
selective pressures that each can exert on the other (Woolhouse et al., 2002). Host-parasite coevolution
is driven by the reciprocal evolution of host resistance (the genetic, biochemical and/or physiological
profiles that inhibit parasite establishment, survival and/or development within the host (Coustau et al.,
2000)) and parasite infectivity (the infective capacity of the parasite, when applied to suitable host
tissues, to produce the next infective stage) and/or virulence (parasite-induced host mortality/reduced
lifetime reproductive success (Read, 1994)), which together contribute to ‘compatibility’, the ability of
a given parasite to infect a given host. These factors all have a genetic background and thus are subject
to microevolutionary pressures such as, for example, those described by the frequency dependent
selection model i.e. the parasite will adapt to (infection and transmission success) the most common
host genotype which will (providing there is a large enough negative impact on the host) increase the
fitness, and consequently frequency, of rare host genotypes, therefore selecting for a reciprocal
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adaptation of rare parasite genotype etc ad infinitum. Such patterns of oscillating host-parasite
genotype frequencies in this coevolution model are referred to as Red Queen dynamics (Jaenike, 1978,
Bell, 1982, Hamilton, 1980, Ebert & Hamilton, 1996), a term first used to describe patterns of
extinction rates by Van Valen (1973) who suggested that in order for a species to survive in a given
niche or ecological zone where tightly co-evolving interactions between different species exist (e.g.
predator-prey, parasite-host), it must constantly adapt to a shifting biotic environment, through a series
of “moves” and “counter-moves” , in other words, a species must constantly evolve (or “run”) in order
to stay exactly where it is, hence the Red Queen reference from Lewis Carroll’s Through the Looking
Glass (Carroll, 1872). The Red Queen hypothesis is but one of several coevolution theories to explain
the patterns of genetic adaptation, others such as the ‘Cost-benefit trade off’ models are also of interest
such as the ‘Cost of Resistance’ theory in which it is suggested that the adaptation of resistance of a
host to a parasite is associated with a ‘cost’ to the hosts competitive fitness, such that in the absence of
the parasite the resistant genotype is less competitive and therefore less frequent than the susceptible
host genotype (Woolhouse et al., 2000, Woolhouse et al., 2002, Webster et al., 2001). Coevolution
between resistance and infectivity traits is ‘antagonistic’, i.e. their effects on the fitness of the host and
parasite are in opposite directions, their relative selective strengths being determined in part by the
level of parasite virulence. In contrast, whilst by definition increased virulence leads to decreased host
fitness, it may also lead to either decreased or increased parasite fitness and hence the potential for
either antagonistic or mutualistic coevolution (Ebert, 1994). The implications of host-parasite
coevolution for the medical and veterinary sciences, particularly in the context of infectious disease
epidemiology, are only just beginning to be recognised (Woolhouse et al., 2002). Coevolution may be
particularly important as a means of maintaining resistance and infectivity and/or virulence
polymorphisms (Thompson and Burdon, 1992) and has important repercussions for our understanding
of traits such as host-parasite compatibility, range and virulence. Likewise, understanding how
pathogens respond to evolved changes in host characteristics may provide a good model for their all
too apparent potential to respond to other kinds of change, such as the use of new drugs or vaccines to
combat disease (Ebert, 1998).
With the advent of modern molecular techniques such as Polymerase Chain Reaction (PCR) and DNA
sequencing, molecular markers are an ideal tool for research into the parasite’s and host’s genetic
components of these host-parasite interactions and of the impact of the method of treatment or control
used by parasite control programs. Such studies could elucidate the micro-evolutionary processes
driving the epidemiology and evolution of medically and economically important parasites such as
schistosomes. Today programs such as the Schistosome Control Initiative (SCI) use mass drug
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administration (MDA) either at the school or whole population level, to control the morbidity impact
of Schistosoma infections. So far SCI has helped over eight sub-Saharan countries (initially major
programs in Tanzania, Uganda, Zambia, Mali, Niger, Burkina Faso, Rwanda and Burundi, with
subsequent and/or complementary support to counties such as Cameroon, Cote d’Ivoire, Mozambique)
to develop, maintain and monitor schistosomiasis morbidity control programs (Fenwick et al., 2009).
The use of MDA as a means of morbidity control has potentially introduced new and strong selection
pressures on the local schistosome population especially with regards to potential emergence of
resistance to praziquantel (PZQ), currently the only available drug effective against all species of
schistosomes. There has indeed been evidence of differential response to PZQ treatment between
species and within species from both laboratory and field studies (Alonso et al., 2006; Doenhoff et al.,
2002; Gryseels et al., 2001; Ismail et al., 1999). The impact of MDA on schistosome evolution is of
paramount importance to such control programs since it has been theorised that the probability and
rate of drug resistance depends on; the underlying genetics of resistance, the frequency of resistant
genotypes in the population and the strength of selection imposed (Webster et al., 2008). The strength
of selection is influenced by several factors such as size of refugia in the population that was treated
and the relative fitness of the drug resistant parasites in the absence of drug induced selection (i.e. cost
of resistance). Studies have shown that reduced sensitivity to PZQ and/or PZQ resistance is a
genetically based phenotypic characteristic of certain schistosome genotypes (Liang et al., 2003)
however there is to this date no molecular marker for PZQ resistance or tolerance although this lack
has been recognised as an important issue in parasitic helminth control and an international consortium
for the development of single nucleotide polymorphism (SNP) markers for detecting anthihelmintic
resistance has been formed (Prichard et al., 2007). Another potential impact of MDA on parasite
adaptation and evolution regards the parasites life-history trait such as longevity, fecundity and
virulence. Virulence is of particular interest as the aim of schistosomiasis control is to reduce
morbidity in the human host. Theoretical studies suggest that though virulence can be detrimental to
the parasite by reducing their longevity in the host, in certain conditions, where longevity is likely to
be reduced, it can be beneficial, conferring to the parasite advantages such as increased transmission,
competitive dominance over a limiting resource, overcoming host defences (Frank, 1996; May and
Anderson, 1983). Theoretical studies have also suggested that virulence may be an adaptive
advantage in multiple or mixed genotype infections, as within-host competition may favour genotypes
or strains that exploit host resources rapidly thereby having higher transmission rates than competing
less virulent strains (Anitia et al., 1994). Thus treatment of a PZQ susceptible population of parasites
may indeed trigger evolutionary changes in the parasites virulence levels, either by reducing the
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longevity of the parasite thus favouring more virulent strains or, equally plausible, reducing intra-host
diversity, removing the advantage of virulent strains and thus selecting for less virulence. However,
concerning the evolution of virulence and the impact of treatment, it is also important to consider two
other key factors: the host’s immune system which may or may not behave or adapt differently when
faced with genetically diverse infections e.g. due to antigenic variation within and between species and
potential for strain-specific immunity (Cheesman et al., 2006; Gower et al., 2005; Mutapi, 2001;
Wijayalath et al., 2008), and the different conditions faced by a multi host parasite such as
schistosomiasis when infecting its intermediate host or as a free-living larvae, in which case the
competitive advantage or disadvantage of a virulent genotype may be reduced or altered in these
different conditions (Webster et al., 2008). Once again studies on parasite adaptation and impact of
treatment are hindered by the lack of molecular marker for potentially genetic life-history traits such
as virulence. Therefore, in the absence of specific markers for PZQ resistance/tolerance and parasite
virulence, neutral molecular markers, such as microsatellites, and thus analysis of population genetics
are the most effective way of elucidating the various factors influencing parasite genetic heterogeneity
and monitoring the impact of MDA on parasite adaptation and evolution (Curtis and Minchella, 2000;
Curtis et al., 2002).
Polyparasitism
Although polyparasitism is accepted as the rule rather than the exception in the developing world and
while there has been increased theoretical interest on the impact of polyparasitism, both in the
epidemiological and clinical sense (Ashford et al., 1992; Chunge et al., 1995; Ezeamama et al., 2005a,
b; Eziefula and Brown, 2008; Fleming et al., 2006a; Keiser et al., 2002; Keusch and Migasena, 1982;
Koukounari et al., 2010; Lyke et al., 2006; McKenzie, 2005; Nguhiu et al., 2009; Saldiva et al., 1999;
Silva et al., 2007; Tchuem Tchuente et al., 2003; Thiong'o et al., 2001), infectious diseases are still
being researched using an isolationists approach which though essential to our understanding of the
outcome of the infection and its epidemiology, may not be indicative of the complexity in the field.
Parasites such as schistosomiasis, soil-transmitted helminths, lymphatic filariasis, and onchocerciasis
and all other parasites collectively called Neglected Tropical Diseases (NTDs), occur in areas with
similar socio-economic (poverty stricken areas with poor sanitation and hygiene) and environmental
(e.g. humidity, temperature range) conditions with matching distribution patterns. In areas of high
endemicity, people are often infected by more than one parasitic species at any given time, i.e. they are
polyparasitized, and hence new control initiatives are targeting NTDs, notably helminths, as a group
with combined, rapid-impact treatment packages (Hotez et al., 2007a; Hotez et al., 2007c; Hotez et al.,
2006). When planning control strategies and public health measures it is important to consider how
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synergistic or antagonistic interactions of co-infections may clinically affect individuals and how co-
endemicity may affect the epidemiology of the parasites (Keusch and Migasena, 1982).
Polyparasitism may have a large impact on both the parasites and the host involved since it may affect
parasite growth, maturation, reproductive success and survival along with the susceptibility, morbidity
outcome and immune response of the host. For example synergistic mechanisms in hookworm and
Ascaris lumbricoides co-infections appear to produce higher egg counts for both parasites compared
with single infections (Fleming et al., 2006b). Infections with one species may increase the risk to
another pathogen, for instance genital schistosomiasis may render an individual more susceptible to or
at risk of acquiring immunodeficiency virus due to open lesions (Vennervald and Dunne, 2004).
However, the full mechanism/s involved and the effect of co-infections is very difficult to elucidate as
many factors from host-specific immunity, host behavioural/exposure differences, to parasite strain,
influence the outcome of such interactions. In the case of schistosomiasis, due to the increased use of
ecological modifications such as dam construction and irrigation schemes to channel water sources in
Africa (Steinmann et al., 2006), coupled with an increased migration level and subsequently
introduction of new infections to local areas and/or increased availability of naïve susceptible hosts to
local infections, shifts in the distribution of S. mansoni and S. haematobium have raised the likelihood
of sympatric associations between species and, schistosome co-infections in Africa (Cunin et al., 2000;
Cunin et al., 2003; De Clercq et al., 1997; Ernould et al., 1999; Friis et al., 1996; Garba et al., 2010;
Garba et al., 2004; Koukounari et al., 2010). Few studies have, however, looked at how co-infection
with both S. haematobium and S. mansoni affects the development and progression of schistosomiasis
nor how removal of parasite inter-specific interactions such as competition through differentially
effective treatment may impact morbidity reversal (Koukounari et al., 2010), alter re-infection rates
and/or increase the spread of drug tolerance i.e. affect the epidemiology and evolution of this
macroparasite. Polyparasitism and its’ associated inter-specific interactions be it competition for host
resources or altering host immune response in favour for certain parasites and to the detriment of
others, will undoubtedly affect the diversity of genotypes able to infect, or establish within, a
polyparasitized host. Thus inter-specific interactions between species in the same host may be
predicted to impact the genetic heterogeneity of each parasite involved which may have repercussions
regarding the genetic diversity and hence phenotypic plasticity of a local parasite population. This will
also potentially impact the evolution of life-history traits such as virulence and longevity, altering
transmission rates and hence epidemiology. Research into human schistosome co-infections could
yield crucial information of both theoretical and medical interest and greatly benefit the
implementation of control programs.
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Thesis Aims and Structure
As outlined from the previous section, the impact of S. haematobium and S. mansoni coinfections on
morbidity outcome and intra-specific genetic diversity remains largely unknown and understudied.
Indeed, the number of empirical studies addressing the impact of coinfections on morbidity and the
impact of treatment on said coinfections is surprisingly low considering how irrigation schemes and
damn constructions are increasing the risk of coinfections, as can be exemplified, for instance, through
recent reports on the emergence of new species in previously single-species schistosome endemic foci
(Garba et al., 2004). Yet, to the author’s knowledge, very few studies have looked at the impact of
inter-specific interactions on intra-specific diversity and genetic population structure of parasites,
though the impact of inter-specific interactions on parasite life histories where intra-specific genetic
diversity can play an important role, such as virulence, has been raised as a vital focus for future
research (Rigaud et al., in press). Therefore the principle aim of this research is to elucidate the
potential impact of schistosome species inter-specific interactions on host morbidity outcome and
parasite genetic population structure within the human host in sub-Saharan Africa. Results will be of
both theoretical and applied importance, in terms of improving our understanding of intra-host parasite
competition, evolution and the genetics of adaptation and virulence in this and other host-pathogen
systems, as well as enabling the interpretation of prevailing patterns of infection and disease, guiding
future disease control activities. Specific aims of this research project are to determine:
I. The presence of inter-specific interactions between the two major human schistosome
species in sub-Saharan Africa; S. haematobium and S. mansoni in natural human host
infections.
II. The effects of S. mansoni and S. haematobium co-infections and associated inter-specific
interactions on human host morbidity outcome.
III. The impact of inter-specific interactions in S. mansoni and S. haematobium co-infections on
parasite genetic diversity
IV. The impact of anti-schistosome praziquantel chemotherapy on co-infection, inter-specific
interactions and genetic diversity of S. mansoni and S. haematobium.
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To address these questions I, in association with field teams where applicable, collected morbidity data
and genetic material from parasitological surveys in two countries in sub-Saharan Africa. These data
collected and analysed are presented in three self-contained chapters, each with their own
Introduction, Materials and Methods, Results and Discussion sections, as well as tables and figures.
Firstly, Chapter 2 presents the species-specific morbidity data collected from school children in an S.
haematobium and S. mansoni co-endemic area in the Coastal province of Kenya. Statistical analysis
was used to determine whether there were difference in morbidity outcome between groups of children
split by infection status, i.e. single infected, coinfected or uninfected. Then to determine impact of
MDA with PZQ a further data collection survey was undertaken 12 months later and the species
specific morbidity data was analysed separately and then, where possible, longitudinally across time
points.
For Chapter 3 I collected schistosome genetic material from parasitological surveys undertaken for
CONTRAST pre treatment, 6 weeks post treatment, 6 months post treatment and 12 months post
treatment in two S. haematobium - S. mansoni mixed infection areas and 2 S. haematobium only
endemic areas in Niger, West Africa. Microsatellite markers developed by the Webster research group
at Imperial College (Golan et al., 2008; Gower et al., 2007) were used to determine the impact of
schistosome coinfections and PZQ treatment on the genetic diversity and population structure of S.
mansoni and S. haematobium in co-endemic and single species endemic settings.
In Chapter 4 the schistosome genetic material collected in the parasitological survey described in
Chapter 2 is presented to elucidate the impact of coinfections and PZQ treatment in a co-endemic area
in East Africa. Additionally in this chapter a new technique, previously only developed for S. mansoni
(Valentim et al., 2009), was optimised for S. haematobium and the benefits of this technique for future
research is discussed.
Finally in Chapter 5 the key findings of chapter 2-4 are brought together in a General Discussion
where the results of this thesis are discussed in terms of their implications on schistosome
epidemiology and evolutions, future research efforts and techniques and in relation to the control of
schistosomiasis in sub-Saharan Africa.
At the end of this thesis two Appendices (I-II) are attached relating to techniques used in Chapters 2-4,
as well as an additional Appendix (III) with results that were not included in chapters 3 and 4. A final
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Appendix (IV) includes the titles, abstracts, and/or full text where appropriate, of primary journal
papers I have co-authored to date as part of/in association with, this PhD thesis.
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Figures
Figure 1: Schistosoma species distribution
(taken from Gryseels et al 2001)
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Figure 2: Ideal transmission site, irrigation canal in Namarigoungou in Niger
Photo by Gouvras. A
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Figure 3: S. mansoni: male and female worm in copula
(from Smyth JD (Smyth, 1994))
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Figure 3: Schistosoma life cycle
Taken from CDC; http://www.dpd.cdc.gov/dpdx/HTML/Schistosomiasis.htm
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MORBIDITY OF MIXED VERSUS SINGLE INFECTIONS OF SCHISTOSOMA
MANSONI AND S. HAEMATOBIUM AT BASELINE AND 12 MONTHS POST
PRAZIQUANTEL TREATMENT IN KENYA, EAST AFRICA
Summary
Schistosomiasis is a debilitating parasitic disease caused by a digean trematode of the genus
Schistosoma. However the two species responsible for the majority of the disease in sub-Saharan
Africa are actually associated with two very different pathological profiles, as one S. mansoni is
associated with liver and intestinal tract damage, the other, S. haematobium is associated with bladder
and urino-genital tract damage. Thus previously the majority of surveys on schistosomiasis related
morbidity and the impact of mass drug administration (MDA) as a means of controlling the disease,
have concentrated on an isolationists, single species approach to monitoring the morbidity in the
human host. However it has only recently come to light that in areas where both species of
schistosomes are present, and where coinfections with both parasites are common, the outcome of the
species-associated pathology may be affected by subtle inter-specific interactions. It was therefore the
aim of this study to determine whether inter-specific interactions are indeed altering the impact of
species-specific morbidity measures and how this may affect the monitoring and outcome of MDA is
such co-endemic foci. A study was undertaken in two neighbouring schools in Taveta, Kenya.
Children were grouped by infection status i.e. uninfected, S. haematobium only infected, S. mansoni
only infected and coinfected. Clinical examination of the liver and spleen was performed and urinary
albumin levels were recorded at baseline. At 12 months post MDA these tests were repeated with the
addition of ultrasonographic profiles of the liver, spleen and bladder for a more differential diagnosis
of schistosome morbidity. It was found that S. haematobium associated morbidity, was lower in the
coinfected group relative to single S. haematobium infections even when accounting for infection
intensities. Thus an inter-specific interaction between the two species is suspected to affect the
outcome of urinary schistosomiasis in this focus. Little impact of coinfections on S. mansoni specific
morbidity was detected however interestingly there was an association of S. haematobium infections
with liver morbidity. Although there have been documented cases of this in the literature, S.
haematobium related liver morbidity is often ignored in the morbidity assessment of control programs.
The results presented in this study indicate that control programs should use two or more species-
specific morbidity indicators in areas of mixed S. haematobium - S. mansoni foci and monitor the
impact of S. haematobium on liver morbidity.
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Introduction
Schistosomiasis is a prevalent, chronic and debilitating disease caused by a parasitic digean trematode
(Schistosoma genus) which is estimated to infect over 200 million people with 700 million living at
risk of infection (WHO, 2002). Urinary schistosomiasis, resulting from infection by Schistosoma
haematobium, affects over 112 million people in sub Saharan Africa with associated pathology of
haematuria affecting an estimated 70 million individuals and an estimated 18 and 10 million
individuals respectively suffer from major bladder wall pathology and hydronephrosis with a high risk
of progression to severe disease such as kidney failure and bladder cancer (Botelho et al., 2009a;
Botelho et al., 2009b; van der Werf et al., 2003). Intestinal schistosomiasis in sub-Saharan Africa is
mainly caused by infection with S. mansoni, estimated to be the cause of bloody diarrhoea in 4.4
million people, and hepato-splenomegaly, a severe clinical manifestation of the disease is estimated to
affect 8.5 million people (van der Werf et al., 2003). Additional subtle morbidities (such as chronic
pain, growth stunting and anaemia which are harder to quantify as they may have other etiological
causes) together with the aforementioned severe manifestations have an estimated global health
burden of between 6 and 13.5 million DALYs (Disability Adjusted Life Years) (King et al., 2006)
though even this is believed to be an underestimation of the actual global burden of schistosomiasis
(King et al 2009).
In the developing world co-infections and polyparasitism are the norm especially since parasites such
schistosomiasis, soil-transmitted helminths, lymphatic filariasis, onchocerciasis, for example,
collectively called Neglected Tropical Diseases (NTDs), occur in areas with similar socio-economic
(poverty stricken areas, poor sanitation and hygiene) and environmental (e.g. humidity, temperature
range) conditions and often have matching distribution patterns. In areas of high endemicity people
are, therefore, often infected by more than one parasitic species at any given time, i.e. they are
polyparasitised, and hence new disease control initiatives are targeting NTDs, notably helminths, as a
group with combined, rapid-impact mass drug administration (MDA) treatment packages (Hotez et al.,
2007b; Hotez et al., 2007c; Hotez et al., 2006). When planning such control strategies and public
health measures it is important to consider how synergistic or antagonistic interactions of co-infections
may clinically affect individuals and how co-endemicity may affect the epidemiology of the parasites
(Keusch and Migasena, 1982). Polyparasitism may have a large impact on both the parasites and the
host involved since it may affect parasite growth, maturation, reproductive success and survival along
with the susceptibility, morbidity and immune response of the host. For example synergistic
interactions between hookworm and Ascaris lumbricoides co-infections appear to show higher egg
counts for both parasites compared with single infections (Fleming et al., 2006b). Polyparasitism may
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also affect the outcome of treatment. For example, regression of hepatomegaly after treatment with
praziquantel (PZQ) has been observed to be small in areas of high malaria exposure compared to areas
of low malaria exposure (Booth et al., 2004). However, the full mechanism and effect of such co-
infections is very difficult to elucidate as many factors from host-specific immunity to parasite strain
influence the outcome of such interactions. Indeed, another study on S. haematobium: Plasmodium
falciparum interactions has suggested that light infections of S. haematobium may have a protective
effect against malaria, by lowering P. falciparum densities (Briand et al., 2005). In contrast, infection
with one species may also increase the risk to another pathogen, for example genital schistosomiasis
may render an individual more susceptible to or at risk of acquiring human immunodeficiency virus
(HIV), and other sexually transmitted infections (STIs)due to open lesions (Vennervald and Dunne,
2004). Few studies have, however, looked at how intra-Genera co-infection with both S.
haematobium and S. mansoni may affect the development and progression of schistosomiasis. One
such study by Cunin et al, (Cunin et al., 2003) in Northern Cameroon investigated the relationship
between S. mansoni: S. haematobium inter-specific interactions and morbidity in humans. The authors
reported that S. haematobium: S. mansoni mixed infection appeared to have a lowering effect on S.
mansoni hepatomegaly and splenomegaly, relative to that observed for S. mansoni single infections. In
fact they reported an association between low frequency of S. mansoni related morbidity, S. mansoni
eggs in urine and high S. haematobium intensities (Cunin et al., 2003). In their paper it was suggested
that this lowering effect of mixed infection on morbidity could be due to S. haematobium males
mating with S. mansoni females and deviating the eggs to the urinary tract, thereby reducing the
amount of egg granulomas in liver tissues.
This hypothesis also had support from a laboratory study by Webster et al. (Webster et al., 1999)
which described heterospecific mating of S. haematobium; S. mansoni mixed infections in hamsters. S.
haematobium males were shown to be competitively dominant over S. mansoni males, due to a greater
ability to remove females from homospecific S. mansoni pairs. Heterospecific mating in schistosomes
can either produce hybrid offspring, notably when species are from the same group e.g. S.
haematobium and S. intercalatum, or parthenogenetic offspring occurring when species are from two
different groups e.g. S. haematobium and S. mansoni (Southgate et al., 1998). The shape of the egg
and notably the spine are formed by the female’s vitellaria, hence a S. mansoni female will produce
lateral spined eggs regardless of the species of the male. This supports the observation in the Cunin et
al. (Cunin et al., 2003) and others (Ernould et al., 1999) that the frequency of S. mansoni lateral spined
eggs in urine seemed to increase with increasing S. haematobium intensities. However the Cunin et al.
(Cunin et al., 2003) study did not consider potential S. haematobium-related morbidity, notably of the
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urinary tract. The inference could, nevertheless, be plausibly made that mixed infections involving S.
mansoni egg deviation to the urinary tract would exacerbate urinary schistosomiasis associated
morbidity. Yet conversely, a study by Friis et al. (Friis et al., 1996) using ultrasonography to detect S.
mansoni and S. haematobium related morbidity in Zimbabwean school aged children, found that S.
mansoni egg output was a significant predictor of liver size in the presence but not in the absence of S.
haematobium (Friis et al., 1996). Therefore one could speculate that an inter-specific interaction
between the two infecting species was aggravating S. mansoni related pathology. Of further interest is
the impact such an interaction may have on S. haematobium associated pathology. Whilst Cunin et al.
(Cunin et al., 2003) did not use any S. haematobium morbidity markers, Friis et al. (Friis et al., 1996)
did use ultrasonography to look at S. haematobium related urinary tract and bladder pathology, yet no
association was found for S. haematobium egg output or for the presence or absence of S. mansoni
(Friis et al., 1996). As this was a primarly school based survey (ages 6-19), one could propose that the
children may have been too young to exhibit significant S. haematobium related morbidity detectable
by ultrasonography although there is evidence of urltasonography being a useful and sensitive tool in
the detections of subtle S. haematobium and S. mansoni related morbidity in young human hosts
(Koukounari et al., 2006; Webster et al., 2009). Nevertheless, the authors of both studies advised
further research into S. mansoni and S. haematobium interactions and their effect on human morbidity
(Cunin et al., 2003; Friis et al., 1996). Thus recently a study looking retrospectively at the species-
specific associated morbidity measures in Mali found similar results to the Cunin et al. (2003) study in
Cameroon, where S. mansoni related morbidity was infect lower in coinfection relative to single S.
mansoni infections (Koukounari et al., 2010). A novel finding the Koukounari et al. (2010) study was
that, whilst S. mansoni associated morbidity was lower, S. haematobium associated morbidity was
higher in coinfections, thereby supporting the hypothesis that inter-specific interactions were in fact
deviating eggs away from the mesenteric venules, the ovipositioning site of S. mansoni, to the venus
plexus, the preferred ovipositioning site of S. haematobium and therefore switching differential
morbidity outcome in the human host (Koukounari et al., 2010)
As schistosomiasis control and research efforts such as those undertaken by the Schistosome Control
Initiative (SCI) and CONTRAST (a multidisciplinary consortium) are centred on the reduction and
prevention of schistosome-related morbidity, the impact of treatment on these potential schistosome
interactions is of paramount importance and interest, especially as different schistosome species and
even strains can have varying levels of sensitivity to PZQ, the drug of choice. A study conducted in
Senegal by Ernould and colleagues (Ernould et al., 1999) looked at the effect of MDA with PZQ in
three villages, one with S. haematobium only infections, one with S. mansoni only infections and one
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where both infections were highly prevalent. The treatment was effective against S. haematobium in
both single and mixed villages (reductions in prevalence’s from 64% to 12% and from 66% to 26%
respectively). However prevalence and infection intensity reductions were considerably less for
intestinal schistosomiasis (potentially due, at least in part, to high re-infection rates) in both the single
S. mansoni and mixed villages (reductions in prevalence from 59% to 45 % and 74% to 56%
respectively). Furthermore the authors found that in longitudinal surveys measuring the respective
prevalence and infection intensity of these parasites in the three villages, S. haematobium levels
remained well below pre-treatment levels in both the single and mixed village, whereas S. mansoni
prevalence levels increased to pre-treatment levels in the single species infection village and surpassed
pre-treatment levels in the mixed species infection village (prevalence of 93% and the average egg
excretion reached 108eggs/10ml (Ernould et al., 1999). In the mixed infection village the authors
observed that the prevalence of S. mansoni ectopic eggs was initially 31%, however this followed the
same pattern as S. haematobium, constantly decreasing throughout the survey in spite of increasing
intestinal schistosomiasis. It was therefore suggested that this weak reduction of prevalence of S.
mansoni infections was due to the removal of an inter-specific interaction between S. haematobium
and S. mansoni by PZQ treatment coupled with the differential re-infection transmission rates of the
two parasites species ultimately resulting in a significant increase in S. mansoni prevalence to above
pre-treatment levels. Such results further emphasize the requirement to fully determine the impact
schistosome inter-specific interactions may be having on the prevalence, morbidity and treatment
outcome in co-endemic foci.
The aim of this study was to determine whether schistosome-induced morbidity is different in mixed
S. mansoni – S. haematobium infections relative to single S. mansoni-or S. haematobium-only
infections and how annual MDA chemotherapy may affect such infection intensity and the morbidity
profiles of these two species. Unique to this study is the incorporation of two different methods of
assessing schistosome-species specific morbidity indicators at follow up (though, due to logistical
constraints, not at baseline): for S. mansoni associated morbidity we used clinical palpations and
ultrasonographic profiles of the liver and spleen, for S. haematobium associated pathology we used
ultrasonographic profiles of the bladder and urinary tract and urinary albumin levels, found to be a
good indicators of S. haematobium related urinary tract damage.
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Hypothesis
In areas of S. haematobium and S. mansoni co-endemicity, inter-specific interactions in coinfected
individuals will directly or indirectly affect the species-specific morbidity outcome. MDA with PZQ
will not only reduce morbidity but will also alter the inter-specific interaction leading to a change in
morbidity outcome.
Predictions
1. Morbidity resulting from intestinal schistosomiasis i.e. liver pathology, hepatomegaly and
splenomegaly will be more prevalent and more severe in single S. mansoni infections relative to
mixed S. mansoni – S. haematobium infections if indeed S. haematobium diverts the eggs to the
urinary tract during mixed infections, and likewise
2. If the above occurs then a higher incidence and level of urinary schistosomiasis morbidity would
be observed in mixed S. mansoni – S. haematobium infections relative to single infections
3. PZQ treatment will alter the impact of inter-specific interactions on the schistosome species
associated morbidity
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Materials and Methods
Study Area and population
Taveta is a small town in the Taveta District of the Coast Province in Kenya on the border with
Tanzania (GPS coordinates 3° 24' 0" South, 37° 41' 0" East, Figure 1). A baseline survey was
undertaken in two neighbouring schools within Taveta, Abori and Kilwalwa. These two schools were
randomly selected from a list of schools in the area where S. haematobium and S. mansoni co-
infections were prevalent (Kariuki C person.com). School children from classes 1 to 6 (ages 5 to 19)
were randomly selected and entered into the survey. Their infection status was determined by
parasitological examination and they were classified into four groups: those infected with S.
haematobium only; those with S. mansoni only; those infected with both species (co-infected); and
those infected with neither of these species (uninfected). Children were given a unique identification
number (which was used in the analysis to meet ethical requirements of anonymity) and their full
name, sex, age, height and weight was recorded. All children of both schools were treated with
40mg/kg praziquantel (PZQ) after the survey, at the same time as MDA across all the other schools in
the area. At 12 months post MDA follow-up, children were recruited and entered into the survey.
However when our survey was undertaken school teachers went on a nation-wide strike and hence
schools were closed. Whilst the headmasters of the two schools were aware of our survey, a lot of
children were not, however, present and had to be found one at a time. Some of them were out
working and inaccessible hence drop-out rates were higher than anticipated.
Parasitological examination
Stool and urine samples were collected from children from Abori and Kilwalwa. Double Kato-Katz
slides and urine filtration slides were prepared from each child. At baseline this was only performed
once per child due to logistical constraints, whereas at follow up the WHO recommended protocol of a
double Kato Katz over three consecutive days was followed (WHO, 2002). A 10 ml syringe was used
to filter 10 ml of urine through a millipore filter with 20μl pores. These filters where then inspected
under x40 magnification for S. haematobium eggs. If eggs were found, the number of eggs was
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counted as an indirect measurement of intensity of infection (egg/10ml). For stool examinations, a
small amount of stool was pressed through a sieve to remove large debris; the product was then placed
into a template on a slide which gave exactly 41.8mg of stool. The template was removed leaving this
specific measurement of stool on the slide. A strip of cellophane stained with glycerol and malachite
green was placed onto the slide and pressed down. Each slide was allowed to clear for 30min, and
then inspected at x40 magnification for S. mansoni eggs. For each positive slide (i.e. presence of
eggs) the eggs were counted to calculate intensity of infection (eggs/gram).
Clinical examination
Clinical palpation of the liver and spleen was performed on each child. The enlargement of the liver
beneath the Mid-Sternum line (MSL) and Mid-Clavicular line (MCL) was measured in cm.
Enlargement of the spleen around the Mid-Clavicular line and Mid-auxiliary (MAL) line was
measured in cm. Liver and spleen pathology was also assessed by palpation; i.e. liver tenderness and
consistency (not palpable, soft, firm and hard). All clinical palpations were consistently performed by
the same qualified individual who was blind to the parasitological results.
Urinary Albumin test
High albumin levels in urine samples are indicative of damaged kidneys and/or urinary tract
(Gansevoort et al., 2005). It has been shown in previous studies to be a good biochemical marker for
S. haematobium infections (Rollinson et al., 2005). A HemoCue Albumin photometer machine was
used to determine the level of albumin in urine samples provided by children with known infection
status i.e. infected with either S. mansoni only, S. haematobium only, co-infected with S. mansoni and
S. haematobium or uninfected by either. Albumin levels of above 30mg/l were considered indicative
of kidney and urinary tract damage (as outlined in manual) (Rowe et al., 1990).
Ultrasonography
Ultrasonographic profiles were performed by an experienced ultrasonographer following
recommended ultrasonography protocols (Figure 5) (Richter, 1996). The TDR practical guide for
ultrasound in schistosomiasis was used to standardize the results (Richter, 1996).
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Bladder: Standard examination of the bladder and upper urinary tract was used to detect lesions. The
Urinary bladder intermediate score was calculated from observations that are specific to S.
haematobium but do not necessarily represent severe morbidity. The Upper urinary tract intermediate
score was calculated to assess lesions associated with severe morbidity, but which are not necessarily
specific to schistosomiasis. For comparing between groups, the Positive Global Score was obtained
by adding the two intermediate scores for each individual.
The Liver and Spleen: The standard examination of the liver and spleen was used to detect periportal
fibrosis, portal hypertension and organomegaly. The Image pattern score was determined reflecting
abnormalities in liver texture; Periportal Thickening Score and Portal Hypertension was obtained for
signs of increase in portal hypertension. In addition, liver size and abnormalities were also recorded,
although it should be noted that variations in liver size are non-specific and are not necessarily due to
schistosomiasis. The size of the left liver lobe was measured in a longitudinal section in the left
parasternal line (PSL). The length was then adjusted for height using Annexe A as described in TDR
protocol. The right liver lobe was measured using the longitudinal section in the mid clavicular line,
this could not be adjusted for height using Annexe A as these scores were calculated for measurements
using longitudinal section in the right anterior auxillary view. Measurement of the spleen was
obtained by measuring in the left oblique view, recording the maximum length through the splenic
hilus. This was adjusted for body height (Appendix I).
Data analysis
Data from the original cohort, including those who dropped out during the follow-up, served as the
baseline data. Arithmetic mean intensity by single and dual infections was also examined at baseline
and follow-up for children who had complete data during the two time points of the study. Pathology
characteristics by infection status were examined for groups of children who had complete data for
these two parameters (i.e. parasitological and specific pathology exam) plus each specific time point
(i.e. baseline or follow-up). Result tables and figures together with 95% confidence intervals (CI)
were obtained using software SAS version 9.1 (SAS Institute, Cary, NC, United States of America).
As urinary albumin levels were collected pre and post MDA (as opposed to ultrasonography) the
following tests were done using SPSS version 16 (SPSS Inc. 233 S. Walker Drive, Chicago, Illinois
USA) to address the prediction that inter-specific interactions were increasing S. haematobium
associated morbidity. Firstly a Mann-Whitney U Test was used to compare mean albumin levels
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between genders at baseline and post MDA. If a significant difference was found than the following
testes were done separately for each gender at baseline and post MDA. Pearson product-moment
correlation coefficient was calculated to determine correlation between urinary albumin levels and S.
haematobium infection intensities after both measures had been transformed by Log 10 to meet
assumptions of normality. And finally a one-way between groups analysis of covariance (ANCOVA)
was used to compare albumin levels between infection status groups (single S. haematobium, single S.
mansoni, coinfected and uninfected) whilst controlling for S. haematobium infection intensities.
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Results
At baseline 470 children were recruited of which 50.85 % were males. The median age was 10 years
old (range: 5-19). Parasitological examination by single kato-katz and urine filtration revealed that 44
% of these children were infected by either single S. mansoni or S. haematobium or with both
(coinfected) (see Table 1 for percentages and numbers in each infection status group). At follow-up,
199 children were recruited and 54% were infected (see Table 1 for percentages and numbers in each
infection status group). The mean ages of children in each infection status group, along with 95% CI
limits, are shown in Table 2 for baseline and follow up respectively. It is important to note that the
mean ages across infection status groups were not significantly different, which is of paramount
importance when considering the morbidity measures detected in each infection status groups (i.e. the
age factor is effectively controlled for here).
Baseline Pathology Results
Liver pathology was assessed by clinical examination of 447 children and spleen pathology of 451
children. Figure 2a depicts what percentage of children pathology is in each infection status group at
baseline. Unusually 59% of children with liver pathology were uninfected whereas 34% of children
with liver pathology were actually infected with S. haematobium only. As for spleen pathology, 33%
of children with pathology were uninfected, 62% were in the S. haematobium only group.
Urinary albumin levels were collected from 94 children, 40 girls and 54 boys. Of those children that
had higher than 30ul/l of albumin in their urine i.e. that indicated urinary tract pathology (Rowe et al.,
1990) 15% were uninfected, 55% had S. haematobium only infections, 2% had S. mansoni only
infections and 28% were coinfected with both schistosome species (Figure 2a).
At baseline boys had significantly higher albumin levels than girls (Z = -2.754, d.f. = 1, P = 0.006).
For the following tests the data were split by gender in order to analyse separately. There was a strong
positive correlation between the two variables for boys (r = 0.839, n = 54, p< 0.0005) and for girls (r =
0.819, n = 40, p< 0.0005). In both sexes high levels of urinary albumin were associated with high
infection intensities (eggs per10ml). After adjusting for infection intensity there was a significant
difference between the urinary albumin levels of different infection intensity groups for boys (
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F=13.157, p= 0.0005, df = 3, eta squared= 0.446) and girls ( F= 3.708, p= 0.020, df= 3, eta squared=
0.241). There was a strong relationship between urinary albumin levels and infection intensities in
infection status groups for boys (eta squared= 0.345, p< 0.05, df= 1) and girls (eta squared= 0.241,
p<0.05, df= 1) (Tables 3 and 4 for table of means of urinary albumin and S. haematobium infection
intensities by infection status).
Post MDA Pathology Results
Liver pathology was assessed by clinical examination of 160 children and spleen pathology of 146
children. Figure 2b depicts percentage of children with each pathology characteristic by infection
status at follow up. As in baseline the uninfected group showed the largest percentage of liver
pathology but also spleen pathology (46% and 39% respectively). 27% of children with liver
pathology were infected with S. haematobium only whereas 11% were infected with S. mansoni only
and 15% were infected with both species. Of those children with spleen pathology 29% had S.
haematobium only infection, 8% with S. mansoni only and 23% were coinfected.
At follow-up liver pathology was also assessed using ultrasonography, specifically looking for S.
mansoni associated pathology along the left parasternal line, across 159 children. Figure 2b shows the
percentage of children with liver pathology as assessed by ultrasonographic measures along the left
parasternal line in each infection status group. Yet again the uninfected group showed the highest
percentage of children displaying liver pathology (38%). 33% of children with liver pathology were
infected with S. haematobium only, 13% S. mansoni only and 16% were coinfected.
Urinary tract pathology as assessed by urinary albumin levels higher than 30ul/l, 187 children were
assessed. 58% were infected with S. haematobium only and 28% were coinfected (Figure 2b). Urinary
tract damage as assessed by ultrasonography of the bladder and urinary tract used to calculate positive
global scores across 160 children. Of the children with urinary tract damage as assessed by
ultrasonography, 64% were infected with S. haematobium and 28% were coinfected (Figure 2b).
At follow up there was no significant difference between the albumin levels of boys and girls (Z = -
0.426, d.f. = 1, P = 0.670). It was not necessary to split data by gender. There was a strong positive
correlation between urinary albumin levels and S. haematobium infection intensities (r = 0.626, n = 95,
p< 0.0005). High levels of urinary albumin were associated with high infection intensities (eggs
per10ml). After adjusting for S. haematobium infection intensity, contrary to baseline, the difference
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between the urinary albumin levels of different infection intensity groups was not significant (
F=1.365, p= 0.246, df = 1, eta squared= 0.246). However there was a strong relationship between
urinary albumin levels and S. haematobium infection intensities in infection status groups (Eta
squared= 0.404, p< 0.005, df= 1 (Table 3 and 4 for table of means of urinary albumin and S.
haematobium infection intensities by infection status).
Longitudinal analysis results
Figure 3 shows infection status at baseline and follow-up for the 186 children with infection status
data at both time points. The first notable point here was the marked difference between the
percentages of children with S. haematobium-only infections. This decreased from 56% at baseline to
34% 12 months post treatment. There was also an increase in the percentage of uninfected children
from 30% at baseline to 44% 12 months post treatment. A small increase in co-infected children (9%
to 15%) was also observed. The percentage of children with S. mansoni-only infections showed
minimal change across the two time points.
Table 5a shows liver pathology as measured by clinical examination for the 148 children with
complete data at both baseline and 12 month post MDA. At baseline, 70 children had no apparent
pathology whereas at follow-up 87 of these children had no apparent liver pathology. There was an
increase in the percentage of uninfected with no pathology from baseline to follow-up. There was also
an increase in the percentage of coinfected with no pathology from baseline to follow up (3% to 7%)
but not so for S. haematobium only infections with no pathology (27% to 23%). Table 5b shows
spleen pathology as assessed by clinical examination for the 136 children that had complete data at
baseline and 12 months post MDA. At baseline 129 children had no spleen pathology whereas at
follow-up 106 had no pathology. There was an increase in the percentage of children that were
uninfected, S. mansoni only infected and coinfected with no pathology from baseline to follow up.
However percentage of children with no pathology and infected with S. haematobium decreased from
baseline to follow-up (51% to 24%). Table 5c shows the urinary tract pathology as assessed by
urinary albumin levels greater that 30mg/l for the 43 children that had complete data for both baseline
and 12 months post MDA. At baseline only 8 of these children had no apparent pathology whereas at
follow-up 26 of these children had no pathology. The percentage of children that were uninfected, and
those that had S. mansoni infection, and no pathology increased from baseline to follow up. Of those
children with urinary tract pathology as assessed by urinary albumin levels the percentage of those
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with S. haematobium only and of those that were coinfected decreased from baseline to follow up (S.
haematobium only 58% to 23% and coinfected 16% to 12%).
When considering infection intensity at baseline and follow-up in single-species infection compared to
co-infections, complete longitudinal datasets were available for 186 children. The arithmetic mean
was calculated for infection intensities of S. mansoni (eggs per gram) and S. haematobium (eggs per
10ml) in single and co-infections at baseline and follow-up (figures 4). The mean infection intensity
of S. mansoni decreased in coinfections from 71.9 epg to 15.2 epg, and for single S. mansoni
infections, from 37.2 epg to 10.6 epg at baseline and follow up respectively. The mean infection
intensity of S. haematobium decreased in single infections from 231.4 eggs per 10ml to 108.7 eggs per
10ml at baseline and follow up respectively. In coinfections, in contrast, the mean infection intensity
for S. haematobium increased from 178.19 eggs per 10ml to 185.92 eggs per 10ml at baseline and
follow-up respectively. However both these figures should perhaps be interpreted with caution as the
95% confidence intervals were rather large.
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Discussion
The primary aim of this study was to determine whether schistosome-induced morbidity is different in
S. mansoni and S. haematobium co-infections compared to single schistosome species infections. Four
groups of children were examined by clinical palpation for liver and spleen pathology and urinary
albumin levels at baseline with the addition of ultrasonography at follow-up; those infected with S.
haematobium only, those with S. mansoni only, those with schistosome co-infections and children
infected with neither of these two species (uninfected). From the literature I predicted that S. mansoni
associated morbidity would be lower in co-infected children relative to S. mansoni only infections due
to schistosome inter-specific interactions (Cunin et al., 2003; Koukounari et al., 2010). I also
predicted that urinary tract morbidity, measured by urinary albumin levels and ultrasonography at
follow up, would be higher in co-infections compared to S. haematobium only infections. The results
at baseline and follow-up did not, in general, support these predictions. However, there was evidence
of differences in morbidity in the different infection status groups with urinary tract damage indicating
an impact, direct or indirect of coinfections on morbidity outcome.
Of the children with liver pathology at baseline, 59% were uninfected and 34% were infected with S.
haematobium only, whereas the smallest percentage of those with liver pathology was associated with
S. mansoni only and coinfections. At follow-up a similar pattern was observed with uninfected and
single S. haematobium accounting for the majority of the liver pathologies as assessed by clinical
examination and ultrasonography. S. haematobium is known to cause low grade liver pathology in
humans hence the morbidity seen in S. haematobium only group may not be unusual (Abdelwahab et
al., 1992; Nafeh et al., 1992), although such morbidity measures are rarely assessed for this species
(Koukounari et al., 2010). However, what is unusual is the high percentage of those with liver
pathology that were currently uninfected (this may be due to other infections which will be discussed
below). Another unusual observation was that 62% of children with spleen pathology were infected
with S. haematobium only at baseline. Since 33% of children at baseline with spleen pathology were
uninfected this may in fact be due to other aetiological agents of spleen and liver morbidity, such as
malaria. Indeed it is possible that S. haematobium infections exacerbate the effect of these infections
on spleen morbidity as S. mansoni is suspected of doing (Wilson et al., in press). Although at follow-
up only 29% of those with spleen pathology (as assessed by clinical examination) were infected with
S. haematobium only and 39% were uninfected making it more likely that this pathology is due to
another infection rather than an effect of S. haematobium.
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One could have assumed that the pathology observed here within the uninfected group could
potentially have been simply a factor indicative of age, with potentially older children having been
exposed to more diseases, including previous (and previously cleared) schistosome infections),
affecting the liver and spleen thus showing more pathology. However, indication that this is not a
sufficient explanation within the current study may be provided through a comparison of mean age
between infection status groups, where there were no significant differences in age groups between
infection status groups, at either baseline or follow-up. Hence, in other words, it appears highly
unlikely that this pathology is due to past schistosome infections and subsequent pathology, now
resolved or no longer shedding eggs. Other infections or conditions that result in similar clinical
symptoms of the liver and spleen such as malaria, leishmania, malnourishment and sickle cell anaemia
are plausible explanations, although again it may not be apparent why they should differentially
impact the schistosome uninfected group here. However, one plausible explanation for the observed
higher liver morbidity levels recorded within the schistosome uninfected group here may perhaps lie
with another trematode species, the ruminant fluke belonging to the genus Fasciola. Indeed , a recent
study in Taveta has detected high prevalences of F. gigantica in cattle and sheep (Mungube et al.,
2006), and other studies have shown that Fasciola can be a zoonotic human disease and cause damage
to the liver (Dorny et al., 2009). Furthermore, studies have shown that infection with Fasciola inhibits
infection by schistosomes - where the immunological response caused by a Fasciola infection in the
murine model provides cross immunity to schistosomes (Carabin H. pers.comm in humans, quotes on
animal models (Haroun and Hillyer, 1988; Hillyer, 1984; Hillyer, 2005; Yagi et al., 1986)). At the
very least we propose that further research into the potential infection and interaction status of
Fasciola and Schistosoma in humans is highly warranted.
Urinary tract damage as assessed by urinary albumin levels greater than 30mg/l was clearly associated
with S. haematobium infections as 55% of children with urinary tract damage were infected with S.
haematobium only. A strong correlation was found between infection intensity measured by eggs per
10ml and urinary albumin levels in boys and girls. Interestingly coinfections could only account for
28% of children with this urinary tract pathology possibly indicating an effect either direct or indirect
of inter-specific interactions especially as S. haematobium infection intensity measured by eggs per
10ml between S. haematobium only infections and coinfections were not that different at baseline
(Table 4) and a significant difference was found between the urinary albumin results of each infection
status group even when controlling for S. haematobium infection intensities. Although the biological
process behind this effect is unknown there are few plausible explanations: Firstly, one could propose
that the lowered urinary albumin levels in coinfections could simply be the result of the presence of S.
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mansoni eggs in the liver and subsequent damage, decreasing the output of the albumin protein in the
blood thereby reducing the amount of protein that seeps out of the damaged membrane of the vesicle
plexus into the bladder. Thus lower levels of urinary albumin are observed in infections of both
species compared to just S. haematobium alone where S. mansoni eggs are absent from the liver. One
could also stipulate that whatever is causing the liver pathology in the uninfected children could be
having a synergistic affect with S. mansoni on the liver of coinfected individuals thereby further
reducing the production of albumin by the liver. A way to test this hypothesis may be to measure the
levels of blood albumin in uninfected, S. haematobium and S. mansoni single and coinfected
individuals. However this does not explain the lower bladder pathology as assessed by Positive
Global Scores using ultrasonography in the coinfected group relative to single infections at follow-up.
Here the morbidity measure is more direct, measuring the pathology via ultrasound on the bladder
wall, and more species specific as these pathologies have been associated directly with the presence of
S. haematobium eggs in the bladder tissues (Richter, 1996). We can hypothesize that this may be due
to the phenomenon of hetero-specific pairing as inferred by Cunin et al. (Cunin et al., 2003) however
in this case this hetero-specific pairing and possible divergence of the eggs to one predominant
ovipositioning site causes the decrease of S. haematobium related morbidity observed in the coinfected
group compared to single S. haematobium infections. Thus we can stipulate that in Taveta co-
infections with S. mansoni and S. haematobium leads to predominately S. mansoni male – S.
haematobium female pairings resulting in the majority of eggs being released in the mesenteric veins
thus less eggs are being trapped in the urinary tract and bladder. Unusually the follow up data for
urinary albumin did not find a significant difference between infection status groups once controlling
for S. haematobium infection intensities and one can see that S. haematobium infection intensity is
slightly higher in coinfected relative to single S. haematobium infected group at follow up (Table 4).
Nevertheless this result further highlights the uniqueness and importance of the ultrasonography
results as despite this difference in infection intensities between infection status groups less urinary
tract pathology is being detected in the coinfection group relative to single S. haematobium infections.
Of course another explanation for the lower pathology witnessed in the co-infected group both at
baseline and at follow-up could be due to a phenomenon called heterologous immunity, a term coined
by Le Roux in the 1960’s used to explain infection resistance or a reduction in worm count or worm
fecundity of one species due to an immune response triggered by the primary infection by another
species (Taylor, 1991). Many studies of heterologous immunity to schistosomes have been done in
animal models but few have looked at the effects in schistosomes infecting humans. Heterologous
immunity remains a controversial subject with differing opinions on its importance in parasite
epidemiology.
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At follow up the percentage of children with S. haematobium only infections was significantly less
than at baseline (34% and 56% respectively figure 3) and the percentage of uninfected children
increased (30% at baseline to 44% at follow up, figure 3). These are encouraging results seeing as the
transmission rate of S. haematobium in the area is quite high (Kariuki C person. com.). Notably the
percentage of coinfected children also showed a small yet noticeable increase from baseline to follow
up (9% to 15%) although to be considered cautiously since at follow-up the diagnosis for S. mansoni
was more sensitive compared to baseline. However it is possible that this increase was also due to the
effect of treatment on a direct or indirect inter-specific interaction between S. haematobium and S.
mansoni. This effect may be due to a differential treatment response to PZQ of these two species,
whereby S. haematobium is successfully removed but S. mansoni is not and/or the removal of the
competitively dominant S. haematobium from certain susceptible hosts has allowed S. mansoni to
establish itself before any primary (and antagonistic) S. haematobium infection occurring (e.g.
heterologous immunity triggered by S. haematobium to the detriment of S. mansoni).
When considering the longitudinal data of the 148 children with liver pathology as assessed by clinical
palpation, the number of children without liver pathology increased (Table 5a). The percentage of
uninfected children with no apparent pathology was higher at follow up than at baseline, which may
indicate that treatment with PZQ and thus removal of schistosomes can resolve liver pathology
symptoms. Conversely the longitudinal data for spleen pathology indicated a decrease in number of
children without spleen pathology as assessed by clinical palpation (Table 5b) at baseline (129) and
follow up (106) and this seemed to be linked with a decrease in percentage of children with S.
haematobium only and no spleen pathology (51% at baseline and 24% at follow up). This may be
linked to other aetiological causes of spleen pathology in conjunction with S. haematobium infections
such as malaria. The longitudinal data for urinary tract damage as assessed by microalbuminurea
should be interpreted with caution as the sample size here was rather small (43 children).
Nevertheless, there was a decrease in the number of children with urinary pathology, and the
percentage of uninfected children with no pathology is noticeably higher in the follow up data than at
baseline (40% and 14% respectively) which highlights the benefit of at least annual MDA with respect
to reduction in the frequency of specific morbidity in treated children.
A major study design constraint to be considered is that only one duplicate Kato-Katz smear was done
per child at baseline. The recommended method is to do duplicate Kato-Katz smears over three
consecutive days so as to increase the sensitivity of the test. However due to time constraints at
baseline only one duplicate Kato-Katz smear could be processed per child. Thus our actual infection
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intensity measures are likely to be inaccurate and our controls may not be uninfected but the single
duplicate Kato-Katz smear failed to pick up light infections. The follow up study used duplicate Kato-
Katz over three consecutive days. This aided in identifying light S. mansoni infections and increased
sample size of single S. mansoni infections as well as provides more accurate infection intensities and
actual uninfected controls thus we are likely to have detected more infected individuals at follow up
relative to baseline therefore our results possibly underestimates the reduction in prevalence pre and
post treatment. Additionally at follow up a larger sample size for urinary albumin test was also used
to increase power of statistical analysis however the MDA appears to have had an impact on the inter-
specific interactions observed at baseline since ANCOVA did not find a significant difference in
albumin levels by infection status groups post treatment when controlling for infection intensities. It
suggests that post MDA urinary albumin levels, contrary to urinary tract pathology as assessed by
ultrasonography) is less likely to be effected by inter-specific interactions thus highlighting the
importance of using more than one morbidity measure to assess the impact of coinfections in an S.
haematobium – S. mansoni foci on human host morbidity outcome and MDA.
In summary, the objective of this study was to determine whether schistosome induced morbidity is
different in S. mansoni and S. haematobium coinfections compared to single infections. Our results
indicate that some form of inter-specific interactions between S. mansoni and S. haematobium may be
affecting, directly or indirectly, S. haematobium associated morbidity as measured by urinary albumin
levels and ultrasound positive global scores. These findings raise some interesting questions regarding
polyparasitism and host-parasite dynamics, and underline the importance of further research into inter-
specific interactions on parasite disease morbidity and treatment.
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Figures
Figure 1: Map of Taita and Taveta distict
From : United Nations Office for the coordination of humanitarian affairs (ochaonline.un.org)
TAVETA
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Figure 2a: Percentage of children (number of children) displaying each pathology characteristic by
infections Status at baseline
Figure 2b: Percentage of children (number of children) displaying each pathology characteristic by
infections status at follow-up
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Figure 3: Percentage of children (186 children) in each infection status group at baseline and follow-
up with 95% CI
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Figure 4a: Mean of S. mansoni intensity of infection (epg) in single and coinfections at baseline and
follow-up (number of children)
Figure 4b: Mean of S. haematobium intensity of infection (eggs/10ml) in single and coinfections at
baseline and follow-up (number of children)
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Figure 5: Ultrasonography in Taveta
Photo by Gouvras. A
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Tables
Table 1: Number and percentage of children in each infection status group at baseline and follow-up
Baseline
Infection Status
Number of children Percentage of children
S. mansoni 15 3.2
S. haematobium 155 32.7
Co-infected 33 7.1
Uninfected 267 57
Total 470 100
Follow-up
Infection Status
Number of children Percentage of children
S. mansoni 14 7.0
S. haematobium 64 32.2
Co-infected 30 15.1
Uninfected 91 45.7
Total 199 100
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Table 2: Mean Age by Infection Status at baseline and follow-up with 95% CI limits
Baseline
Infection Status
Mean Age 95% CI
Coinfected 11.7 11.1 to 12.3
Uninfected 9.5 9.2 to 9.8
S. haematobium only 10.1 9.7 to 10.4
S. mansoni only 11.1 9.8 to 12.4
Follow-up
Infection Status
Mean Age 95% CI
Coinfected 10.43 9.4 to 11.4
Uninfected 10.01 9.4 to 10.6
S. haematobium only 11.14 10.6 to 11.7
S. mansoni only 10.86 9.3 to 12.4
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Table 3: Mean Urinary Albumin by Infection Status at baseline and follow-up
Baseline
Infection Status
Mean Urinary Albumin
Levels (mg/l)
95% CI
Coinfected 483.16 325.61 to 640.70
Uninfected 23.17 12.68 to 33.65
S. haematobium only 668.76 451.08 to 886.43
S. mansoni only 34.61 10.78 to 60.65
Follow-up
Infection Status
Mean Urinary Albumin
Levels (mg/l)
95% CI
Coinfected 283.63 140.63 to 426.64
Uninfected 16.64 12.25 to 21.04
S. haematobium only 282.37 171.15 to 393.58
S. mansoni only 8.64 5.44 to 11.84
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Table 4: Mean S. haematobium infection intensity by Infection Status at baseline and follow-up
Baseline
Infection Status
Mean S. haematobium
(eggs/10ml)
95% CI
Coinfected 227.62 103.4 to 351.8
Uninfected 0 0
S. haematobium only 204.52 158.5 to 250.6
S. mansoni only 0 0
Follow-up
Infection Status
Mean S. haematobium
(eggs/10ml)
95% CI
Coinfected 177.7 99.2 to 256.2
Uninfected 0 0
S. haematobium only 100.9 60.6 to 141.2
S. mansoni only 0 0
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Table 5a: Frequency numbers for liver pathology as assessed from clinical exams by infection status at
baseline and follow-up (from dataset with n=148-longitudinal data)
Time
Baseline Follow-up
Infection status
No pathology Pathology No pathology Pathology
Not Infected 20 (13.51) 28 (18.92) 38 (25.68) 28 (18.92)
S. haematobium only 40 (27.03) 44 (29.73) 34 (22.97) 17 (11.49)
S. mansoni only 5 (3.38) 1 (0.68) 4 (2.70) 6 (4.05)
Co-infected 5 (3.38) 5 (3.38) 11 (7.43) 10 (6.76)
Total 70 78 87 61
Note: Overall percentages are given in brackets within each cell of the above table.
Table 5b: Frequency numbers for spleen pathology as assessed from clinical exams by infection status
at baseline and follow-up (from dataset with n=136-longitudinal data)
Time
Baseline Follow-up
Infection status
No pathology Pathology No pathology Pathology
Not Infected 47 (34.55) 0(0.00) 54 (39.71) 11 (8.09)
S. haematobium only 69 (50.74) 6 (4.41) 32 (23.53) 9 (6.61)
S. mansoni only 4 (2.94) 1 (0.74) 7 (5.15) 3 (2.20)
Co-infected 9 (6.62) 0 (0.00) 13 (9.56) 7 (5.15)
Total 129 6 106 30
Note: Overall percentages are given in brackets within each cell of the above table
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Table 5c: Frequency numbers for pathology as assessed by albumin levels>30 mg by infection status
during 2 years (from dataset with n=43-longitudinal data)
Time
Baseline Follow-up
Infection status
No pathology Pathology No pathology Pathology
Not Infected 6 (13.95) 2 (4.65) 17 (39.53) 2 (4.65)
S. haematobium only 1 (2.33) 25 (58.14) 4 (9.30) 10 (23.26)
S. mansoni only 1 (2.33) 1 (2.33) 4 (9.30) 0 (0.00)
Co-infected 0 (0.00) 7 (16.28) 1 (2.33) 5 (11.63)
Total 8 35 26 17
Note: Overall percentages are given in brackets within each cell of the above table
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THE IMPACT OF COINFECTION AND CHEMOTHERAPY ON THE
POPULATION GENETICS OF SCHISTOSOMA HAEMATOBIUM AND S.
MANSONI WITHIN SINGLE AND MIXED INFECTION FOCI OF NIGER AS
DETERMINED BY MULTILOCUS MICROSATELLITE ANALYSIS
Summary
Schistosoma haematobium and S. mansoni, the major causative agents of schistosomiasis in Africa,
often have overlapping distributions, and hence can lead to mixed species infections within the same
human host. Such co-infections and indeed co-endemicity may, through potential inter-specific
interactions, be predicted to impact epidemiological and evolutionary traits and thus have important
consequences for control strategies. For instance, any differential impact upon genetic variation and
heterogeneity may determine aspects of host specificity, parasite virulence and reproductive fitness.
In order to characterize any potential genetic variation in areas of co-endemicity, miracidia collected
from single and/or mixed-species infected children from across four contrasting villages in the south
west region of Niger, West Africa, were genotyped using multiplex microsatellite analyses. It was
found that for Namarigoungou, and to a lesser extent Diambala, two villages endemic to both species
of schistosomes, allelic richness was significantly higher in S. mansoni coinfections compared to
single S. mansoni infections. There was also evidence of a non-significant trend of higher allelic
richness in S. haematobium coinfections relative to single infections, potentially indicative of inter-
species competitive interactions within their hosts. Furthermore, in coinfected villages, it was
apparent that S. haematobium was rapidly being replaced by S. mansoni after praziquantel treatment,
as no eggs hatched from samples collected post treatment whereas S. haematobium in single species
villages persisted post treatment. However, in contrast to that recently observed for S. mansoni in East
Africa, no generalized post praziquantel genetic bottleneck appeared to be occurring for either species
here in West Africa, within single or coinfection villages, with the exception of Diambala where small
yet significant structuring was observed across treatment time points. The potential effects of such
interactions on parasite transmission and control are discussed.
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Introduction
The three main components impacting on host-parasite interactions are the external abiotic
environment, the host species’ ever-changing antagonistic environment and the parasites' diverse
mechanisms of overcoming the host’s defenses. Even for parasites with single-host life cycles, the
diversity of their particular host population requires reciprocal adaptation of parasites in the parasite
population to ensure local survival and reproduction. For any parasite with an indirect life cycle
involving two very different obligatory hosts, such as from invertebrate to vertebrate host as is
inherent within the Schistosoma spp., the stochastic nature of transmission dynamics from one host to
another can randomly remove potentially successful parasites. Likewise, as each host system
represents a differentially dynamic hostile environment, the schistosome population must be able to
adapt and co-evolve in order to survive. It is therefore not so surprising that schistosome species show
significant intra-specific phenotypic differences (Davies et al., 2002b; Haas, 2003; Kalbe et al., 2004;
Moné and Fournier, 1994; Norton, 2006; Norton et al., 2008)to name a few) and genotypic diversity
(Davies et al., 1999; Fallon et al., 1995; Lu et al., 2010; Norton et al., 2010; Pinto et al., 1997; Rudge
et al., 2008; Rudge et al., 2009; Sire et al., 2001; Stohler et al., 2004; Theron et al., 2004).
Furthermore, whilst recent studies addressing the impact of inter-specific interactions within hosts on
the establishment, reproduction and/or virulence of parasite species highlight the importance and need
of further research in multi-host-multi parasite systems to elucidate mechanisms of evolution and
ecology in the host-parasite model (Rigaud et al., in press; Sandland et al., 2007), surprisingly little
empirical research has, however, yet been initiated to understand the impact of inter-specific
interactions on intra-specific diversity and, in particular, parasite population structure. Indeed, the
lack of population genetic studies in this area may be perhaps the most surprising considering the role
intra-specific interactions can play in maintaining genetic and phenotypic diversity across a range of
key traits of theoretical and applied importance, included that relating to the evolution of virulence in a
population (Choisy and de Roode, 2010; Davies et al., 2002a; Gower and Webster, 2005; May and
Nowak, 1995).
To the authors knowledge there has been no research done on the impact of schistosome species
coinfections on intra-specific genetic diversity. Yet different schistosome species have similar
epidemiological settings and are known to infect the same intermediate and/or definitive host species
(Cosgrove and Southgate, 2002; Cunin et al., 2003; Dewitt et al., 1964; Norton et al., 2008; Pages and
Theron, 1990; Tchuem Tchuente et al., 1995; Tchuente et al., 1994; Webster et al., 2006; Webster et
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al., 1999; Webster et al., 2004; Zwingenberger et al., 1990). It is therefore highly plausible to expect
inter-specific interactions as the two, or more, parasite species compete for the same ecological niche,
nutritional resources and even mates within the same host. Moreover, in the case of S. mansoni and S.
haematobium within their definitive host, both parasite species migrate to the hepatic portal system to
undergo growth and sexual maturation, and hence are likely to be directly competing for resources at
this stage. Another source of potential competition lies in the fact that schistosomes, in contrast to all
other members of the Trematoda phylum, are dioecious and pairing is obligatory in order for the
female worm to attain sexual maturity. This pairing occurs in the hepatic portal system of the
definitive host, after which the male carries the female to the ovipositioning site which is species
specific (the mesenteric venules for S. mansoni and the venus plexus for S. haematobium, thereby
accounting for the different egg excretion routes for each species - i.e. eggs in stool and eggs in urine
respectively). Whilst it was originally assumed that, once paired, schistosomes remained
‘monogamous’ for the entirety of their lives (Tchuem Tchuente et al., 1996; Tchuem Tchuente et al.,
1995), more recent studies have, however, revealed that the opposite can be true, depending on
circumstances, where competition for mates and mate ‘switching’ occurs as the norm, especially since
natural infections are often gender biased with a predominance of male worms and males worms
therefore compete for another limiting resource, the female worm (Southgate et al., 1998; Tchuem
Tchuente et al., 1996; Tchuem Tchuente et al., 1995; Webster et al., 1999). Furthermore, another
recent finding has revealed that, in certain mixed species schistosome infections, male worms can
form heterologous pairing i.e. mate with a female worm from another species (Southgate et al., 1998;
Tchuem Tchuente et al., 1996; Tchuem Tchuente et al., 1995; Webster et al., 1999). Such
heterologous pairings will either result in hybridization and hybrid eggs when the two schistosome
species in the pair are from the same group (S. haematobium group, S. mansoni group, S. japonicum
group see general introduction) or will reproduce via parthenogenesis resulting in offspring of the
same species as the female but excreted in the species-specific ovipositioning site of the male
(Cosgrove and Southgate, 2003a, b; Southgate et al., 1995; Tchuem Tchuente et al., 1995; Webster et
al., 1999), thereby explaining the phenomenon of ectopic eggs (eggs of one species being excreted in
another species preferred ovipositioning site e.g. S. mansoni eggs in urine) often observed in mixed
species infection areas (Cunin et al., 2003; Ernould et al., 1999). Studies have also shown that where
coinfections occur, although homologous pairings appear to be preferred by all species, when unpaired
males are present inter-specific competition for mates exists and one species will normally be more
dominant in ‘stealing’ mates from the other species (Southgate et al., 1995). Laboratory experiments
on S. haematobium and S. mansoni coinfections have also detected the occurrence of inter-specific
competition for females and the formation of heterologous pairs leading to parthenogenetic (Webster
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et al., 1999). In the study by Webster et al. (Webster et al., 1999), S. haematobium males were
competitively dominant over S. mansoni males and removed females from S. mansoni males in
homologous or heterlogous pairs, when females were scarce.). There has indeed been evidence of this
inter-specific competition occurring in mixed S. haematobium –S. mansoni foci in the field as
evidenced by the reporting of ectopic eggs which have now been shown to be less likely due to a spill
over effect of high infection intensities and more likely to heterologous pairing between S. mansoni
and S. haematobium (Cunin et al., 2003; Ernould et al., 1999). Such inter-specific interactions need to
be further researched in an epidemiological and evolutionary setting as they potentially have an impact
on the outcome of transmission (Ernould et al., 1999), differential S. mansoni or S. haematobium
morbidity (chapter 2) and on the genetic population characteristics of both species. Furthermore,
elucidating the microevolutionary factors shaping the epidemiology of schistosomiasis is paramount
especially to current control programs that rely on the mass drug administration (MDA) of the only
currently available drug, praziquantel (PZQ), to control the morbidity burden of this socio-
economically important disease. In the absence of molecular markers for PZQ tolerance/resistance
and/or for virulence, population genetics provides a fundamental tool for the monitoring of potential
emergence of resistance to PZQ, to determine genetic factors that may influence morbidity outcome
on the human host and to elucidate the impact of different MDA strategies in different settings on the
parasites genetic and phenotypic plasticity. Although PZQ resistance has only been detected in a few
cases, despite, in certain areas/countries years of MDA (e.g. Egypt and China), recent evidence has
reported a potential significant impact of MDA on the population genetics of S. mansoni under certain
conditions (Norton et al., 2010). In two schools in Tanzania, the genetic diversity of the S. mansoni
population was significantly reduced compared to pre treatment levels. This strong bottleneck effect
one year after MDA was surprising considering the supposedly large refugia (untreated, immature
stages, larval and intermediate host stages), large generation lengths and potential cost of resistance
observed in schistosome populations (Webster et al., 2008). It was suggested that this bottleneck
could have been due to a combined effect of the treatment of 7 to 11 year old children (the optimum
age group for schistosome transmission) and PZQ-assisted partial acquired immunity whereby treated
children may be less susceptible to infection with genotypes closely related to the ones they were
infected with prior to treatment, thereby greatly reducing the effective population size of S. mansoni
post MDA. An alternative, more concerning potential explanation, may indicate a novel selection
pressure imposed by the MDA on the S. mansoni population thereby, increasing the frequency of
certain alleles/genotypes, potentially more tolerant of PZQ or able to withstand the host’s PZQ-
assisted immune response (Norton et al., 2010). Clearly further studies, including those using neutral
markers such as microsatellites, are necessary to monitor the impact of MDA on the local parasite
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population. This may also be particularly pertinent for S. haematobium where molecular research has
lagged far behind ((Rollinson, 2009); and see chapter 4 of this thesis).
I propose here to use multilocus microsatellite analysis, as described in Gower and colleagues (Gower
et al., 2007) and a new unpublished assay partially amended from Golan and colleagues (Golan et al.,
2008), to determine the potential impact of inter-specific interactions within the human definitive host
on intra-specific genetic diversity. The technique described in Gower et al. (Gower et al., 2007)
allows direct sampling from the definitive host thereby, in addition to its ethical superiority, avoids
any potential selection bias and “bottleneck effect” that occur in laboratory passaged samples.
Microsatellites are appropriate molecular markers for this study as they are co-dominant, polymorphic
and selectively neutral (not under any selective pressure) and enable us to look at the genetic diversity
and population structure of infra-populations (all the parasites in an individual host) and component
populations (all the parasites of a given species in an entire host population) (Jarne and Lagoda, 1996;
Rodrigues et al., 2002).
Hypothesis
In the schistosome life cycle the site of growth, sexual maturation and pairing for all human
schistosome species is the hepatic portal system. Therefore one can predict that inter-specific
interactions such as competition for resources, density-dependent factors and mate pairing will
differentially affect the establishment and reproduction of schistosome genotypes thereby altering the
intra-specific genetic diversity of each species.
Predictions
1. Inter-specific interactions, whether direct via competition for resources or indirectly via the
hosts immune system, will reduce the range of different genotypes of either species able to establish in
a coinfected host therefore intra-specific genetic diversity will be reduced for both species in mixed
infections infra-populations (population of parasites in an infected individual) relative to single species
infection infra-populations when controlling for infection intensities (using allelic richness rather than
allelic numbers).
2. Intra and inter-specific diversity will be reduced post treatment compared to baseline for both
species when controlling for infection intensities as treatment with PZQ is known to aide in the partial
acquired immunity to schistosomes therefore the number of different genotypes able to establish a
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previously treated host will diminish, thereby reducing intra-specific genetic diversity. And
additionally as PZQ is known to be differentially effective against the two species and indeed against
different genotypes within species it can be assumed that MDA will bias future infections towards the
species or genotypes that are more tolerant of PZQ or at least have a life history trait that becomes
advantageous post MDA. Therefore inter-specific competition will be altered and potentially its
impact, or evidence of its impact, will be removed.
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Materials and Methods
Study Sites
Parasite samples were collected from four villages in the south west region of Niger, West Africa:
Namarigoungou, Diambala, Libore and Falmado (Figure 1). Namarigoungou and Diambala, two
neighbouring villages located in Tillaberi Department north of the capital Niamey (14.313 N, 1.300
E), are located in the Niger River Valley and are adjacent to the Niger River. The main livelihood in
these villages is the cultivation of rice, the paddies for which are irrigated via numerous canals from
the river. The Tillaberi Region was a known S. haematobium focus, although in 2001 an extensive
malacological survey was conducted and Biomphalaria pfeifferri, a major intermediate host species
for S. mansoni, was identified in five villages in this region (Labbo et al., 2003). Consequently, a
parasitological survey was conducted in 2002/2003 and S. mansoni was found in Namarigoungou
(prevalence 5.9% -19.5%) (Garba et al., 2004). S. mansoni has now spread to Diambala and other
villages in this area and appears to have overtaken S. haematobium as the dominant schistosome
species in the area (Garba et al., 2004) and in press). The other two villages in the study, Libore and
Falmado, are S. haematobium only foci. Libore is a village in the Kollo Department near Niamey
(13.308 N, 2.330 E). The main livelihood in the village is also based on rice and the rice paddies are
again irrigated via canals from the Niger River. Falmado is a small village in the Dosso Department
south of Niamey (12. 514 N, 2.861 E). Unlike the above mentioned villages, Falmado is not adjacent
to the Niger River and does not depend on rice cultivation. Falmado is instead encircled by marshes
which they themselves appear to be fed by the Niger River (see Figure 1). Both Bulinus and
Biomphalaria snail species have been found in the marshes (Labbo R and Barkire N pers.com. and
unpublished data), however only S. haematobium is known to infect the inhabitants of the village
(Garba, A. unpublished data, in press).
Recruitment and treatment of children to the study
One hundred and fifty randomly selected school-aged (ages 6-15) children were entered in
longitudinal cohort surveys at baseline, 6 weeks, 6 months and 12 months post MDA in each of the
four villages. Children were given a unique identification number after their names, age, and gender
were recorded. The children were then provided with two pots labeled with their unique identification
number, one for urine and one for stool samples. Infection status was then determined via
parasitological examination and any infected child was asked to provide a full pot of each sample for
miracidia collection and hatching (see ‘Parasitological examination’ below). After the baseline survey
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all children in each school (except Falmado, see below) were given two doses of PZQ (40mg/kg, the
second dose given two weeks after the first). As there is no school in Falmado, the children were
therefore assembled in the village’s meeting hall and given two doses of PZQ (40mg/kg), again the
second dose given two weeks after the first. The use of two doses, two weeks apart here, help ensure
effective treatment both of the currently adult schistosome stages in the first treatment, and the
previously immature stages, which are known to be insusceptible to PZQ (Pica-Mattoccia and Cioli,
2004).
Parasitological examination
Double Kato Katz slides and urine filtration slides were prepared for each child over three consecutive
days (WHO, 2002) (Figure 2 and 3). Identification of schistosome eggs confirmed infection with at
least one pair of schistosome worms. Intensity of infection was estimated indirectly via the geometric
mean of the number of eggs per gram of faeces or per 10ml of urine over the three consecutive days.
Once an infection was confirmed, samples of urine and/or stool were collected and eggs were washed
and amassed into Petri dishes for hatching. Once hatched, miracidia were collected from each sample
and stored on Whatman FTA® cards (Figure 4, see Appendix II).
Molecular Analysis of Parasite Samples
Multiplex PCR, using microsatellite loci, was utilized to genotype schistosome DNA from S. mansoni
miracidia, as described by (Gower et al., 2007). For S. haematobium individual miracidia were
genotyped using a newly developed assay allowing genotyping at 8 microsatellite loci (Gower, C.M.
and colleagues unpublished data) utilizing five novel and three previously published S. haematobium
microsatellite loci in a single reaction (Golan et al., 2008). Novel primer pairs had been designed for
the previously published loci that were compatible with the novel multiplex assay.
Microsatellite Loci
Seven-microsatellite loci were used to genotype S. mansoni parasite DNA, namely SMD28, SMDA28,
SDM25, SMD89, CA11-1, SMS9-1 and SMU31768 (see table 1a). The forward (5’ strand) primer of
each pair was fluorescently labeled with NED, 6-FAM, VIC, PET and NED. Overlapping size ranges
were labeled with different coloured fluorescent dyes. Eight microsatellite loci were used to genotype
S. haematobium parasite DNA namely C2, C11, C102, C111, C116, C131, C146 and D3. The forward
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primers of each pair were labeled as described above. Table 1b shows information for the three
published primers; the others were developed recently and are yet to be published.
Multiplex PCR
S. mansoni miracidia stored on indicating Whatman FTA® cards were removed using a Harris
MicroPunch® and placed in a 96-welled microplate. Miracidia samples were washed in FTA
purification reagent (Fisher Scientific) and Tris-EDTA (TE) Buffer and then dried at 55°C for 20
minutes prior to adding 25μl of reagent mix constituting of 2.5µl primer mix (1pmol/µl of each primer
in deionised water), 12.5µl Multiplex mix (NaCl2, dNTP, HotStarTaq DNA polymerase) and 10µl
pure dionised H2O (Qiagen Multiplex PCR Kit). A Gene Amp® PCR system 9700 (Applied
Biosystems, Cheshire, UK) or a PTC-200 Thermal Cycler (MJ Research) was used to perform a step-
down PCR commencing with a hot-start activation at 95°C for 15 minutes, followed by 40 cycles of
30 seconds at 94°C, 90 seconds at annealing temperature (2 cycles at each temperature from 58 to
49°C followed °C by 20 cycles at 48°C), 60 seconds at 72°C and a final extension of 30 minutes at 60.
The amplified fragments were diluted in N,N’-dimethyl formamide and along with LIZ-500 size
standard (Applied Biosystems) were separated by capillary electrophoresis using an ABI Prism 3730
Genetic Analyser (performed by DNA Facility at the Natural History Museum, London). S.
haematobium miracdia stored on indicating Whatman FTA® cards were removed and washed as
described for S. mansoni. Reactions were performed in 25µl reagent mix with a ratio of 1:9:10 for
primer mix, distilled water and Multiplex mix (Qiagen Multiplex PCR Kit). A step-down PCR
commencing with a hot-start activation at 95°C for 15 minutes, followed by 20 cycles of: 30 seconds
at 94°C, 90 seconds at annealing temperature (2 cycles at each temperature from 60°C to 51°C every
1°C then 20 cycles at 50°C ) then 60 seconds at 72°C followed by 20 cycles of: 30 seconds at 94°C, 90
seconds at 53°C, 60 seconds at 72°C and a final extension at 60°C for 30 minutes. The amplified
fragments were dilated 5 fold in autoclaved deionised water and along with Genescan-500 LIZ size
standard (Applied Biosystems) separated by capillary electrophoresis using ABI PRISM 3730 Genetic
Analyser at the Geneservice facility at Oxford University.
Controls
DNA from one of five S. mansoni and S. haematobium adult worm isolates from Uganda (kindly
supplied by P.H.L. Lamberton) stored on Whatman FTA® cards were genotyped on each plate as a
positive control to ensure microsatellite marker consistency and allele assignment. Three negative
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controls (water only, Whatman FTA® card and water stored on Whatman FTA® card) were run on
each plate to ensure there is no contamination of the mastermix/microplate/ Whatman FTA® card.
Genetic Data Analysis
Number of miracidia samples used in analysis
Molecular analysis was performed on between 10 and 35 miracidia per child (with the exception of
Diambala whose baseline samples were small therefore between 5 and 30 miracidia were used) to
ensure an adequate representation of the genetic population of the schistosome species in the area.
Allele size was determined using GeneMapper Version 4.0 (Applied Biosystems). Analysis was
restricted to miracidia with at least three allele calls when using S. mansoni primers and at least four
allele calls when using S. haematobium primers to reduce risk of false amplification or stuttering.
When testing reproducibility of allele calls from repeated runs of positive controls (adult S.
haematobium), the S. haematobium primer D3 displayed high error rates especially of the false allele
type, and thus it was excluded from the analysis (further analysis on error rates is described in chapter
4). In Namarigoungou, 1337 miracidia from a total of 58 children and 90 miracidia from 6 children at
baseline were used in the subsequent analysis for the S. mansoni and S haematobium populations
respectively. For Diambala, 584 miracidia from 25 children were analyzed for the S. mansoni
population. However, as an insufficient quantity of S. haematobium samples could be collected for
analysis due to low number of children excreting S. haematobium eggs in this region, only S. mansoni
was therefore analyzed in this village. In Falmado, a total of 558 miracidia from 20 children were
analyzed. Because there was only one child that excreted S. haematobium larvae at 6 weeks post
treatment and 1 child at 6 months post treatment these two children were only included in the
Bayesian clustering and the neighbour-joining tree analysis. All other analysis was done using
samples collected at baseline and 12 months post treatment. For Libore, a total of 847 miracidia from
37 children were analyzed. There was no collection performed 6 months post treatment at this village,
due to a logistic problem in the field, and thus only samples from baseline, 6 weeks and 12 months
post treatment were collected and analyzed here (Table 2).
Population structure, genetic diversity indices and software
For each parasite infra-population, from baseline, 6 weeks post treatment, 6 month post treatment and
12 months post treatment, the number of alleles (An) and allelic richness (Ar) were calculated using
70
FSTAT version 2.9.3.2 (Goudet, 2002), the number of private alleles (Ap), being alleles only found in
one infra-population, were calculated using GDA version 1.1 (Lewis and Zaykin, 2001). The infra-
populations from each treatment time point was pooled together to give 4 treatment time point groups
and observed heterozygosity (Ho), expected heterozygosity (He) and departures from Hardy-Weinberg
equilibrium (H-W) was tested for using Arlequin version 3.5 (Excoffier et al., 2005). For each parasite
infra-population (parasites collected from each child) grouped first by infection status (single v.s.
coinfection) then by treatment time point, allelic richness (Ar), Ho (observed heterozygosity), Nei’s
unbiased gene diversity (Hs) (Nei and Saitou, 1986) and the inbreeding coefficient (Fis) were
calculated in the relevant villages using FSTAT version 2.9.3.2 (Goudet, 2002). Significant
differences of diversity indices between groups were calculated by permuting 15000 times.
Parasite genetic structure in each village was determined by calculating Wright’s hierarchical F-
statistics in Arlequin using an Analysis of Molecular Variance (AMOVA) method ((Excoffier et al.,
2005)). A three level hierarchical analysis was performed so that genetic variance could be partitioned
into Level 1 (individual miracidia), Level 2 (population of miracidia in a single child i.e. infra
populations) and Level 3 (miracidia grouped by children grouped by treatment time points or infection
status). A hierarchical analysis is necessary to account for the potential relatedness of miracidia from
each infra-population. Ninety five percent confidence intervals (95% CI) were calculated by
bootstrapping over populations and subpopulations for each locus in Arlequin and testing for Fst
values greater than zero at the P<0.05 significance level. The neighbour-joining tree method in
Powermarker (Liu and Muse, 2005) based on the C.S. Chord genetic distance (Cavalli-Sforza and
Edwards, 1967) was employed for phylogenetic reconstruction. The reliability of tree topology was
tested by generating 100 bootstrapped trees in Powermarker. These trees were then analyzed in
PHYLIP version 3.67 (Felsenstein, 1993) using the consensus package to calculate bootstrapping
values for each cluster. STRUCTURE version 2.1 (Pritchard et al., 2000) was used to infer population
structure based on Bayesian clustering analysis. Simulations in STRUCTURE were carried out using
the admixture option (allowing for some mixed ancestry within individual isolates as advised by
program authors and is considered best by Falush et al. (Falush et al., 2003) in the case of subtle
population structure) with a burn-in of 10000 and a run length of 100 000 using a model in which
allele frequencies were assumed to be correlated within populations. To detect the true number of
cluster (K), an ad hoc statistic ‘Ln P(D)’ of K provided by STRUCTURE was used as described by the
programs manual ((Pritchard et al., 2000).
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Preliminary analysis was performed to determine whether samples could be pooled together across
villages. Thus all baseline S. mansoni miracidia samples were combined and analyzed to see if there
was any genetic differentiation across geographical areas in Niger. Similarly all baseline S.
haematobium miracidial samples were combined and analyzed to see if there was any genetic
differentiation across geographical areas in Niger. Weak genetic differentiation was detected between
villages for both species thus subsequent analysis was done separately for each village (see results
section for more details). Additional analysis was also performed across two different baseline time
points in Namarigoungou, which were collected prior to MDA and across baseline infra-populations
grouped by gender for all villages. These results (not shown) confirmed that there was neither
significant structuring nor a significant difference in allelic richness or gene diversity values between
the two baseline time points in Namarigoungou, or between girls and boys.
Ethical Considerations
Ethical clearance was obtained from the Niger National Ethical Committee (Niamey, Niger) and from
the NHS-LREC review board of St Mary’s Hospital, Imperial College (London, UK) application
03.36. In the field, the objectives of the study were first explained to the local village chiefs and
political and religious authorities who gave their consent to conduct the study. Written consent for the
schoolchildren to participate in longitudinal monitoring of the national control program for
schistosomiasis was given by head teachers, and/or village chiefs where there were no schools, due to
the fact that in African villages, written consent of the child’s guardian is often very difficult to obtain
owing to the associated impoverished conditions and often low literacy. Each individual child also
gave verbal consent before recruitment.
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Results
S. mansoni across geographical areas
All baseline S. mansoni infra-populations were combined and analyzed to see if there was any genetic
differentiation across geographical areas in Niger. Bayesian clustering analysis using STRUCTURE
detected a small yet significant population structure with K=3. Neighbouring-joining tree showed
baseline samples from Diambala clearly clustering together and approaching significance (62% after
bootstrapping 100 times). The hierarchical AMOVA estimated the variance component between the
two village groups was estimated to account for 3.8% of the total genetic variation with an average
estimated Fst value of 0.038 (95% CI from bootstrapping: 0.024 to 0.057). Thus weak yet significant
genetic differentiation was detected in the baseline S. mansoni parasite population grouped by village
in Niger (Table 3a). However these results should be interpreted with caution as baseline sampling of
infra-populations (parasites infecting one host i.e. child) were considerably smaller in Diambala
relative to Namarigoungou. This may have artificially inflated the Fst value for between group genetic
differentiation. Nevertheless, a potential difference in genetic population structure may indeed be
present between these two locations therefore all subsequent analysis was done on samples from each
area separately.
S. haematobium across geographical areas
All baseline S. haematobium infra-populations were combined and analyzed to see if there was any
genetic differentiation across geographical areas in Niger. STRUCTURE analysis revealed no
discernable clustering of genotypes according to area nor were there any clear clusters observable in
the neighbour-joining phenograms constructed at the individual child level. However, the hierarchical
AMOVA estimated the variance component between the two villages to account for 0.86% of the total
genetic variation with an average estimated Fst value of 0.0086 (95% CI from bootstrapping: 0.005 to
0.013). This indicates that there was potentially a weak genetic differentiation of the baseline parasite
population grouped by village in the S. haematobium population in Niger (Table 3b). It is therefore
possible that a potential difference in genetic population structure may indeed exist between these
locations and therefore all subsequent analysis was performed on samples from each area separately.
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Impact of infection status (single species v.s. coinfection) on population
genetics of S. mansoni and S. haematobium
Namarigoungou
Baseline infra-populations (children) were grouped according to infection status i.e. whether infected
by S. mansoni only, S. haematobium only or infected with both species (coinfected). Although
differences in Hs, Ho and Fis were not significant between infection status groups, allelic richness was
significantly different between S. mansoni only and coinfected groups, with allelic richness being
higher for S. mansoni in coinfected children relative to single S. mansoni infections (Table 4). This
also appeared to be the case for S. haematobium levels of allelic richness which were higher in
coinfections relative to single infections, although this was not significant after 15000 permutations. It
should be noted that samples sizes were small thus the power to detect a difference was limited.
STRUCTURE analysis revealed no discernable clustering of genotypes according to infection status
nor were there any clear clusters observable in the neighbour-joining phenograms constructed at the
individual child level in either species. Hierarchical AMOVA indicated that among infections status
group variation did not account for any of the genetic variation of either S. mansoni or S. haematobium
samples.
Diambala
Baseline infra-populations (children) were grouped according to infection status. Differences in Ar,
Hs, Ho and Fis were not significant between different infection status groups, nevertheless S. mansoni
coinfected group had higher Ar relative to single S. mansoni infections as observed in
Namarigoungou, but the small sample sizes probably limited the power of the test therefore the results
were not statistically significant (Appendix III). STRUCTURE analysis revealed no discernable
clustering of genotypes according to infection status nor were there any clear clusters observable in the
neighbour-joining phenograms constructed at the individual child level. Hierarchical AMOVA
indicated that among infections status group differentiation accounted for 3.1% of the genetic variation
of S. mansoni with an average estimated Fst value of 0.031 (95% CI from bootstrapping: -0.002 to
0.065). Whilst this suggests a potential yet weak genetic sub-structuring of the parasite population
grouped by infection status in Diambala, 95% CI were large and include zero indicating no evidence
of genetic differentiation which is in agreement with P value after 16000 permutations (P value was
0.147).
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Impact of PZQ treatment on S. mansoni genetic diversity and population
structure
Namarigoungou
Measures of number of alleles and allelic richness of infra-populations grouped by treatment time
points indicated high levels of polymorphism at all seven markers. For samples pooled by treatment
time points there was a significant departure from H-W equilibrium proportions in the majority of Ho
at each locus (Table 5). Across all loci the number of alleles and private alleles appeared to decrease
across treatment time points, although the Ar of did not decrease. In Table 6 the measures of Ar, Hs,
Ho and Fis of infra-populations grouped by treatment time points were not significantly different.
STRUCTURE analysis revealed no discernable clustering of genotypes according to treatment time
points, nor were there any clear clusters relating to treatment observable in the neighbour-joining
phenograms constructed at the individual child level (Appendix III). Likewise, the hierarchical
AMOVA estimated the within infra-population variance component to account for the majority of the
genetic variation (99.2%). The variance component between treatment time point groups (Baseline, 6
weeks Post treatment, 6 months post treatment and 12 months post treatment) was estimated to
account for only 0.01% of the total genetic variation with an estimated Fst value of -0.00013 (95% CI
from bootstrapping: -0.00097 to 0.00063). This indicates that there was no significant genetic
differentiation of parasite population between different treatment time points in the S. mansoni
population in Namarigoungou (Table 7).
Diambala
Measures of number of alleles and allelic richness of infra-populations grouped by treatment time
points indicated high levels of polymorphism at all seven markers. Departure from H-W proportions
was observed in the majority of loci of pooled samples grouped by time point. Across all loci the
number of alleles, private alleles and allelic richness of infra-populations did not appear to decrease
across treatment time points (Table 8). However, in Table 6, measures of Ar, Hs, Ho and FIS across
infra-populations grouped by treatment time points were significantly different with Ar and Hs highest
at baseline relative to post treatment groups. Fis was also highest at baseline whereas Ho was lowest
at baseline relative to post treatment (Table 9). Bayesian clustering analysis using STRUCTURE
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detected a small yet significant population structure from pre and post treatment samples in this
village. With K=4 there was a significant yet weak structuring (Figure 5). Neighbouring joining
phenogram clustered baseline samples together and this was supported by bootstrapping 100 times
with 37% of trees clustering the baseline samples together (Figure 6). The hierarchical AMOVA
estimated the within infra-populations variance component to account for 98% of the genetic variation.
The variance component between treatment time point groups (Baseline, 6 weeks post treatment, 6
months post treatment and 12 months post treatment) was estimated to account for 0.39% of the total
genetic variation with an average estimated Fst value of 0.0039 (95% CI from bootstrapping: 0.00059
to 0.00825). This indicates that there is a weak yet significant genetic differentiation of parasite
population grouped by different treatment time points in the S. mansoni population in Diambala (Table
10). However these results should be interpreted with caution, as baseline sampling from infra-
populations (miracidia from each child) were considerably small relative to post treatment sample of
infra-populations in this village, which may have artificially inflated the Fst values for between group
differences.
Impact of PZQ treatment on S. haematobium genetic diversity and population
structure
Namarigoungou
Measures of number of alleles and gene diversity indicated high levels of polymorphism at six of the
seven markers. Departure from H-W proportions was observed at all loci except C111 and C2 (Table
10). Locus C131 was lacking in Hs and was low in Ar (Table 11). There were few S. haematobium
infected children in the post MDA survey, and none of the collected eggs hatched (Garba, A.
unpublished data, in press).
Falmado
Measures of number of alleles and allelic richness of grouped infra-populations indicated high levels
of polymorphism at 6 of the 7 markers. Departure from H-W proportions was observed at the majority
of loci of pooled samples grouped by treatment time points. Across all loci the number of alleles and
private alleles were lower at 12month post treatment compared to baseline however this is due to
different sample size as allelic richness did not follow this trend (Table 12). The diversity indices of
infra-populations grouped by treatment time points of Ar, Hs, Ho were lower and Fis was higher at 12
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months post treatment relative to baseline though these values were not significantly different (Table
13). STRUCTURE analysis revealed no discernable clustering of genotypes according to treatment
time points nor were there any clear clusters observable in the neighbour-joining phenograms
constructed at the individual child level (Appendix III). The hierarchical AMOVA estimated the
within infra-population variance component to be 99.6%, whereas the variance component between
treatment time point groups (Baseline and 12 months post treatment) could not account for any of the
total genetic variation ( -0.022%), with an average estimated Fst value of -0.00023 (95% CI from
bootstrapping: -0.00104 to 0.00058). This indicates that there was no significant genetic
differentiation of parasite population between pre and post treatment in the S. haematobium population
in Falmado (Table 14).
Libore
Measures of number of alleles and allelic richness of infra-populations grouped by treatment time
points indicated high levels of polymorphism at six of the seven markers. Departure from H-W
proportions was observed at the majority of loci across pooled samples grouped by time point except
locus C146. Across all loci the number of alleles, private alleles and allelic richness did not appear to
decrease across treatment points (Table 15). Table 12 shows the genetic diversity indices of infra-
populations grouped by time points; Ar, Hs, Ho and Fis were not significantly different across
treatment time points. STRUCTURE analysis revealed no discernable clustering of genotypes
according to treatment time points nor were there any clear clusters observable in the neighbour-
joining phenograms constructed at the individual child level (Appendix III). The hierarchical
AMOVA estimated the within infra-population variance component to be 98.3% whereas the variance
component between treatment time point groups (Baseline, 6 weeks post treatment and 12 months post
treatment) could only account for 0.01% of the total genetic variation with an average estimated Fst
value of 0.00011 (95% CI from bootstrapping: -0.00143 to 0.00237). This indicates that there was no
significant genetic differentiation of parasite population between different treatment time points in the
S. haematobium population in Libore (Table 16).
77
Discussion
To the author’s knowledge this is the first study of the population genetic characteristics of both S.
mansoni and S. haematobium in mixed infection villages. The results show that microsatellite markers
are useful tools for describing the genetic population structure of schistosomes. I tested the hypothesis
that S. mansoni and S. haematobium coinfections impact, directly or indirectly, the intra-specific
diversity of both parasite species, by collecting and analyzing miracidial samples from single and
coinfected children in two mixed infection villages in Niger. Although, again to the author’s
knowledge, there have been very few models focusing on the effect of simultaneous infection with
multiple intra-genera species on the genetic diversity and population structure of parasites within
humans hosts (Mideo, 2009). I used the prediction that genetic diversity indices would be lower in
mixed schistosome species infections relative to single infections as it could be suspected that
competition for resources would hinder the establishment of certain parasite genotypes, thereby
resulting in fewer different genotypes of adult parasites of each species contributing to the miracidial
population samples from coinfected children. The results presented in the current study appear to
support this hypothesis as Fis values were generally higher in coinfected individuals relative to single
infections (though not significant) potentially indicating that inbreeding was occurring. However,
certainly in S. mansoni and potentially also in S. haematobium, allelic richness was actually observed
to be higher in coinfected children relative to single infected children (Figures 7). One could,
therefore, initially infer perhaps that inter-specific competition was leading to an increased level of
egg output and this was dramatically affecting genetic diversity indices. However, allelic diversity was
specifically used as a measure of genetic diversity because it controls for the effect of sample size by
rarefaction (Mousadik and Petit, 1996). Additionally, an increased egg output due to inter-specific
competition would plausibly relate only to certain competitive worms and therefore the eggs would be
highly related, consequently reducing allelic richness. In any case infection intensities measured by
egg output (eggs per gram, eggs per 10ml for S .mansoni and S. haematobium respectively) were not
significantly different between coinfections relative to single infections and the general egg output for
both species whether in single infected or coinfected children were in the medium infection intensity
category, as defined by WHO guidelines (WHO, 2002) (Garba A. unpublished data, in press). Thus
this difference in allelic richness between single and coinfected is independent of egg output. It is
plausible however that there is a density dependent factor occurring in coinfected infra-populations
whereby, instead of a few worms producing the majority of eggs, the opposite is occurring, and many
worms are producing few eggs. Or alternatively this phenomenon of higher allelic richness in
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coinfections relative to single infections could plausibly be explained by inter and intra-specific
competition for mates and thus an increased rate of schistosome mate swapping occurring at the intra-
specific level leading to increased recombination events between different pairings of adult worms and
thus haplotypes. Indeed, both laboratory and field studies have shown that heterologous pairings in
mixed schistosome species infections do occur and in a biased sex ratio often occurs with a particular
species being competitively dominant over another and thereby when unpaired, able to ‘steal’ a female
from the competitively weaker species (Southgate et al., 1995; Tchuem Tchuente et al., 1995; Webster
et al., 1999). Furthermore, in the afore-mentioned published studies, it was also demonstrated that
there is a preference for homologous pairings, and hence mate switching may only be commonplace
until a same species mate is found. Additionally it has been suggested that mate selections and
“switching” is actively done by the male worm, preferring females with high fecundity rates, therefore
the competition for mates is intensified by the preference for the fewer number of high-fecundity
females (Tchuem Tchuente et al., 1996). All such findings thereby support the hypothesis that mixed
infections of S. mansoni and S. haematobium, where hybridization does not occur, leads to an increase
of different recombination events thus increasing intra-specific genetic diversity.
The lack of genetic differentiation observed across different treatment time points in Namarigoungou
suggest that treatment with PZQ does not seem to affect parasite genetic population structure in this
village. However, conversely, treatment with PZQ did seem to impact the genetic population structure
and genetic diversity in the neighbouring village of Diambala (Figure 8). The differences between
these two villages may appear rather odd considering their proximity to one another and their similar
epidemiological settings. However, as the preliminary analysis of S. mansoni samples grouped by
village showed that even between neighbouring villages genetic differentiation can occur highlighting
the very focal nature of schistosomiasis epidemiology. Indeed the widely dispersed nature of villages
in Tillaberi, combined with potential difference in refugia and effective population size between the
two villages, could plausibly explain this discrepancy between the S. mansoni population of
Namarigoungou and Diambala. It is therefore indeed possible for the parasite population of one
village to show genetic differentiation between treatment time points and reduced levels of genetic
diversity post PZQ treatment relative to baseline, whereas a neighbouring yet potentially separate
population of parasites may indicate a lack of sub-structuring and genetic bottlenecking post PZQ
treatment. These factors will also potentially be influenced by the stochastic nature of genetic drift
and the potentially limited gene flow between geographical sites and separation of transmission sites
leading to increased sub-structuring across villages. The results on the impact of PZQ treatment on
genetic diversity of S. mansoni in Diambala has also been detected in a similar study performed in
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Tanzania (Norton et al., 2010)where genetic diversity indices were significantly lower in post
treatment samples relative to baseline. The lack of sub-structuring across treatment time points and
lack of impact of PZQ treatment on genetic diversity indices in the S. mansoni population of
Namarigoungou may be a local epidemiological factor relating to the proportion of the parasite
population in refugia in this village and/or to the presence of more than one human schistosome
species in the area. If there is indeed an inter-specific interaction occurring in coinfected hosts it could
be plausible that this interaction is preventing certain S. mansoni strains from establishing thereby, as
predicted, reducing the number of different genotypes able to infect a coinfected host, yet the
increased rate of mate switching and increased recombination events between different adult worms
masks this phenomenon and thus genetic diversity as measured by allelic richness and Hs is higher in
coinfections than single infections. However, once PZQ treatment is administered it is clear that its
effect on S. haematobium in the area is very dramatic, whereas S. mansoni infections appear rapidly
bounce back (Garba, A. unpublished data, in press). Therefore one could interpret this as S
.haematobium is removed from the definitive host environment post PZQ, and in the absence of these
inter-specific interactions, different S. mansoni genotypes are able to establish themselves once more.
Whilst this hypothesis requires further research, some support may be provided here since the
inbreeding coefficient values were observed to be higher in coinfections relative to S. mansoni single
infections and appears to subsequently decrease across treatment time points, although it is important
to note that these differences were not significantly different after 15000 permutations (Table 4).
Further support was also suggested by a study by Ernould et al. (Ernould et al., 1999), where it was
clearly shown that S. mansoni prevalence levels and infection intensities increased dramatically 10
months post PZQ treatment to levels higher than pretreatment in a mixed infection village, whereas S.
haematobium all but disappeared. Such a dramatic increase was not observed in the single S. mansoni
village in the study, although the general difference of the response of the two parasite species to
MDA, regardless of whether in mixed species or single species villages, was noted (Ernould et al.,
1999). In Namarigoungou and Diambala in the current study, S. mansoni infections were more
prevalent than S. haematobium infections but the differences of impact of MDA on the population
structure of S. mansoni highlights that the epidemiology of each village must be different. That being
said it is important to note that Diambala had small baseline miracidia sample size compared to post
MDA and this may have affected the outcome of the results.
In agreement with previous molecular analysis of the genetic population structure of S. haematobium
using Randomly Amplified Polymorphic DNA markers (RAPDs) (Brouwer et al., 2001; Dabo et al.,
1997; Davies et al., 1999; Shiff et al., 2000), combined with recent unpublished microsatellite and
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barcoding studies performed on S. haematobium samples in Tanzania, Mali, Cameroon, Senegal and
Zanzibar also indicating a universal lack of genetic sub-structuring in the population of S.
haematobium (Lamberton PHL, Gower C, Doel A, Webster B), there seems to be no genetic
differentiation in any of the S. haematobium populations analyzed in this study (Figure 9). In the
current study pre and post treatment samples did not reveal any effect of PZQ treatment on S.
haematobium genetic population structure or diversity. In fact, in the mixed infection villages S.
haematobium all but disappeared post PZQ treatment with S. mansoni completely replacing it.
Nevertheless, it is interesting to note that contrary to previous studies using barcoding (Webster B
unpublished data) S. haematobium parasites as analyzed by microsatellite markers do have high levels
of genetic diversity although perhaps to a lesser degree than S. mansoni.
Conclusions
To the author’s knowledge this is the first empirical study examining the impact of human
schistosome coinfections and subsequent inter-specific interactions on the intra-specific genetic
diversity of parasite populations. This study supports the hypothesis that inter-specific interactions
such as competition for resources, density-dependent factors and mate pairing will differentially affect
the establishment and reproduction of schistosome species genotypes thereby altering the intra-
specific genetic diversity of each species. Surprisingly, whilst the predictions were of lowered genetic
diversity in coinfections compared to single infections, the opposite, in fact, was found with allelic
richness being higher in S. mansoni and S. haematobium coinfections. This may have important
implications in the evolution of schistosome life-history traits such as reproductive fitness and
virulence, and merits further research (Rigaud et al., in press). The lack of impact of PZQ treatment
on S. mansoni population in Namarigoungou which is contrary to what was found in Tanzania (Norton
et al., 2010) highlights the importance of focal transmission and epidemiology of schistosomes, as
does the noted difference of the results found in the neighbouring village of Diambala. The general
lack of population genetic differentiation in S. haematobium populations is in agreement with past
studies highlighting the high levels of gene flow in this species, however a weak difference was found
between villages which may be due to the different epidemiological and geographical settings of
Libore and Falmado (Niger River and marshes respectively). S. haematobium genetic diversity as
detected by microsatellite markers was relatively high compared to past studies using bar-coding and
RAPDs (Brouwer et al., 2001; Dabo et al., 1997; Shiff et al., 2000). This discrepancy in S.
haematobium population genetic characteristics between different markers warrants further research.
However it is important to note that genetic population studies in S. haematobium lags far behind
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those of S. mansoni and S. japonicum (Rollinson, 2009) therefore further studies are required to
determine the genetic make-up of S. haematobium populations and their evolution in different
epidemiological settings and control programs.
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Tables
Table 1a: S. mansoni Microsatellite primers Locus, Gene Bank number, repeat motif, size range and
reference papers
Locus Gene Bank Repeat Motif Size Range (bp) Reference
SMDA28 AF325659 GATA 92 - 128 Curtis et al. (2001)
SMD25 AF202965 CA 272 – 312 Durand et al. (2000)
SMD28 AF202966 CAA 230 - 245 Durand et al. (2000)
SMD89 AF202968 TC 138 - 169 Durand et al. (2000)
CA11-1 AI068336 GA, GT 191 - 231 Blair et al. (2001)
SMS9-1 AF330106 GT 178 - 208 Blair et al. (2001)
SMU31768 U31768 GAT 179 - 247 Durand et al. (2000)
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Table 1b: S. haematobium Microsatellite primers Locus, Gene Bank number, repeat motif, size range
and reference papers
Locus Gene Bank Repeat Motif Size Range (bp) Reference
C102 N/A ATT 183-194 Unpublished
C2 EF608044 TTA 119 - 222 Golan et al (2008)
C11 N/A TAA, TAA 105-112 Unpublished
C111 N/A ATT 200-209 Unpublished
C131 EF608045 TTA 204 - 256 Golan et al (2008)
C146 N/A TAA,TGG,TAA 155-174 Unpublished
D3 EF608047 TAGA, TTGA 287 - 306 Golan et al (2008)
Table 2: Number of children from whom S. mansoni and S. haematobium miracidia were collected at
each time point in each village
S. mansoni Number of
Children
S. haematobium Number of children
Treatment Time
Point
Namarigoungou Diambala Namarigoungou Falmado Libore
Baseline 27 4 6 13 12
6W PT 9 6 0 1 13
6M PT 14 10 0 1 N/A
12M PT 8 5 0 5 12
Total 58 25 6 20 37
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Table 3a: Three level hierarchical AMOVA of baseline S. mansoni infra-populations (children)
grouped by villages (Namarigoungou and Diambala)
Source of
variation
Sum of
squares
Variance
components
Percentage
variation
Among villages 10.68 0.09 3.89
Among infra-populations
Within villages
85.99 0.02 0.79
Within infra-populations 2443.56 2.204 95.31
Total 2540.23 2.31
Table 3b: Three level hierarchical AMOVA of baseline S. haematobium infra-populations (children)
grouped by villages (Namarigoungou, Falmado and Libore)
Source of
variation
Sum of
squares
Variance
components
Percentage
variation
Among villages 20.06 0.02 0.86
Among infra-populations
Within villages
85.16 0.02 1.01
Within infra-populations 2654.19 2.14 98.13
Total 2759.40 2.18
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Table 4: Impact of Coinfections on the mean diversity indices of S. mansoni and S. haematobium
infra-populations grouped by infection status (coinfection vs. single) in two mixed infection villages
Namarigoungou
Infection Status (number of children)
Ar Ho Hs Fis
S. mansoni Coinfected (8C) 5.016 0.586 0.634 0.075
Single S. mansoni infected (6C) 4.738 0.6 0.614 0.023
S. haematobium Coinfected (4C) 4.022 0.487 0.612 0.203
Single S. haematobium Infected (2C) 3.708 0.505 0.595 0.151
Diambala
Infection Status (number of children)
Ar Ho Hs Fis
S. mansoni Coinfected (3C) 2.84 0.511 0.797 0.358
Single S. mansoni infected (2C) 2.202 0.376 0.607 0.38
Ar, allelic richness; Ho, observed heterozygosity; Hs, Genetic Diversity; Fis, inbreeding coefficient;
Red - Significant difference (P<0.05) after 15000 permutations
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Table 5: Impact of praziquantel treatment on S. mansoni samples in Namarigoungou
Ca11_1 S9_1 SMD25 SMD28
An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho
Baseline 20 0 5.75 0.58 0.50 α 22 4 3.63 0.52 0.48 α 14 1 7.07 0.85 0.81 α 15 0 2.73 0.54 0.49 α
6Weeks PT 21 3 8.84 0.58 0.55 α 13 0 4.64 0.53 0.47 α 11 0 8.45 0.85 0.83 α 6 0 2.64 0.51 0.50 α
6Months PT 17 0 5.23 0.58 0.49 α 17 3 3.17 0.52 0.47 α 17 0 6.53 0.85 0.81 13 3 2.61 0.53 0.49 α
12Months PT 17 1 8.90 0.60 0.55 α 10 2 3.89 0.46 0.49 α 10 0 8.68 0.85 0.84 α 5 0 2.29 0.50 0.48 α
Mean 18.75 1 7.18 0.59 0.53 15.5 2.25 3.83 0.51 0.48 13 0.25 7.68 0.85 0.83 9.75 0.75 2.57 0.51 0.48
SMD89 SMDa28 SMU31768 Overall
An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho
Baseline 7 1 2.79 0.53 0.37 α 19 3 6.21 0.75 0.70 α 14 3 4.04 0.64 0.89 α 15.86 1.71 4.60 0.63 0.61 α
6Weeks PT 5 0 3.31 0.52 0.44 α 16 4 8.08 0.72 0.67 α 10 2 4.53 0.61 0.86 α 11.71 1.29 5.78 0.62 0.62 α
6Months PT 6 1 2.73 0.52 0.39 α 16 3 5.59 0.75 0.73 α 9 1 4.12 0.66 0.89 α 13.57 1.57 4.28 0.63 0.61 α
12Months PT 4 0 3.04 0.54 0.34 α 10 0 7.28 0.75 0.75 8 0 5.07 0.63 0.92 α 9.14 0.43 5.59 0.62 0.62 α
Mean 5.5 0.5 2.97 0.50 0.38 15.25 2.5 6.79 0.74 0.72 10.25 1.5 4.44 0.64 0.89 12.57 1.25 5.07 0.62 0.61
An , number of alleles; Ap , number of private alleles; Ar, allelic richness; He , expected heterozygosity; Ho, observed heterozygosity.
α Significant difference in heterozygosity (P<0.05)
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Table 6: Impact of MDA on the mean diversity indices of S. mansoni infra-populations grouped by
time points in two mixed infection villages
Ar, allelic richness; Ho, observed heterozygosity; Hs, Genetic Diversity; Fis, inbreeding coefficient
Red - Significant difference (P<0.05) after 15000 permutations
Namarigoungou Treatment Time Points
(number of children)
Ar Ho Hs Fis
Baseline (27C) 4.153 0.603 0.625 0.035
6W Post Treatment (9C) 4.056 0.616 0.607 0.019
6M Post Treatment (14C) 4.134 0.612 0.626 0.022
12M Post Treatment (8C) 4.117 0.625 0.614 -0.018
Diambala Treatment Time Points
(number of children)
Ar Ho Hs Fis
Baseline (5C) 2.584 0.462 0.719 0.357
6W Post Treatment (6C) 2.257 0.62 0.59 -0.051
6M Post Treatment (10C) 2.366 0.6 0.616 0.025
12M Post Treatment (5C) 2.325 0.614 0.605 -0.016
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Table 7: Three level hierarchical AMOVA of S. mansoni infra-populations (children) grouped by
treatment time points in Namarigoungou
Source of variation Sum of
squares
Variance
components
Percentage
variation
Among treatment time point
groups
8.53 0.0 -0.01
Among infra-populations
within treatment time point
groups
156.92 0.02 0.79
Within infra-populations 5293.59 2.17 99.22
Total 5459.04 2.19
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Table 8: Impact of praziquantel treatment on S. mansoni in Diambala
Ca11_1 S9_1 SMD25 SMD28
An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho
Baseline 8 2 2.75 0.72 0.44 α 14 4 3.05 0.80 0.38 α 10 2 3.19 0.84 0.35 α 12 5 3.11 0.82 0.44 α
6Weeks PT 13 1 6.42 0.67 0.60 α 7 0 3.11 0.41 0.30 α 9 0 6.45 0.81 0.83 6 1 2.36 0.49 0.53 α
6Months PT 15 3 6.47 0.61 0.53 α 15 2 4.20 0.45 0.41 α 12 2 7.42 0.81 0.77 α 11 4 2.91 0.52 0.48 α
12Months PT 12 2 8.04 0.65 0.54 α 11 2 4.60 0.41 0.32 α 10 0 7.61 0.79 0.77 3 0 2.27 0.47 0.49 α
Mean 12 2 5.92 0.64 0.53 11.75 2 3.74 0.45 0.34 10.25 1 6.17 0.78 0.69 8 2.5 2.66 0.53 0.49
SMD89 SMDa28 SMU31768 Overall
An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho
Baseline 6 3 1.97 0.46 0.35 α 9 0 3.19 0.85 0.65 α 9 1 2.68 0.71 0.63 α 9.71 2.43 2.85 0.74 0.46 α
6Weeks PT 5 1 2.73 0.50 0.45 α 11 0 5.42 0.72 0.70 α 6 0 3.55 0.59 0.93 α 8.14 0.43 4.29 0.60 0.62 α
6Months PT 6 2 3.20 0.55 0.43 α 13 2 6.80 0.77 0.69 α 10 0 4.29 0.64 0.88 α 11.71 2.14 5.04 0.62 0.60 α
12Months PT 4 0 3.10 0.55 0.51 α 10 1 7.06 0.76 0.75 6 3 4.33 0.62 0.92 α 8 1.14 5.29 0.61 0.61 α
Mean 5.25 1.5 2.75 0.52 0.47 10.75 0.75 5.62 0.76 0.71 7.75 1 3.71 0.63 0.84 9.39 1.54 4.37 0.61 0.58
An , number of alleles; Ap , number of private alleles; Ar, Allelic Richness; He , expected heterozygosity; Ho, observed heterozygosity.
α Significant difference in heterozygosity (P<0.05)
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Table 9: Namarigoungou S. haematobium at baseline for samples
An Ap He Ho
C102 6 1 0.448 0.469 α
C11 7 4 0.644 0.2.65 α
C111 14 1 0.662 0.617
C116 3 1 0.915 0.763 α
C131 9 1 0.296 0.000 α
C146 5 1 0.767 0.705 α
C2 6 0 0.662 0.617
Mean 7.143 1.286 0.628 0.491
An, number of alleles; Ap, number of private alleles; He, expected heterozygosity; Ho, observed
heterozygosity.
α Significant difference in heterozygosity (P<0.05)
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Table 10: Three level hierarchical AMOVA of S. mansoni infra-populations (children) grouped by
treatment time points in Diambala
Source of
variation
Sum of
squares
Variance
components
Percentage
variation
Among treatment time point
groups
17.03 0.01 0.39
Among infra-populations
Within treatment time point
groups
78.76 0.035 1.60
Within infra-populations 2277.62 2.13 98.01
Total 2373.41 2.18
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Table 11: Mean diversity indices across loci of S. haematobium infra-populations at baseline in
Namarigoungou; Ar, allelic richness; Ho, observed heterozygosity; Hs, Genetic Diversity
S. haematobium Locus Ar Ho Hs
C102 3.13 0.49 0.44
C11 3.85 0.27 0.69
C111 4.02 0.62 0.68
C116 9.09 0.78 0.93
C131 2.13 0.00 0.00
C146 5.49 0.70 0.73
C2 3.97 0.62 0.68
Mean 4.53 0.49 0.59
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Table 12: Impact of praziquantel treatment on S. haematobium in Falmado
C102 C11 C111 C116
An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho
Baseline 7 0 2.99 0.38 0.37 α 7 3 2.65 0.46 0.42 α 9 1 3.95 0.69 0.75 α 14 1 8.29 0.89 0.83 α
12M PT 8 0 4.03 0.38 0.34 α 4 1 2.63 0.43 0.27 α 6 0 4.51 0.69 0.70 14 1 9.91 0.89 0.82 α
Mean 7.5 0 3.51 0.38 0.71 5.5 2 2.64 0.44 0.34 7.5 0.5 4.23 0.69 0.72 14 1 9.10 0.89 0.83
C131 C146 C2 Overall
An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho
Baseline 7 0 2.20 0.44 0.03 α 14 5 5.13 0.73 0.72 α 7 1 3.82 0.69 0.75 α 9.29 1.57 4.15 0.61 0.55 α
12M PT 7 0 2.66 0.48 0.04 α 10 2 5.80 0.71 0.70 α 6 0 4.52 0.69 0.71 7.86 0.57 4.86 0.61 0.51 α
Mean 7 0 2.43 0.46 0.03 12 3.5 5.46 0.72 0.71 6.5 0.5 4.17 0.69 0.73 8.57 1.07 4.51 0.61 0.58
An , number of alleles; Ap , number of private alleles; Ar, Allelic Richness; He , expected heterozygosity; Ho, observed heterozygosity.
α Significant difference in heterozygosity (P<0.05)
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Table 13: Impact of MDA on the mean diversity indices of S. haematobium infra-populations grouped
by time points in two single infection villages
Falmado Treatment Time Points
(number of children)
Ar Ho Hs Fis
Baseline (13C) 4.117 0.551 0.614 0.102
6W Post Treatment (5C) 0 0 0 0
6M Post Treatment (5C) 0 0 0 0
12M Post Treatment (5C) 3.883 0.512 0.604 0.152
Libore Treatment Time Point
(number of children)
Ar Ho Hs Fis
Baseline (11C) 3.83 0.534 0.614 0.13
6W Post Treatment (0C) 3.866 0.528 0.622 0.151
12M Post Treatment (12C) 3.827 0.513 0.606 0.152
Ar, allelic richness; Ho, observed heterozygosity; Hs, Genetic Diversity; Fis, inbreeding coefficient
Red - Significant difference (P<0.05) after 15000 permutations
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Table 14: Three level hierarchical AMOVA of S. haematobium infra-populations (children) grouped by
treatment time points in Falmado
Source of
variation
Sum of
squares
Variance
components
Percentage
variation
Among treatment time
point groups
2.38 -0.00 -0.02
Among infra-populations
Within treatment time
points groups
41.00 0.01 0.39
Within infra-populations 2014.99 2.133 99.63
Total 2058.38 2.14
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Table 15: Impact of praziquantel treatment on S. haematobium in Libore
C102 C11 C111 C116
An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho
Baseline 7 0 2.78 0.39 0.36 α 4 1 2.37 0.48 0.36 α 8 1 3.74 0.69 0.67 α 15 1 7.41 0.90 0.84 α
6W PT 8 0 3.12 0.37 0.36 9 4 2.70 0.51 0.31 α 9 0 4.48 0.69 0.68 α 15 1 9.25 0.91 0.82 α
12M PT 7 1 3.72 0.39 0.35 α 6 2 2.97 0.50 0.31 α 12 3 4.97 0.67 0.68 14 0 10.85 0.91 0.83 α
Mean 7.33 0.33 3.20 0.38 0.36 6.33 2.33 2.68 0.50 0.33 9.67 1.33 4.40 2.05 0.67 14.67 0.67 9.17 0.89 0.83
C131 C146 C2 Overall
An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho
Baseline 3 0 2.01 0.40 0.00 α 12 0 5.12 0.79 0.80 7 0 3.72 0.69 0.69 α 8 0.43 3.88 0.62 0.53
6W PT 3 0 2.09 0.43 0.01 α 13 2 5.82 0.76 0.75 7 0 4.38 0.71 0.73 α 9.14 1 4.55 0.63 0.52
12M PT 6 3 2.36 0.34 0.02 α 11 0 7.28 0.79 0.73 10 2 4.97 0.69 0.68 9.43 1.57 5.30 0.61 0.51
Mean 4 1 2.15 0.39 0.01 12 0.67 6.07 0.78 0.76 8 0.67 4.36 0.69 0.70 8.86 1 4.58 0.81 0.52
An , number of alleles; Ap , number of private alleles; Ar, Allelic Richness; He , expected heterozygosity; Ho, observed heterozygosity.
α Significant difference in heterozygosity (P<0.05)
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Table 16: Three level hierarchical AMOVA of S. haematobium infra-populations (children) grouped by
treatment time points in Libore
Source of
variation
Sum of
squares
Variance
components
Percentage
variation
Among treatment time point
groups
7.98 0.00 0.01
Among infra-populations
Within treatment time point
groups
130.04 0.04 1.71
Within infra-populations 3344.49 2.14 98.28
Total 3482.51 2.18
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Figures
Figure 1: Map of Tillaberi, Kollo and Dosso, Niger
Amended from (Garba et al., 2010)
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Figure 2: Parasitological technique, Kato-Katz preparation in Niger
Photo by Gouvras, A
Figure 3: Parasitological technique, Urine filtration preparation in Niger
Photo by Gouvras, A
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Figure 4: Miracidia collection and DNA storage in Niger
Photo by Gouvras, A
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Figure 5: Diambala S. mansoni Bayesian clustering, K=4 (represented by 4 different colours), each
line is an individual isolate. 1-5: Baseline infra-populations, 6 -10: 6 weeks PT infra-populations, 11-
20: 6M PT infra-populations, 21-25: 12MPT infra-populations
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Figure 6: Diambala Neighbour-joining consensus tree with bootstrapping 100 times
Where Dxxx is child i.d., Base is Baseline (Red Line), PT6W is 6 weeks post treatment (Green Line),
PT6M is 6 months post treatment (Blue Line) and PT12M is 12 months post treatment (Orange Line)
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Figure 7; Impact of Infection Status (single vs. coinfection) on Allelic Richness (Ar) in mixed
infection villages
Namarigoungou: S. mansoni coinfected 8 children, S. mansoni only 6 children; S. haematobium
coinfected 4 children, S. haematobium only 2 children. Diambala: S. mansoni coinfected 3 children, S.
mansoni only 2 children.
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Figure 8; Impact of treatment on S. mansoni Allelic Richness (Ar) in mixed infection villages
Namarigoungou: Baseline 27 children, 6W Post Treatment 9 children, 6M Post Treatment 14 children
and 12M Post Treatment 8 children; Diambala: Baseline 5 children, 6W Post Treatment 6 children,
6M Post Treatment 10 children and 12M Post Treatment 5 children.
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Figure 9; Impact of treatment on S. haematobium Allelic Richness (Ar) in one mixed infection and
two single infection villages
Falmado: Baseline 13children, 6W Post Treatment 0 children, 6M Post Treatment 0 children and 12M
Post Treatment 5 children; Libore: Baseline 11 children, 6W Post Treatment 13 children and 12M Post
Treatment 12 children; Namarigoungou: Baseline 5 children, 6W Post Treatment 0 children, 6M Post
Treatment 0 children and 12M Post Treatment 0 children
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SCHISTOSOMA HAEMATOBIUM AND S. MANSONI GENETIC POPULATION
ANALYSIS USING MICROSATELLITE MARKERS FOLLOWING WHOLE
GENOME AMPLIFICATION (WGA) IN A MIXED SPECIES ENDEMIC
REGION OF COASTAL KENYA
Summary
Schistosoma haematobium and S. mansoni are the two major species of schistosomes known to infect
humans in sub-Saharan Africa. With the advent of new irrigation schemes and dam constructions,
coupled with high migration rates, areas of sympatry and hence coinfections of these two species have
become a common occurrence across much of sub-Saharan Africa. Yet empirical research on the
potential impact of such inter-specific coinfections is lacking, especially with respect to the effect on
the genetic population characteristics of the parasites. One major explanation for this was simply
reflective of the lack of empirical research on the S. haematobium species in general, due to few
available tools and inherent logistical difficulties in laboratory maintenance. In this study I used
microsatellite markers to test the hypothesis that inter-specific interactions between S. haematobium
and S. mansoni are affecting the intra-specific genetic diversity of both species in an East African
setting. Furthermore, I introduced a new technique that could potentially greatly benefit schistosome
genetic analysis and specifically optimize it for the first time, for S. haematobium. And finally the
impact of praziquantel (PZQ) treatment on the genetic population structure of both species in this
mixed infection foci was determined. The results presented in this chapter support the hypothesis that
coinfections do alter the genetic diversity of both parasite species, with genetic diversity indices and
inbreeding being higher in coinfections relative to single infections, for both species at baseline. Mass
drug administration (MDA) with PZQ also had an impact on the genetic diversity of species
populations, reducing the genetic diversity of the S. haematobium population and conversely
increasing the genetic diversity of the S. mansoni population, within single species infections.
Moreover, the impact of coinfections on S. haematobium diversity, as observed at baseline, appeared
to be removed 12 months post MDA, potentially indicating a disruption of inter-specific interactions
by MDA. The implications of the novel techniques and traits presented here, for both future
schistosome population genetic analyses, together with schistosome epidemiology, evolution and
control in general, are discussed.
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Introduction
Schistosomiasis, caused by the parasitic blood flukes of the Schistosoma Genus, remains one of the
most important s human parasitic diseases in terms of socio-economic impact (King et al., 2005). An
estimated 207 million persons are currently infected worldwide, over 85% of which live in sub-
Saharan Africa (Steinmann et al., 2006). Recently revised estimates on the global burden of this
disease conclude that a scale of 3–70 million disability adjusted life years (DALYs) are lost to
schistosomiasis (reviewed in (King and Dangerfield-Cha, 2008). In sub-Saharan Africa, Schistosoma
haematobium and S. mansoni are the predominant human schistosome species. Their epidemiology
and distribution are very similar and with the advent of new irrigation schemes and dam constructions,
co-endemicity of these two species is becoming a common occurrence in many regions (Cunin et al.,
2000; Cunin et al., 2003; Garba et al., 2004; Labbo et al., 2003; Steinmann et al., 2006). This
sympatry raises some important questions regarding the impact of mixed species coinfections on
human schistosome morbidity (dealt in Chapter 2) and schistosome evolution. Both S. haematobium
and S. mansoni colonize the same site in the definitive human host for growth and sexual maturation,
i.e. the hepatic portal vein and blood system, before moving to their specific ovipositioning sites, and
hence potentially compete for the same ecological niche, nutritional resources and, since schistosomes
are dioecious and pairing is obligatory in order for the female worm to attain sexual maturity, mates.
This pairing occurs in the hepatic portal system of the definitive host, after which the male carries the
female to the ovipositioning site which is species-specific (the mesenteric venules for S. mansoni and
the vesical venous plexus for S. haematobium explaining the different egg excretion methods for each
species i.e. eggs in stool and eggs in urine respectively). It was once thought that schistosomes were
‘monogamous’ yet it is now known ‘mate switching’ is a common occurrence, especially as infections
are often gender biased with a predominance of male worms (Southgate et al., 1998; Southgate et al.,
1995; Tchuem Tchuente et al., 1996; Tchuem Tchuente et al., 1995; Webster et al., 1999). Male
worms therefore compete for female worms and in mixed schistosome infections male worms can
form heterologous pairing i.e. mate with a female worm from another species (Southgate et al., 1998;
Southgate et al., 1995; Tchuem Tchuente et al., 1996; Tchuem Tchuente et al., 1995; Webster et al.,
1999). In these settings S. haematobium and S. mansoni heterologous pairs will reproduce via
parthenogenesis, resulting in offspring of the same species as the female but excreted in the species-
specific ovipositioning site of the male (Cosgrove and Southgate, 2003; Southgate et al., 1998;
Southgate et al., 1995; Tchuem Tchuente et al., 1995; Webster et al., 1999), thereby accounting for
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the presence of ectopic eggs (in this sense; eggs of one species being excreted in another species
preferred ovipostioning site e.g. S. mansoni eggs in urine, see glossary) (Cunin et al., 2003; Ernould et
al., 1999). Furthermore, studies have also shown that where coinfections occur, although
homologous pairings appear to be preferred by all species, in mixed species infection, the unpaired
males of one species will normally be more dominant in ‘stealing’ females from the other species
(Southgate et al., 1998). In a laboratory study by Webster et al. (Webster et al., 1999), S.
haematobium males were competitively dominant over S. mansoni males and removed females from S.
mansoni males in homologous or heterologous pairs when females were scarce (Webster et al., 1999).
In addition, the presence of ectopic eggs in mixed schistosome species infections in the field has been
suggested as evidence of this inter-specific competition occurring between S. haematobium –S.
mansoni (Cunin et al., 2003; Ernould et al., 1999). Recent studies have also suggested that S.
haematobium and S. mansoni coinfections may have an important impact on host morbidity and the
outcome of species-specific morbidity measures in particular (Cunin et al., 2003; Koukounari et al.,
2010). Furthermore, one could predict that inter-specific interactions in the human host, whether
through direct competition or indirectly via the host’s immune system, could affect the intra-specific
genetic diversity of each interacting species. This may be of profound evolutionary and
epidemiological importance as it has been shown through empirical and theoretical studies that intra-
specific diversity can impact the evolution of critical life-history traits such as virulence, longevity and
reproductive fitness (Davies et al., 2002a; Gower and Webster, 2004, 2005; Rigaud et al., in press), not
to mention the potential spread of praziquantel (PZQ) insusceptible genotypes after mass drug
administration (MDA) (Webster et al., 2008). However, to the author’s knowledge, there has been
little empirical research performed on the impact of schistosome species coinfections on disease
outcome and none on the genetic population of schistosome species within humans.
Chapter 3 addressed the latter in a West African setting. It was found that coinfections did indeed
appear to affect the intra-specific genetic diversity of both parasites in mixed infection villages in
Niger. In that study/chapter, the prevalent species was S. mansoni relative to S. haematobium. (Garba,
A. unpublished data, in press), with the latter species infections becoming absent post PZQ MDA.
Also of interest was the lack of sub-structuring and reduced genetic diversity post MDA observed in
the S. mansoni population in one of the mixed infection villages and in two single species S.
haematobium villages in Niger (see chapter 3). This apparent lack of a bottleneck effect of PZQ
treatment on the S. mansoni population contrasted to that observed in previous recent studies in
Tanzania (Norton et al., 2010) and Uganda (unpublished observations, Lamberton, P.H.L and
colleagues), where genetic diversity was significantly reduced post MDA. It was suggested that this
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may be due to the focal nature of schistosomiasis in particular regarding the different epidemiological
settings of the study sites in Niger vs. Tanzania/Uganda (both from Lake Victoria) such as the,
proportion of parasite population in refugia and presence of two human schistosome species. The lack
of sub-structuring in S. haematobium was largely supported by previous studies using different
(Randomly Amplified Polymorphic DNA) markers (Brouwer et al., 2001; Dabo et al., 1997; Shiff et
al., 2000) and current studies in Mali and Cameroon (Webster, J and Gower, C pers.com) using
microsatellite markers.
However, such comparative studies on S. haematobium population genetics per se are few and far
between. Indeed, this contrasts starkly to the significant increase in the research interest focused on
Schistosoma mansoni and Schistosoma japonicum, culminating most recently in the successful
sequencing and mapping of both the genomes of these species in 2009 (Webster et al., 2010). One
reason for the distinct paucity of information and research on S. haematobium is partly due to the
innate difficulty faced with all human schistosome studies, namely that the adult stages live inside the
venules of the liver thereby making direct sampling only possible through subsequent indirect
laboratory animal passage (or post-mortem). Furthermore, whereas S. mansoni and S. japonicum
successfully use other mammals as their definitive hosts, and hence are relatively easy to transfer to a
laboratory-passage model, S. haematobium is far less flexible, rarely infecting any species other than
Homo sapiens and still rarer, non-primates. Therefore maintaining it in the laboratory is only achieved
by passaging through an inefficient host, the hamster, often leading to large host selection bias and
loss of field collected ‘wild’ strains (Pinto et al., 1997).
However, recent developments and improvements in molecular sampling and techniques now enables
us to perform genetic studies in the field by using direct sampling and analyses of the schistosome
larval stages, the miracidium and cercaria, and thereby avoid the inherent biological, ethical and
logistical issues of obtaining adult worms through laboratory animal passage (Shrivastava et al., 2005;
Gower et al., 2007). Both have advantages and disadvantages. For example although cercariae provide
numerous genetically identical samples, snail collections are extensive and laborious often requiring
thousands of snails to be collected in order to obtain just a handful of schistosome infected ones even
in endemic areas. Miracidia collected from infected humans is a less labour-intensive method.
Nevertheless, molecular analyses on such larval stages remains problematic, since only a limited
amount of DNA can be extracted from miracidia, due primarily to their small size (S. mansoni and
S.haematobium-180 µm x 80 µm, S. japonicum- 80 x 63 µm). A solution is thus to utilize PCR-based
methodology to amplify the extracted DNA from miracidial samples collected directly from the field.
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One initial methodological development here involved microsatellite amplification of single S.
japonicum larvae (Shrivastava et al., 2005). However, this methodology required samples to be frozen
on collection and was limited to single locus analyses per individual, which not only requires prior
information about parasites in the region regarding the presence of linkage (dis)equilibrium between
the loci used in the study (Rosenberg et al., 2002), but also requires a large number of larval samples
per individual host (the number required being the product of the sample size per locus and the number
of loci). A substantially refined alternative methodology, which allowed for the larval sampling and
PCR amplification of up to seven microsatellite loci from individual S. mansoni larvae collected
directly from infected individuals and stored at room temperature on Whatman FTA® cards prior to
analysis was then developed (Gower et al., 2007). Nevertheless, though a significant breakthrough in
terms of opportunity for population genetic analyses of schistosomes, even the latter technique was not
without certain logistical difficulties. In particular, in addition to the issues inherent in all PCR
amplification techniques, where precise optimization and strict protocols in the laboratory are
imperative and where poor quality DNA could potentially bias the results with genotyping errors
having to be carefully controlled for, the aforementioned small size and limited DNA of individual
miracidia created further demands. To be precise, the nature of this approach, using standard
Whatman FTA® cards, effectively prevented the possibility of repeat genotyping on single miracidia,
thereby precluding the assessment of certain types of genotyping errors, in addition to limiting each
miracidium (or cercaria) to analyses using only one set of primers or a single genetic technique.
Furthermore, following such single analyses per single larva, no further DNA material was available
for archiving for future analyses as new tools and molecular markers become available. Multiple
displacement amplification, a technique used for whole genome amplifications (WGA), offers a
straightforward method of increasing DNA yield in these situations where the DNA starting material is
limited. This technique has been successfully applied to human genetics and a variety of other
organisms including, very recently, S. mansoni (Valentim et al., 2009). One would therefore suspect
that such WGA methodology for S. haematobium may be particularly pertinent. Firstly, given the
paucity of knowledge generally available on this species, and hence the limited microsatellite primers
available relative to that of the other schistosome species of human importance, WGA allows us to
elucidate and thereby quantify any potential genotyping errors associated with the available
microsatellite primers. Furthermore, a key benefit of WGA for S. haematobium lies in the fact that it
will help us confirm precise members of the S. haematobium group. This is pertinent because recent
studies have revealed that suspected S. haematobium infections in humans, characterized by blood and
schistosome eggs in urine, can, across several regions of West Africa in particular, be instead
indicative of either S. bovis, or a S. bovis - S. haematobium hybrid infection instead (Huyse et al.,
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2009). Furthermore, in areas of S. mansoni and S. haematobium mixed infections, ectopic and/or
hybrid eggs, as a consequence of some form of intra-host parasitic interaction and potential
competition, can be found in the urine (Cunin et al., 2003; Ernould et al., 1999). Given the limited
quantity of DNA available from single miracidia hatched from eggs for multiplex microsatellite
analyses alone, WGA could thereby provide sufficient quantities of stored DNA for repeat analyses
using a range of primers and methods to elucidate accurately the actual species, or species hybrid,
sampled from such individuals, in addition to allowing an archive of DNA for the future.
One further aim of the current study was therefore, for the first time, to develop, optimize and apply
WGA for S. haematobium adults and, in particular, larval stages and to test its suitability for the use in
genetic analysis following microsatellite amplification. Such methodology would thus be able to
complement that available for S. mansoni. Furthermore, we aimed here to apply directly such
innovative and optimized tools onto a novel and critical dataset, in order to elucidate the genetic
population structure of S. haematobium and S. mansoni in a mixed infection foci in the province of
Coastal Kenya, both before and after MDA with praziquantel (PZQ) chemotherapy. In particular I
aimed to elucidate the potential impact of coinfections on the intra-specific genetic diversity of both
schistosome species pre- and post-MDA.
Hypothesis
In the schistosome life cycle the site of growth, sexual maturation and pairing for all human
schistosome species is the hepatic portal system. Therefore one can predict that inter-specific
interactions such as competition for resources, density-dependent factors and mate pairing will
differentially affect the establishment and reproduction of schistosome genotypes thereby altering the
intra-specific genetic diversity of each species. Furthermore MDA has been shown to alter the
population genetics of schistosomes, potentially by reducing the effective population size of the
parasites, either by treating the optimum age group for transmission (6 to 15 year olds) and/or by
introducing a PZQ assisted partial immunity.
Predictions
1. WGA, which has already been shown to be a suitable technique for the analysis of S. mansoni
can also be applied, and is beneficial to S. haematobium genetic populations studies.
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2. Inter-specific interactions, whether direct via competition for resources or indirectly via the
host’s immune system, will reduce the range of different genotypes of either species able to
establish in a coinfected host – and therefore intra-specific genetic diversity will be reduced in
S. haematobium infra-populations (population of parasite in an infected individual) in mixed
infections relative to single infection infra-populations when controlling for infection intensities
(i.e. using allelic richness rather than allelic numbers). Similarly intra-specific genetic diversity
will be reduced in S. mansoni infra-populations in mixed infections relative to single infections
infra-populations when controlling for infection intensities.
3. Intra and inter-specific diversity will be reduced post treatment compared to baseline for both
species when controlling for infection intensities as treatment with PZQ is known to aid in the
partial acquired immunity to schistosomes. Therefore the number of different genotypes able to
establish a previously treated host will diminish, so reducing intra-specific genetic diversity.
And additionally, as the two species’ response to PZQ is known to be quite different and indeed
as is that of different genotypes within species (Webster et al., 2008) it can be assumed that
MDA will bias future infections towards the species or genotypes that are more tolerant of PZQ
or, at least, have a life history trait that becomes advantageous post MDA. Hence inter-specific
competition will be altered and potentially its impact, or evidence of its impact, will be
removed.
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Materials and Methods
Study Area and population
Taveta is a small town in the Taveta District of the Coastal Province in Kenya on the border with
Tanzania (Figure 1, GPS coordinates 3° 24' 0" South, 37° 41' 0" East). At baseline and 12 month post
MDA, a survey took place in two neighbouring schools: Abori and Kilwalwa. The details of the
collection of data and samples from children are outlined in chapter 2 of this thesis.
Parasitological examination and parasite DNA collection, storage and
extraction
As outlined in chapter 2, children (ages 6 to 16) entered in the study were given a unique identification
number after their names, age, and gender were recorded. They were then provided with two pots
labeled with their unique identification number, one for urine and one for stool samples. Infection
status and infection intensities were then determined via parasitological examination by double Kato-
Katz slides and urine filtration. Positive children were asked to provide a full pot of each sample
allowing for miracidia collection and hatching. Eggs from each sample were washed and collected
into Petri dishes for hatching. Once hatched, miracidia were collected from each sample and stored
on Whatman FTA® cards (see Annex II).
Whole Genome Amplification
Schistosoma miracidia stored on indicating Whatman FTA® cards were removed using a Harris
MicroPunch and placed in a 96-welled microplate. Miracidia samples were washed in FTA
purification reagent (Applied Biosystems) and Tris-EDTA (TE) Buffer and then dried at 55°C for 20
minutes or for one hour at room temperature. The REPLI-g UltraFast Mini Kit from Qiagen was used
according to the manufacturers’ instructions. When used on Whatman FTA® stored DNA (after
extraction protocol see above) care was taken to ensure that the reagents reacted with the Whatman
FTA®. The plate was placed in a Thermocell Dry Block Heater and heated to 30 degrees Celsius for
90 minutes and then to 65 degrees Celsius for 3 minutes as per REPLI-g protocol. The plate was then
stored in a -20 freezer.
Molecular Analysis of Parasite Samples
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Multiplex PCR, using microsatellite loci, was utilized to genotype schistosome DNA from S. mansoni
miracidia, as described by (Gower et al., 2007). For S .haematobium individual miracidia were
genotyped using a newly developed assay allowing genotyping at 8 microsatellite loci (Gower et al.,
unpublished data) utilizing five novel and three previously published S. haematobium microsatellite
loci in a single reaction (Golan et al., 2008). Novel primer pairs had been designed for the previously
published loci that were compatible with the novel multiplex assay.
Microsatellite Loci
Seven-microsatellite loci were used to genotype S. mansoni parasite DNA, namely SMD28, SMDA28,
SDM25, SMD89, CA11-1, SMS9-1 and SMU31768 (see table 1a). The forward (5’ strand) primer of
each pair was fluorescently labeled with NED, 6-FAM, VIC, PET and NED. Overlapping size ranges
were labeled with different coloured fluorescent dyes. Eight microsatellite loci were used to genotype
S. haematobium parasite DNA namely C2, C11, C102, C111, C116, C131, C146 and D3. The forward
primers of each pair were labeled as described above. Table 1b shows information for the three
published primers; the others were developed recently and are yet to be published.
Multiplex PCR
S. mansoni miracidia stored on indicating Whatman FTA® cards were removed using a Harris
MicroPunch® and placed in a 96-welled microplate. Miracidia samples were washed in FTA
purification reagent (Fisher Scientific) and Tris-EDTA (TE) Buffer and then dried at 55°C for 20
minutes prior to adding 25μl of reagent mix constituting of 2.5µl primer mix (1pmol/µl of each primer
in deionised water), 12.5µl Multiplex mix (NaCl2, dNTP, HotStarTaq DNA polymerase) and 10µl
pure dionised H2O (Qiagen Multiplex PCR Kit). A Gene Amp® PCR system 9700 (Applied
Biosystems, Cheshire, UK) or a PTC-200 Thermal Cycler (MJ Research) was used to perform a step-
down PCR commencing with a hot-start activation at 95°C for 15 minutes, followed by 40 cycles of
30 seconds at 94°C, 90 seconds at annealing temperature (2 cycles at each temperature from 58 to
49°C followed °C by 20 cycles at 48°C), 60 seconds at 72°C and a final extension of 30 minutes at 60.
The amplified fragments were diluted in N,N’-dimethyl formamide and along with LIZ-500 size
standard (Applied Biosystems) were separated by capillary electrophoresis using an ABI Prism 3730
Genetic Analyser (performed by DNA Facility at the Natural History Museum, London). S.
haematobium miracdia stored on indicating Whatman FTA® cards were removed and washed as
described for S. mansoni. Reactions were performed in 25µl reagent mix with a ratio of 1:9:10 for
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primer mix, distilled water and Multiplex mix (Qiagen Multiplex PCR Kit). A step-down PCR
commencing with a hot-start activation at 95°C for 15 minutes, followed by 20 cycles of: 30 seconds
at 94°C, 90 seconds at annealing temperature (2 cycles at each temperature from 60°C to 51°C every
1°C then 20 cycles at 50°C ) then 60 seconds at 72°C followed by 20 cycles of: 30 seconds at 94°C, 90
seconds at 53°C, 60 seconds at 72°C and a final extension at 60°C for 30 minutes. The amplified
fragments were dilated 5 fold in autoclaved deionised water and along with Genescan-500 LIZ size
standard (Applied Biosystems) separated by capillary electrophoresis using ABI PRISM 3730 Genetic
Analyser at the Geneservice facility at Oxford University.
Controls
On a 96 welled PCR plate the controls for the WGA runs included; extracted DNA from one randomly
selected isolate of S. mansoni or S. haematobium adult worm stored in RNalater® (see section below
for details); one well of WGA master mix only; and one water only well. The controls for the
microsatellite multiplex runs were the positive controls from the WGA PCR plate (adult DNA) the
two negative controls from the WGA plate and one well of microsatellite multiplex mix only and one
of water only. These wells allowed me to test for any contamination at the WGA or the multiplex
PCR stage.
RNAlater stored DNA for Whole Genome Amplification optimization
Seven S. haematobium Senegal strain adults (4 females and 7 males) and 5 S. mansoni Senegal strain
adults (1 female and 4 males) were extracted from the livers of laboratory mice as described in
(Webster and Woolhouse, 1998). Each was stored in 1.5ml of RNAlater (Webster, 2009). The genetic
material was extracted using Qiagen Animal Tissue kit as described by the manufacturer’s manual.
The extracted DNA material was genotyped by straight microsatellite multiplex runs (reference
genotype) and then 4 independent runs using the WGA protocol were run on each S. haematobium
worm (4 replicates) and 3 in the S. mansoni worms (3 replicates). Errors were calculated as outlined
by Pompanon et al. (Pompanon et al., 2005) (see Table 2).
Genetic Data Analysis
Number of miracidia samples used in analysis
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Molecular analysis was performed on up to 30 miracidia per child to ensure an adequate representation
of the genetic population of the schistosome species in the area. Allele size was determined using
GeneMapper Version 4.0 (Applied Biosystems). Analysis was restricted to miracidia with at least 3
allele calls when using S. mansoni primers and at least 4 allele calls when using S. haematobium
primers to reduce risk of false amplification or stuttering. For the genetic analysis of field data, 968 S.
haematobium miracidia from 50 children were included in the analysis. Of these children, 29 were
from baseline time point (556 miracidia) and 21 were from 12 months post treatment time point (412
miracidia). 276 miracidia from 19 children were processed using S. mansoni primers. Of these
children 12 were from baseline time point (176 miracidia) and 7 were from 12 month post treatment
time point (100 miracidia).
Population structure, genetic diversity indices and software
For each parasite species, parasite infra-populations at baseline (all parasites collected from all
children at baseline) and 12 months post treatment were pooled together and the number of alleles
(An) and allelic richness (Ar) was calculated using FSTAT version 2.9.3.2. (Goudet, 2002), the
number of private alleles (Ap), being alleles only found in one infra-population, were calculated using
GDA version 1.1 (Lewis and Zaykin, 2001) and observed heterozygosity (Ho), expected
heterozygosity (He) and departures from Hardy-Weinberg equilibrium was tested for using Arlequin
version 3 (Excoffier et al., 2005). Allelic richness (Ar), observed heterozygosity (Ho), Nei’s unbiased
gene diversity (Hs) (Nei and Saitou, 1986) and the inbreeding coefficient (Fis) were calculated for
each parasite infra-population grouped by infection status (single species infected and coinfected) and
treatment time point (baseline and 12months post MDA) in the relevant villages using FSTAT version
2.9.3.2 (Goudet, 2002) and significant differences between groups were calculated by using 15000
permutations, the highest permutation number available on FSTAT.
Parasite genetic structure in each village was determined by calculating Wright’s hierarchical F-
statistics (Wright 1978) in Arlequin using an Analysis of Molecular Variance (AMOVA) method
(Excoffier et al., 2005). A three level hierarchical analysis was performed so that genetic variance
could be partitioned into Level 1 (individual miracidia), Level 2 (population of miracidia in a single
child i.e. infra-populations) and Level 3 (miracidia grouped by children grouped by treatment time
points or infection status). A hierarchical analysis is necessary to account for the potential relatedness
of miracidia from each infra-population. Ninety five percent confidence intervals (95% CI) were
calculated by bootstrapping over populations and subpopulations for each locus in Arlequin and
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testing for Fst values greater than zero at the P<0.05 significance level. The neighbour-joining tree
method in Powermarker (Liu and Muse, 2005) based on the C.S. Chord genetic distance (Cavalli-
Sforza and Edwards, 1967) was employed for phylogenetic reconstruction. The reliability of tree
topology was tested by generating 100 bootstrapped trees in Powermarker. These trees were then
analysed in PHYLIP version 3.67 (Felsenstein, 1993) using the consensus package to calculate
bootstrapping values for each cluster. STRUCTURE version 2.1 (Pritchard et al., 2000) was used to
infer population structure based on Bayesian clustering analysis. Simulations in STRUCTURE were
carried out using the admixture option (allowing for some mixed ancestry within individual isolates as
advised by program authors and is considered best by Falush et al. (Falush et al., 2003) in the case of
subtle population structure) with a burn-in of 10000 and a run length of 100 000 using a model in
which allele frequencies were assumed to be correlated within populations. To detect the true number
of cluster (K), an ad hoc statistic ‘Ln P(D)’ of K provided by STRUCTURE was used as described by
the program’s manual (Pritchard et al., 2000).
Preliminary analysis was done to determine whether samples could be pooled together across villages.
Thus all baseline S. haematobium miracidia samples were combined and analyzed to see if there was
any genetic differentiation across geographical areas in Taveta, Coastal Kenya. Similarly all baseline
S. mansoni miracidia samples were combined and analyzed to see if there was any genetic
differentiation across geographical areas in Taveta, Coastal Kenya. No clustering or population
differentiation was found (data not shown) so the samples from both schools were pooled together.
Ethical Considerations
Ethical approval was obtained from the Ethical Review Board of National Museums of Kenya/Kenya
Medical Research Institute ethical review committee and from the Imperial College Research Ethics
Committee (ICREC), Imperial College London, UK in combination with the ongoing Schistosomiasis
Control Initiative (SCI) activities. Written consent for the schoolchildren to participate in longitudinal
monitoring of the national control program for shistosomiasis was given by head teachers due to the
fact that in African schools, written consent of the child’s guardian is very difficult to obtain (owing to
the associated impoverished conditions and often low literacy). The parents/guardians verbal consent
was recorded at school committees comprising of parents, teachers and community leaders after they
received satisfactory information about the study. Each individual child also gave verbal consent
before recruitment.
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Results
Optimization of Whole Genome Amplification
RNAlater stored DNA
All of the 11 S. haematobium and 5 S. mansoni adults successfully amplified when using
microsatellite only and the WGA replicates. The ‘mean error rate per allele’ and the ‘mean error rate
per locus’ for each locus is shown in Table 3a and for Table 3b for S. haematobium and S. mansoni
respectively. The overall mean error rates across all loci were 0.07 and 0.1 for S. haematobium
respectively and 0.13 and 0.24 for S. mansoni respectively. However it is important to look at the
nature of the error as well as the rate itself. It was noted that whilst the majority of the errors for both
primer sets were primarily due to failed amplification at a random locus or allele the D3 primer of S.
haematobium had a high level of miscoding (giving different alleles to those found in the reference
genotype). This also was an issue for the smu31768 S. mansoni primer, although this may be due to a
practical error in the WGA preparation that occurred for the third replicate of the S. mansoni WGA
and thus was ignored. When excluding the D3 locus from the samples the mean error rate per allele
and per locus across all loci for S. haematobium was found to be 0.04 and 0.07 respectively. I decided
to exclude the D3 locus from all genetic analysis until further evaluation can be performed.
Analysis of genetic population of mixed schistosome foci in Taveta, Kenya
A preliminary analysis was performed to determine whether there were any differences between the
two neighbouring schools for S. haematobium and S. mansoni samples. No clustering or population
differentiation was found (data not shown) so the samples from both schools were pooled together.
Impact of single vs. coinfection on S. haematobium genetic population
Baseline and post treatment samples were grouped according to infection status i.e. whether infected
by S. mansoni only, S. haematobium only or infected with both species (coinfected). At baseline Ar,
Ho and Hs were all higher in coinfected individuals compared to uninfected whereas Fis was lower in
coinfected (Table 4). However of these values only Ho was significantly different with Fis reaching or
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approaching significance (two-sided P value after 15000 permutations 0.04 and 0.07 respectively). At
12 months post treatment, Ar appeared to be slightly lower and Fis slightly higher in coinfected
relative to baseline whereas there appeared to be little difference in Ho and Hs. However none of these
values were significantly different after permuting 15000 times (Table 5 and Figure 2). The
hierarchical AMOVA estimated the within infra-population variance component to account for 95%
and 94% of the genetic variance at baseline and 12 months post treatment respectively (Tables 6a and
6b), whereas the variance component between single and coinfections accounted for 0.13% and 0.31%
of the genetic variance with an estimated Fst value of 0.0013 and 0.0031 respectively (95% CI from
bootstrapping: -0.00136 to 0.00356 and -0.00036 to 0.0067 respectively). This indicates that there
was no significant genetic differentiation of parasite population between single and coinfections at
baseline or at 12 months post treatment in the S. haematobium population.
Impact of single vs. coinfection on S. mansoni genetic population
Only children at baseline produced enough miracidia for analysis, therefore this analysis was only
performed with baseline samples. Ar, Ho, Hs and Fis were all higher in coinfected individuals
compared to uninfected (Table 4). However of these values only Hs was significantly different with
Ar approaching significance (two-sided P value after 15000 permutations were 0.009 and 0.06
respectively). The hierarchical AMOVA estimated the within infra-populations variance component
to account for 94% of the genetic variance (Table 6c) whereas the variance component between single
and coinfected groups accounted for 1.84% of the genetic variance with an estimated Fst value of
0.018 and 95% CI from bootstrapping: -0.0002 to 0.04). This indicates that there may be a weak
genetic differentiation of parasite population between single and coinfected groups in the S. mansoni
population, however bootstrapping values indicate that this may not be significant.
Impact of PZQ treatment on S. haematobium genetic population
Measure of number of alleles and gene diversity indicated high levels of polymorphism at 6 of the 7
markers, with the exception of locus C131 which was monomorphic for many infra-populations;
however this marker did prove useful in highlighting private alleles. Departures from H-W
proportions were observed across all loci pre and post treatment. Across all loci the number of alleles
and private alleles appeared to decrease from baseline to 12 months post treatment (Table 7).
Measures of Ar, Hs, Ho and Fis across samples were lower at 12 months post treatment relative to
baseline (Table 5) and the two sided P-values obtained after 15000 permutations were significant for
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Ar, Hs and Fis (0.01. 0.02 and 0.01 respectively). STRUCTURE analysis revealed no discernable
clustering of genotypes according to treatment time points nor were there any clear clusters observable
in the neighbour-joining phenograms constructed at the individual child level (results not shown). The
hierarchical AMOVA estimated the within individuals variance component to account for 95% of the
genetic variance (Table 8), whereas the variance component between baseline and 12 months post
treatment accounted for little if any of the genetic variance (-0.04%) of the total genetic variation with
an estimated Fst value of -0.00045 (95% CI from bootstrapping: -0.00135 to 0.00059). This indicates
that there is no significant genetic differentiation of parasite population between baseline and 12
months post treatment in the S. haematobium population.
Impact of PZQ treatment on S. mansoni genetic population
Measure of number of alleles and gene diversity indicated high levels of polymorphism at all 7
markers. All of the loci showed significant loss of heterozygosity and departure from H-W proportions
at baseline and 12 months post treatment. Across the majority of loci the number of alleles and private
alleles appeared to decrease from baseline to 12 months post treatment (Table 9). Measures of Ar, Hs,
Ho across samples were higher at 12 months post treatment relative to baseline (Table 5), although Fis
was lower at 12month post treatment relative to baseline. The two sided P-values obtained after 15000
permutations, were not, however, significant for Ar, Hs and Fis (0.33, 0.18 and 0.43 respectively),
whereas Ho was progressing to the significance level (0.07).
STRUCTURE analysis revealed no discernable clustering of genotypes according to treatment time
points nor were there any clear clusters observable in the neighbour-joining phenograms constructed at
the individual child level (results not shown). The hierarchical AMOVA estimated the within infra-
populations variance component to account for the majority (96%) of the genetic variance (Table 10)
whereas the variance component between baseline and 12 months post treatment did not account for
any of the genetic variance (-0.5% of the total genetic variation with an estimated Fst value of -0.0048
and 95% CI from bootstrapping: -0.0064 to -0.0023). This indicates that there was no significant
genetic differentiation of parasite population between baseline and 12 months post treatment in the S.
mansoni population.
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Discussion
To the author’s knowledge this is the first time that the whole genome amplification technique (WGA)
has been optimized and used for S. haematobium samples and also the first time the impact of
coinfections on the intra-specific genetic diversity of both S. haematobium and S. mansoni has been
addressed in East Africa. The successful optimization of WGA for S. haematobium and S. mansoni
samples may be of great benefit for current and future research on schistosome genetics. There have
always been inherent disadvantages of using the miracidium stage in genetic analysis due to the low
quantity of genetic material thus certain errors such as loss of alleles or simply difficulty in coding can
occur. The limiting amount of genetic material also removes the possibility of repeat genotyping to
check for errors. Thus this technique provides a practical method of increasing the quantity of
template DNA, thus allowing for repeat genotyping of samples to test for errors. More template DNA
also permits the analysis of ectopic or hybrid eggs in areas of multiple schistosome species infections,
which often may require the use of different primer sets or molecular markers for species
identification. Additionally this technique enables archiving of important template DNA for future
research either using different markers for genetic population studies which is severely lacking in S.
haematobium research (Rollinson, 2009) and/or for the development of particular genetic markers of
interest such as potentially PZQ resistance, parasite virulence and pathogenicity. The results presented
in this chapter, using these novel techniques, support the hypothesis that inter-specific interactions
between S. haematobium and S. mansoni in coinfected individuals do affect the genetic diversity of
both species at the intra-specific level. It is interesting to note that contrary to what was predicted,
genetic diversity indices and inbreeding coefficient were higher in coinfected individuals for both
species at baseline; yet, this difference disappeared post MDA in the S. haematobium population. This
may indeed have a plausible explanation. As I highlighted in the introduction, mate switching is a
well known phenomenon in schistosome infections with males pairing with different females
especially in an inter-specific competition setting (Tchuem Tchuente et al., 1996). Also there may
indeed be competition for females in S. haematobium and S. mansoni coinfected individuals, with
unpaired males readily forming heterologous pairs (Webster et al., 1999). Therefore mate switching
could be expected to be higher in coinfected individuals relative to single infections. This would lead
to an increase in different recombination events additionally resulting in an increase in the intra-
specific genetic diversity. The higher measure of inbreeding coefficient in coinfections relative to
single infections may indicate two potential biological explanations; firstly that, in coinfections, less
genotypes of each species are able to establish thus the increase of mate switching is occurring in less
genetically different worms; and/or it has been theorized that competition for mates is actively
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performed by the males for females with high fecundity rates therefore males of both species may be
competing for an even smaller number of females (Tchuem Tchuente et al., 1996). Therefore in both
cases inbreeding will be higher in coinfected individuals relative to single infections. The impact of
MDA on this observed inter-specific interaction is potentially detected in the single vs. coinfection
results 12 months post MDA. Here there is an apparent lack in significant difference between the
intra-specific genetic diversity found in single S. haematobium infections relative to that in
coinfections. Since at both time points in Taveta the prevalence of S. haematobium was higher than
for S. mansoni (chapter 2 and Kariuki C pers.com) it is plausible that after treatment with PZQ S.
haematobium parasites were able to establish themselves before inter-specific interactions, following
subsequent S. mansoni infections, could, through competition or host immune response, hinder the
establishment of diverse S. haematobium genotypes. Therefore in single S. haematobium infections
intra-specific genetic diversity was as high as that found in coinfections, post treatment. However the
observed level of genetic diversity post MDA had not reached the genetic diversity levels detected pre-
treatment, reasons for which are addressed below (Figure 2).
In agreement with other molecular analysis of the genetic population structure of S. haematobium,
(Brouwer et al., 2001; Dabo et al., 1997; Davies et al., 1999)and Gower C unpublished data), there
seems to be no substantial genetic differentiation in the S. haematobium populations analyzed in this
study. However the impact of PZQ treatment on schistosome genetic population heterogeneity is of
particular interest in this case as this is the first time a bottleneck effect has been observed in the S.
haematobium parasite population one year after MDA. In addition an effect of PZQ treatment was
also observed on the S. mansoni population indicating an increase in genetic diversity post treatment
which is contrary to similar studies done in Tanzania and Uganda (Norton et al., 2010) and Lamberton,
P.H.L. unpublished data) where PZQ treatment has resulted in a bottleneck effect on the S. mansoni
population. It is plausible that the unusual effect of PZQ treatment on the two schistosome
populations may be due to the particular epidemiological settings in Taveta, for example the effective
population size, proportion of parasite population in refugia and notably, the sympatry of S.
haematobium and S. mansoni. The previous studies undertaken in Tanzania, Uganda, Cameroon and
Mali (Norton et al., 2010), Lamberton, P.H.L., Gower, C., Doel, A., Webster, J. unpublished data)
were in single species epidemiological settings, whereas chapter three in this thesis describes a similar
coinfection setting in Niger where a lack of bottleneck effect was observed in the S. mansoni
population post treatment. However, in the study in Niger, S. mansoni was the prevalent schistosome
species and S. haematobium all but disappeared post treatment. As already mentioned above, in this
setting in Taveta S. haematobium is the prevalent species and persists after treatment (through
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reinfection) therefore this impact of treatment in a predominantly S haematobium, coinfection area is a
unique find. Contrary to Niger where the less prevalent species all but disappeared post treatment, here
the less prevalent species persists and in fact percentage of children with S. mansoni infections (either
single or in coinfections) is higher post treatment relative to baseline (chapter 2 Tables 1a and 1b).
This may reflect both the differential response of these two species to PZQ MDA and also the
difference in inter-specific interactions and competitive fitness of these species in two different foci
(Niger vs. Kenya). Therefore the reduction in allelic richness of S haematobium post treatment
(Figure 3) may be an indirect impact of the increase in S. mansoni infections post MDA in the area as
is the increase in the allelic richness of S. mansoni post MDA (Figure 3). It would be interesting to
monitor the evolution of the inter-specific dynamics of these two species through continued MDA
control programs in order to determine if S. mansoni eventually replaces S. haematobium as the
prevalent species as has been observed in the Niger River valley, described in chapter 3 (Garba et al.,
2004).
Conclusions
To the author’s knowledge this is the first study examining the impact of human schistosome
coinfections and subsequent inter-specific interactions on the intra-specific genetic diversity of
parasite populations in East Africa. The results obtained support the hypothesis that inter-specific
interactions such as competition for resources and mate pairing will differentially affect the
establishment and reproduction of schistosome species genotypes thereby altering the intra-specific
genetic diversity of each species. Surprisingly, whilst the predictions were of lowered genetic
diversity in coinfections compared to single infections, the opposite, in fact, was found with allelic
richness being higher in S. mansoni and S. haematobium coinfections at baseline. This has important
implications in the evolution of schistosome life-history traits such as reproductive fitness and
virulence, and merits further research (Rigaud et al., in press). Contrary to previous studies which
showed a bottleneck effect on S. mansoni population post treatment (Norton et al., 2010), I found an
increase in the genetic diversity of the S. mansoni population and a decrease in the S. haematobium
population one year post PZQ treatment. This unique observation highlights the importance of
increased research efforts not only in S. haematobium genetic population structure which lags severely
behind that of other important human species (Rollinson, 2009) but also that of monitoring the genetic
population of both species in single and coinfection settings through MDA control programs.
Furthermore this study applies a useful, new technique previously developed for S. mansoni (Valentim
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et al., 2009), to S. haematobium, allowing for repeat genotyping, development of new markers and
archiving of field collected genetic material for future research.
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Tables
Table 1a: S. mansoni Microsatellite primers Locus, Gene Bank number, repeat motif, size range and
reference papers
Locus Gene Bank Repeat Motif Size Range (bp) Reference
SMDA28 AF325659 GATA 92 - 128 Curtis et al. (2001)
SMD25 AF202965 CA 272 – 312 Durand et al. (2000)
SMD28 AF202966 CAA 230 - 245 Durand et al. (2000)
SMD89 AF202968 TC 138 - 169 Durand et al. (2000)
CA11-1 AI068336 GA, GT 191 - 231 Blair et al. (2001)
SMS9-1 AF330106 GT 178 - 208 Blair et al. (2001)
SMU31768 U31768 GAT 179 - 247 Durand et al. (2000)
Table 1b: S. haematobium Microsatellite primers Locus, Gene Bank number, repeat motif, size range
and reference papers
Locus Gene Bank Repeat Motif Size Range (bp) Reference
C102 N/A ATT 183-194 Unpublished
C2 EF608044 TTA 119 - 222 Golan et al 2008
C11 N/A TAA,TAA 105-112 Unpublished
C111 N/A ATT 200-209 Unpublished
C131 EF608045 TTA 204 - 256 Golan et al 2008
C146 N/A TAA,TGG,TAA 155-174 Unpublished
D3 EF608047 TAGA, TTGA 287 - 306 Golan et al 2008
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Table 2: Calculation of genotyping errors as outlined by Pompanon et al. (Pompanon et al., 2005)
Name of error Equation Description
Mean Error per Allele Mean allelic error rate
eα = mα / 2nt
Where mα is the number of allelic
mismatches and 2nt is the number of
replicated alleles
Mean Error per Locus Mean error rate per locus
ep = ml / nt
Where ml is the number of single-
locus genotypes including at least
one allelic mismatch, and nt is the
number of replicated single-locus
genotypes. This equation was used
to identify error prone loci
Table 3a: Genotyping errors for S. haematobium primers following WGA
S. haematobium Locus Mean error per
allele
Mean error per
Locus
C102 0.03 0.07
C11 0 0
C111 0 0
C116 0.24 0.39
C131 0 0
C146 0.01 0.02
C2 0 0
D3 0.3 0.34
Overall Mean 0.07 0.1
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Table 3b: Genotyping errors for S. mansoni primers following WGA
S. mansoni Locus Mean error per
allele
Mean error per Locus
Ca11_1 0.07 0.14
s9_1 0.17 0.28
smd25 0.22 0.22
smd28 0 0
smd89 0.1 0.19
smda28 0.06 0.11
smu31768 0.31 0.56
Overall Mean 0.13 0.21
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Table 4: Impact of single vs. coinfections on mean diversity indices across infra-populations of S.
haematobium at baseline and post treatment and S. mansoni at baseline
S. haematobium Infection Status
(number of children)
Ar Ho Hs Fis
Baseline Single infections(19C) 3.156 0.35 0.599 0.414
Baseline Coinfections(9C) 3.479 0.398 0.614 0.323
12M PT Single infections(10C) 2.927 0.39 0.575 0.322
12M PT Coinfections(11C) 2.882 0.4 0.571 0.299
S.mansoni Infection Status
(number of children)
Ar Ho Hs Fis
Single infections(3C) 2.957 0.378 0.608 0.378
Coinfections(9C) 3.232 0.43 0.698 0.383
Ar, allelic richness; Ho, observed heterozygosity; Hs, Genetic Diversity; Fis, inbreeding coefficient;
Red - Significant difference (P<0.05) or approaching significance after 15000 permutations
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Table 5: Impact of PZQ treatment on the means diversity indices across infra-populations of S.
haematobium and S. mansoni
S. haematobium treatment time points
(number of children)
Ar Ho Hs Fis
Baseline(29C) 3.05 0.364 0.601 0.395
12M PT(20C) 2.897 0.391 0.572 0.35
S. mansoni treatment time points
(number of children)
Ar Ho Hs Fis
Baseline (12C) 3.167 0.42 0.68 0.382
12M PT(7C) 3.275 0.461 0.715 0.355
Ar, allelic richness; Ho, observed heterozygosity; Hs, Genetic Diversity; Fis, inbreeding coefficient;
Red - Significant difference (P<0.05) or approaching significance after 15000 permutations
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Table 6a: AMOVA of S. haematobium baseline samples grouped by Infection Status i.e. Single and
Coinfections
Source of
variation
Sum of
squares
Variance
components
Percentage
variation
Among infection status groups 6.20 0.00 0.13
Among infra-populations within infection
status groups
130.63 0.10 4.68
Within infra-populations 1782.79 2.07 95.18
Total 1919.62 2.18
Table 6b: AMOVA of S. haematobium post treatment samples grouped by Infection Status i.e. Single
and Coinfections
Source of
variation
Sum of
squares
Variance
components
Percentage
variation
Among infection status groups 7.40 0.01 0.31
Among infra-populations within infection
status groups
103.28 0.12 5.74
Within infra-populations 1330.70 1.98 93.94
Total 1441.39 2.11
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Table 6c: AMOVA of S. mansoni baseline samples grouped by Infection Status i.e. Single and
Coinfections
Source of
variation
Sum of
squares
Variance
components
Percentage
variation
Among infection status groups 9.62 0.05 1.85
Among infra-populations within infection
status groups
49.59 0.10 4.09
Within infra-populations 705.01 2.34 94.05
Total 764.22 2.49
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Table 7: S. haematobium mean number of alleles, allelic richness, private alleles, expected heterozygosity, observed heterozygosity at each locus across each
infra-population at baseline and 12months post treatment
C102 C11 C111 C116
An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho
Baseline 14 2 1.74 0.18 0.10 α 16 0 3.46 0.67 0.30 α 14 4 4.57 0.82 0.57 α 23 3 6.27 0.93 0.36 α
12M PT 11 1 1.39 0.14 0.08 α 16 1 2.80 0.63 0.32 α 11 1 3.90 0.82 0.64 α 19 1 4.75 0.90 0.43 α
Mean 12.5 1.5 1.56 0.16 0.09 16 0.5 3.13 0.65 0.31 12.5 2.5 4.23 0.82 0.61 21 2 5.51 0.91 0.40
C131 C146 C2 Overall
An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho
Baseline 9 6 1.24 0.06 0.05 α 18 1 5.15 0.86 0.62 α 13 4 4.47 0.81 0.56 α 15.29 2.86 3.84 0.62 0.37 α
12M PT 6 2 1.10 0.03 0.02 α 17 0 4.37 0.87 0.63 α 11 3 3.86 0.81 0.64 α 13.00 1.29 3.17 0.60 0.40 α
Mean 7.5 4 1.17 0.05 0.03 17.5 0.5 4.76 0.86 0.63 12 3.5 4.17 0.81 0.60 14.14 2.07 3.50 0.61 0.38
An , number of alleles; Ap , number of private alleles; Ar, allelic richness; He , expected heterozygosity; Ho, observed heterozygosity.
α Significant difference in heterozygosity (P<0.05)
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Table 8: AMOVA of S. haematobium samples grouped by treatment time points i.e. baseline
and 12months post praziquantel treatment
Source of
variation
Sum of
squares
Variance
components
Percentage
variation
Among treatment time points groups 4.52 -0.00 -0.05
Among infra-populations within treatment
time points groups
246.83 0.11 5.41
Within infra-populations 3007.17 2.01 94.64
Total 3258.51 2.12
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Table 9: S. mansoni mean number of alleles, allelic richness, private alleles, expected heterozygosity, observed heterozygosity at each locus across each infra-
population at baseline and 12months post treatment
Ca11_1 S9_1 SMD25 SMD28
An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho
Baseline 12 3 3.16 0.66 0.34 α 18 1 3.74 0.78 0.45 α 12 1 3.60 0.76 0.31 α 12 3 2.74 0.63 0.29 α
12M PT 10 1 3.41 0.71 0.44 α 15 0 3.71 0.77 0.47 α 11 0 3.65 0.77 0.43 α 12 3 2.85 0.64 0.26 α
Mean 11 2 3.29 0.69 0.39 16.5 0.5 3.73 0.77 0.46 11.5 0.5 3.62 0.77 0.37 12 3 2.79 0.63 0.27
SMD89 SMDa28 SMU31768 Overall
An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho An Ap Ar He Ho
Baseline 10 3 2.24 0.44 0.29 α 15 1 4.16 0.83 0.52 α 15 1 3.87 0.80 0.74 α 13.43 1.86 3.36 0.70 0.42 α
12M PT 8 1 2.62 0.55 0.30 α 14 2 4.10 0.83 0.50 α 13 0 3.84 0.80 0.83 α 11.86 1 3.45 0.72 0.46 α
Mean 9 2 2.43 0.49 0.30 14.5 1.5 4.13 0.83 0.51 14 0.5 3.85 0.80 0.78 12.64 1.43 3.41 0.71 0.44
An , number of alleles; Ap, number of private alleles; Ar, allelic richness; He , expected heterozygosity; Ho, observed heterozygosity.
α Significant difference in heterozygosity (P<0.05)
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Table 10: AMOVA of S. mansoni samples grouped by Treatment Time Points i.e. Baseline and
12months post praziquantel treatment
Source of
variation
Sum of
squares
Variance
components
Percentage
variation
Among treatment time point groups 3.01 -0.01 -0.48
Among infra-populations within treatment
time point groups
85.57 0.11 4.33
Within infra-populations 1104.71 2.39 96.15
Total 1193.29 2.48
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Figures
Figure 1: Map of Taveta & Taita District
From : United Nations Office for the coordination of humanitarian affairs (ochaonline.un.org)
Taveta
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Figure 2: Impact of single vs. coinfections on the mean allelic richness levels across infra-populations
for S. haematobium pre and post MDA and S. mansoni at baseline
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Figure 3: Impact of PZQ on Genetic diversity indices in S. haematobium and S. mansoni populations
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GENERAL DISCUSSION
In this thesis I used field-collected data to determine whether coinfections with the two major
African human schistosome species, Schistosoma haematobium and S. mansoni, affects human
morbidity outcome and parasite population genetics. Furthermore, the impact of Mass Drug
Administration (MDA) on human morbidity and parasite population genetics in mixed infection and
single S. haematobium foci was elucidated. In Chapter 2, I used species-specific morbidity data
collected from school children in an S. haematobium and S. mansoni co-endemic area in the Coastal
province of Kenya, to determine whether there were differences in morbidity outcome between
groups of children split by infection status, i.e. single infected, coinfected or uninfected. The results
presented indicated a potential impact of inter-specific interactions on S. haematobium-associated
morbidity, as coinfected children presented with lowered levels of S. haematobium-specific
morbidity compared to those with single species infections, although no impact on S. mansoni-
associated morbidity indicators were detected. This contrasted to results obtained in a recent study
performed on human morbidity data from Mali which revealed lower S. mansoni-associated
morbidity and aggravated S. haematobium associated morbidity in coinfections compared to single
infections (Koukounari et al., 2010). This suggests that, although inter-specific interactions between
S. haematobium and S. mansoni does indeed alter human morbidity outcome, the mechanisms by
which this occurs remains unclear and may be different in different epidemiological settings,
reflecting, in part, the focal nature of schistosomiasis. The difference between the effects of inter-
specific interactions on human host morbidity in Mali and in Kenya may also relate to the
differences in the schistosome parasites intra-specific diversity, i.e. S. mansoni genotypes in Mali
may be different to those in Kenya, and hence life history traits such as competitive dominance or
virulence may be different between the two. In addition, the response of the hosts’ immune system
may differ reflecting the heterogeneity of the human host or indeed snail intermediate host.
Ultimately, as parasitologists finally embrace the reality of polyparasitism and the need to study
parasite epidemiology and evolution from an interacting, multi-species community point of view, it
is important to note that human host morbidity outcomes will also be influenced by other infecting
infectious agents, from, for example Plasmodium species, soil transmitted helminths and other
trematodes in particular, not to mention a broad range of additional bacterial, viral and/or protozoal
organisms.
This study also addressed the potential impact of MDA with praziquantel (PZQ) on species-specific
morbidity indicators by collecting data from the same schools 12 months post MDA. There was a
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regression of morbidity, especially when examining those children with longitudinal data (both pre
and post MDA). Additionally there was a general increase in the proportion of uninfected children
and a reduction in infection intensities amongst those remaining infected. However, there also
appeared to be an increase in coinfections post MDA, and, furthermore, the reduction of S.
haematobium-specific morbidity in coinfections persisted post MDA. Another interesting result was
the observed liver morbidity associated with S. haematobium only infections. Past studies have
suggested a negative impact of S. haematobium infections of liver morbidity although, largely due to
the far more substantial impact of S. mansoni infections on liver morbidity, this has often been
overlooked especially by control programs where ultrasonography of the liver is mainly restricted to
S. mansoni infections only. However I suggest that the impact of S. haematobium infection on liver
morbidity should be re-evaluated and included in the assessment of morbidity regression post MDA.
Indeed, since schistosomiasis control programs, such as the Schistosomiasis Control Initiative (SCI),
focus on the regression and control of schistosoma-induced morbidity, these results, and other
studies where similar impact of schistosome coinfections and S. haematobium on the liver have been
detected (Koukounari et al., 2010), highlight the importance of monitoring the impact of
coinfections and S. haematobium-associated liver morbidity in future monitoring and evaluation
surveys integral to control programs.
The aims of chapters 3 and 4 were to determine the impact of S. haematobium and S. mansoni
coinfections on schistosome population genetic structure as assessed by microsatellite loci. The
results supported the hypothesis that inter-specific interactions such as competition for resources,
density-dependent factors and mate pairing will differentially affect the establishment and
reproduction of schistosome species genotypes thereby altering the intra-specific genetic diversity of
each species. Surprisingly, whilst the predictions were of lowered genetic diversity in coinfections
compared to single infections, the opposite, in fact, was found with allelic richness being higher in S.
mansoni and S. haematobium coinfections in mixed-species foci in Niger and Kenya. This finding
could have important implications in the evolution of schistosome life-history traits such as
reproductive fitness and virulence which have been shown to be influenced by intra-specific
diversity within hosts, and thereby merits further research (Rigaud et al., in press).
Interestingly the impact of MDA with PZQ on the population genetics of both S. mansoni and S.
haematobium were quite diverse both within and between studies. In chapter 3, carried out on genetic
material collected from Niger, the lack of impact of MDA on the S. mansoni population in
Namarigoungou was contrary to what was found in the neighbouring village of Diambala (and, as
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observed in recent studies in Tanzania (Norton et al., 2010) and Uganda (Lamberton, P.H.L. and
colleagues, in prep)), where reductions in genetic diversity post MDA and sub-structuring across
treatment time points were detected. The general lack of population genetic differentiation in S.
haematobium populations was in agreement with past studies potentially indicating high levels of gene
flow in this species, however a weak difference was found between villages which may be due to the
different epidemiological and geographical settings of Libore and Falmado (Niger River adjacent vs.
marshes fed by Niger River respectively). However in chapter 4, which presented population genetic
results from a mixed infection focus in Coastal Kenya, I found an increase in the genetic diversity of
the S. mansoni population and a decrease in the S. haematobium population one year post MDA. This
unique observation highlights the importance of increased research efforts not only in S. haematobium
genetic population structure, which lags severely behind that of other important human schistosome
species (Rollinson, 2009), but also that of monitoring the genetic population of both species in single
and coinfection settings through MDA control programs.
As already discussed in each chapter, there were a few caveats that could have been improved on
and/or potentially should be explored in future studies. In chapter 2 the single day double Kato Katz
slide methodology used to detect S. mansoni infections in the baseline survey may have
underestimated the prevalence of S. mansoni, whether in single and coinfected children, as single Kato
Katz have been shown to miss light S. mansoni infections in particular, and has lead the WHO to
recommend double Kato Katz slides to be performed over three consecutive days in order to increase
the accuracy of infection prevalence and intensity calculations (WHO, 2002). Furthermore, a
teachers’ national strike prevented us from locating and including all the previously infected children
from the baseline study, which subsequently reduced the power of our longitudinal statistical analysis.
However this is unfortunately one of the risks in field collected datasets particularly in rural areas of
developing countries. An important recommendation from this study, in agreement with recent work
on schistosomiasis morbidity (Webster et al., 2009) but with the added incentive of elucidating the
impact of mixed infections, is that more than one species-specific morbidity indicator should be
included in the monitoring and evaluation of all human host morbidity outcomes and MDA impact
studies. Indeed the results here (chapter 2), which used ultrasonography only in the 12 month post
MDA survey, would have greatly benefited from complementary incorporation of this technique for
the baseline data, especially as the impact of inter-specific interactions post MDA was detected by
ultrasonography of the bladder but not by urinary albumin results. Had it been possible, tests for
anaemia and stunting may also have contributed additional information on the impact of coinfections
and MDA on human morbidity. An interesting future study to be undertaken in Taveta concerns the
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high frequency of liver morbidity in the schistosome uninfected children. I believe this is almost
certainly due to coinfection with another infectious agent, particularly as the morbidity of this group
was detected by both clinical palpation and ultrasonography. My proposed hypothesis is that of
Fasciola infections which are known be prevalent in ruminants in Taveta and zoonotic infections of
Fasciola gigantica is known to occur (Mungube et al., 2006) in endemic areas. However other
aetiological possibilities should also be researched in order to treat the detected liver morbidity.
The use of population genetics for S. haematobium is still very much in its infancy and lagging far
behind S. mansoni (Rollinson, 2009). As additional genetic material of Schistosoma species is
collected from further foci in different countries and ecological settings, techniques such as WGA,
presented in chapter 4, will allow additional research using diverse molecular markers and techniques
to increase our patchy knowledge of Schistosoma population genetic structure across geographical and
temporal dimensions. Further research into schistosome population structure across different
geographical locations is required to elucidate the differing factors influencing both the local and
regional outcome of schistosomiasis and schistosome evolution. For example Figures 1 and 2 below
are neighbour-joining trees from preliminary analysis performed on the combined baseline dataset of
Niger and Kenya showing clear clustering by country for both S. mansoni, which would be expected
from past studies (Agola et al., 2006; Blank et al., 2009; Curtis et al., 2002; Stothard et al., 2009) but
also for S. haematobium, which has so far not been found (Webster, B. unpublished barcoding data of
S. haematobium). Understanding genetic population differences across geographical settings will
enable us to understand factors potentially influencing the local and regional transmission of
schistosomiasis and impact of control programs. Also this clear geographical clustering has important
implications for schistosome evolution as it could potentially reflect adaptation to local environmental
conditions and particular species and/or local genotypes of the intermediate host. This geographical
structuring for both species may also provide insight into the genetic differences and phenotypic
diversity in different areas/countries, and ultimately into the differential and focal nature of host-
parasite dynamics. It would help us determine which populations undergo high gene flow rates and
which are isolated and undergoing genetic drift. Furthermore this clear population structure may have
important implications in the potential spread of PZQ resistant/tolerant genotypes as this geographical
separation may limit the spread of PZQ resistance across countries. The impact of MDA on both
schistosomes should be monitored throughout control programs as repeated and prolonged exposure to
PZQ may introduce a strong selective pressure on the parasite population. It would also be beneficial
to use population genetics to estimate effective population size at each foci, gene flow between areas
and proportion of parasite population in refugia as these will all impact the strength of selection
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imposed by MDA control programs. Furthermore research into particular alleles and/or genotypes
linked to life history traits such as virulence or fecundity and even human host morbidity outcome
would greatly contribute to our understanding of schistosomiasis epidemiology and evolution.
Likewise, as schistosome species have an obligate asexual cycle in a molluscan intermediate host,
genetic population studies using cercariae and on the snail hosts themselves, combined with the
genetic population analysis of miracidia and outcome of human host morbidity would elucidate the
impact of the intermediate host and mutli-host-parasite dynamics on the population genetics and
evolution of Schistosoma species.
To conclude, this thesis has demonstrated an impact of potential inter and intra-specific interactions
on parasite population genetic dynamics and subsequent human host morbidity across co-endemic
regions on sub-Saharan Africa, all of which may have fundamental implications for our understanding
of the dynamics of multi-host, multi parasite systems in terms of epidemiology, evolution and
subsequent control.
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Figures
Figure 1: Neighbour-joining tree of Niger and Kenya S. haematobium baseline samples. Each line is
an infra-population; red lines are from Niger and green lines from Kenya
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Figure 2: Neighbour-joining tree of Niger and Kenya S. mansoni baseline samples. Each line is an
infra-population; purple lines are from Niger and orange lines from Kenya
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Figure 3: Children from Namarigounou
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APPENDIX I
Ultrasonography Forms
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Record Sheets for S. haematobium and S. mansoni ultrasonographic profile and calculations of liver
size adjusted by height taken from WHO/TDR Practical Guide to the Standardized use of
Ultrasonography for the Assessment of Schistosomiasis-related Morbidity
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APPENDIX II
PROTOCOL FOR COLLECTION OF SCHISTOSOME MIRACIDIA AND CERCARIAE
ON WHATMAN CARDS
AIM: collection of parasite DNA for microsatellite PCR analysis to investigate contribution of
parasite genetics to epidemiological patterns and response to mass chemotherapy.
Stool samples:
 Stool samples will be obtained from every child on plastic sheets. They will be broken up by
a toothbrush and passed though a 425micron sieve with ~1 litre bottled spring water; the suspension
will then be passed through a pitchford funnel consisting of two meshes: the inner mesh of
80microns to collect any debris but let the eggs through, and the outer one of 40 microns to collect
the eggs. Then the eggs will be released into a Petri dish and placed in indirect sunlight for up to 6
hours.
 Following the hatching of eggs, individual miracidia will be picked up using a pipette under
the binocular microscope, and transferred to a new Petri dish containing bottle spring water, in order
to minimize the presence of contaminants.
 Miracidia will then be collected individually using a Gilson pipette set at 5μl and placed
directly onto an FTA Whatman® card in a volume of 5μl of bottle spring water, and allowed to dry
for one hour. This stores the genetic material of the miracidia stably in ambient temperature without
damage.
 The collected and stored parasite DNA will be transported and analysed at Imperial College
London, where: for DNA extraction, a 2.0mm sample disk will be removed from the Whatman
FTA® cards using a Harris Micro Punch and incubated for five minutes in FTA® purification
reagent (Whatman plc, Maidstone, Kent). DNA samples will dry for 10 minutes at 56ºC before use
in PCR reactions.
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 A novel multiplex Polymerase Chain Reaction (PCR) assay will be used for DNA analysis.
PCR reactions will be performed on Gene Amp® PCR System 9700 (Applied Biosystems, Cheshire,
UK). Allele sizes will be calculated using ABI PRISM Genescan v 2.7 and Genotyper v 2.7
software (Applied Biosystems).
Urine Samples:
 Urine samples will be obtained from every child and poured through a pitchford funnel with
a 40 micron mesh to collect the eggs. ≈ 1litre of bottled spring water will be poured through the
mesh to ensure all eggs have collected at bottom. Then the eggs will be released in a Petri dish with
some spring water and placed in indirect sunlight for up to 6 hours.
 Miracidia will then be collected individually using a Gilson pipette set at 5μl and placed
directly onto an FTA Whatman® card in a volume of 5μl of bottle spring water, and allowed to dry
for one hour. This stores the genetic material of the miracidia stably in ambient temperature without
damage.
 The collected and stored parasite DNA will be transported and analysed at Imperial College
London, where; for DNA extraction, a 2.0mm sample disk will be removed from the Whatman
FTA® cards using a Harris Micro Punch and incubated for five minutes in FTA® purification
reagent (Whatman plc, Maidstone, Kent). DNA samples will dry for 10 minutes at 56ºC before use
in PCR reactions.
Cercariae collection:
 Snails will be collected and placed in tubes with 10/20ml of bottled water and left in indirect
light for 2 hours. This will induce the shedding of cercariae from any infected snail. The Tubes will
be checked for cercariae by holding them up to the light, if any are present they will clearly be seen
swimming about.
 After shedding, the water along with the cercariae will be poured into a Petri dish. Each
cercaria will be collected individually with a P20 Gilson pipette (so that the cercariae will not get
stuck onto the side of the tip as can happen with P10) in 5µl of water and stored on a FTA
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Whatman® card for genetic analysis. Two Whatman® cards will be filled (60 cercariae each) per
snail – one for barcoding and one for microsatellite analysis.
 For microsatellite analysis: The collected and stored parasite DNA will be transported and
analysed at Imperial College London, where; for DNA extraction, a 2.0mm sample disk will be
removed from the Whatman FTA® cards using a Harris Micro Punch and incubated for five minutes
in FTA® purification reagent (Whatman plc, Maidstone, Kent). DNA samples will dry for 10
minutes at 56ºC before use in PCR reactions.
A novel multiplex Polymerase Chain Reaction (PCR) assay will be used for DNA analysis. PCR
reactions will be performed on Gene Amp® PCR System 9700 (Applied Biosystems, Cheshire,
UK). Allele sizes will be calculated using ABI PRISM Genescan v 2.7 and Genotyper v 2.7
software (Applied Biosystems).
170
Whatman FTA Card
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APPENDIX III
Additional Results from Chapter 3
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Figure 1: Neighbour-joining tree of Namarigoungou S. mansoni infra-populations Baseline (BN), 6
Weeks (6WN), 6 Months (6MN) and 12 Months (12MN) post MDA
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Figure 2: Neighbour-joining tree of Namarigoungou S. haematobium infra-populations Baseline (BN)
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Figure 3: Neighbour-joining tree of Falmado S. haematobium infra-populations Baseline (BF), 6
Weeks (6WF), 6 Months (6MF) and 12 Months (12MF) post MDA
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Figure 3: Neighbour-joining tree of Libore S. haematobium infra-populations Baseline (BL), 6 Weeks
(6ML) and 12 Months (12L) post MDA
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Figure 4: Neighbour-joining tree of Baseline S.mansoni infra-populations from Namarigoungou (Nxx
& Naxx) and Diambala (DxxBase)
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Figure 5: Neighbour-joining tree of S.haemaoibium infra-populations from Namarigoungou (BNa),
Falmado (BF, 6WF, 6MF, 12MF) and Libore (BL, 6ML, 12ML) at different time points
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The burden of schistosomiasis in infants and preschool-aged children and their mothers is poorly
known. We carried out a cross-sectional epidemiological survey in two villages in Niger: Falmado is
endemic for Schistosoma haematobium only, whereas a mixed S. haematobium–S. mansoni focus has been
reported from Diambala. The survey examined 282 children (149 girls, 133 boys, average age: 2.6 years)
and 224 mothers (average age: 30.1 years). For S. haematobium diagnosis, two urine samples obtained
on consecutive days were subjected to the standard urine ﬁltration method. Additionally, macro- and
microhaematuria were determined. The diagnosis of S. mansoni was based on a single stool sample with
duplicate Kato-Katz thick smears. In Diambala, a standardised, pre-tested questionnaire was admin-
istered to mothers, which recorded demographic data, treatment history with anthelminthic drugs,
household sanitation andwater supply, and bathing practices for their children. Prevalence of egg-patent
S. haematobium infections among young children and their mothers was respectively 50.5% and 55.6%, in
Falmado, and 60.5% and 72.2% in Diambala. The prevalence of S. mansoni infection in Diambala was 43.8%
among children and 52.1% in mothers. Mixed egg-patent infections of S. haematobium and S. mansoni
were revealed in 28.6% of the children and 37.3% of the mothers. Questionnaire data showed that 69.8%
of the children were accompanied by their mothers to schistosomiasis transmission sites before they
were 1 year of age, and that three-quarter of the mothers used water directly drawn from the irrigation
canals to wash their children. To conclude, a substantive proportion of children below the age of 5
years had egg-patent schistosomiasis, inclusive of co-infection with S. haematobium and S. mansoni. In
the context of schistosomiasis control, more attention should be paid on preschool-aged children and
women of childbearing age, so that they can beneﬁt from preventive chemotherapy, which in turn might
e of tincrease effective coverag
. Introduction
Classiﬁed among the neglected tropical diseases (NTDs)
Molyneux et al., 2005; Hotez et al., 2006), schistosomiasis remains
ne of the most important parasitic diseases in the tropics and
ubtropics, and constitutes a major public health problem (van
er Werf et al., 2003; Steinmann et al., 2006). Schistosomiasis is
ndemic in Niger, with 3–4 million people exposed, the majority
∗ Corresponding author at: RISEAL-Niger, 333, Avenue des Zamakoye, B.P. 13724,
iamey, Niger. Tel.: +227 2176 5748; fax: +227 2075 3180.
E-mail address: garbamadou@yahoo.fr (A. Garba).
001-706X/$ – see front matter © 2010 Elsevier B.V. All rights reserved.
oi:10.1016/j.actatropica.2010.03.005hose infected.
© 2010 Elsevier B.V. All rights reserved.
of whom have Schistosoma haematobium infections (Garba and
Aboubacar, 2000), but there are recent signs that Schistosoma
mansoni is expanding along the Niger River Valley (NRV), probably
due to water-resource developments (Steinmann et al., 2006). The
main sites of transmission are the irrigated areas of the Niger River
and the semi-permanent and permanent ponds (Labbo et al., 2008).
Following the World Health Assembly (WHA) resolution 54.19 put
forth in May 2001 (WHO, 2002), Niger is implementing a national
schistosomiasis and soil-transmitted helminthiasis control pro-
gramme with the support of the Schistosomiasis Control Initiative
(Garba et al., 2006, 2009; Fenwick et al., 2009). The objective of
this programme is to reduce morbidity due to schistosomiasis
and soil-transmitted helminthiasis by treating at least 75% of all
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chool-aged children and other high-risk communities where the
revalence exceeds 50% with praziquantel and albendazole, a
trategy termed ‘preventive chemotherapy’ (Savioli et al., 2004;
arba et al., 2006, 2009).
By focusing treatment upon the school-aged population, WHA
esolution 54.19 neglects children of preschool age, thus pre-
enting them from beneﬁting from the praziquantel treatment
iven to their older peers, and hence creating a potential health
nequity (Johansen et al., 2007; Stothard and Gabrielli, 2007). Root
auses include the belief that very young children would not yet
een exposed to infested freshwater bodies, thus an insufﬁcient
nderstanding and documentation of the extent and severity of
chistosomiasis in this age class, and a paucity of pharmacokinetic
afety data of praziquantel among young children (Allen et al.,
002; Geary et al., 2010). However, in endemic zones, women are
requently accompanied by their children, even at young age,when
heygo toponds, rivers or irrigation canals, all ofwhichmaybe con-
aminated with cercariae, the infective stage to humans. Therefore
hildren are likely to come into contact with contaminated water
t a very young age. Recent studies in Nigeria (Maﬁana et al., 2003;
para et al., 2007), Ghana (Bosompem et al., 2004) and Uganda
Odogwu et al., 2006) have shown that infection with S. haemato-
ium and S. mansoni can indeed occur in very early childhood.
The present study pursued two objectives. First, to deter-
ine, the prevalence of schistosomiasis in children below
he age of 5 years and in their mothers in a village where
nly S. haematobium occurred, and in a village where both
. haematobium and S. mansoni were present. The second objective
as to enhance our understanding of the epidemiology of schis-
osomiasis and risk factors for an infection in early childhood. The
esults reported here shed new light on a largely neglected issue
f schistosomiasis epidemiology and control and may therefore
ssist public health experts and disease control managers to devise
dequate strategies to tackle the disease in the preschool-aged
opulation and their mothers.
Fig. 1. Map of the study ar115 (2010) 212–219 213
2. Materials and methods
2.1. Study area
This cross-sectional epidemiological study was carried out in
Diambala and Falmado, in the Western Sahel zone of Niger, in April
2007 (Fig. 1). The two villages have been selected after a survey in
school-aged children has shown ahigh prevalence of schistosomia-
sis. Diambala (geographical coordinates: 14.313N latitude; 1.300W
longitude) is located in the NRV in the department of Tillabéri, near
an irrigated rice zone. The estimated population at-risk of schisto-
somiasis in this department is 193,825 people. Falmado (12.514N
latitude; 2.861W longitude) is located in the department of Birni
Gaouré in the valley of Dallol Foga, surrounded by permanent and
temporary pondswith an at-risk population of 148,833 individuals.
An exhaustive door-to-door census conducted prior to parasito-
logical and questionnaire surveys revealed a total population of
3961 in Diambala and 676 inhabitants in Falmado. In Diambala,
the major schistosomiasis transmission sites are the irrigation
canals and the seven temporarypondswhere favourable conditions
enable the intermediate host snails to thrive. It is a well-known
focus of mixed S. haematobium and S. mansoni and anthelminthic
drugs have been administered prior to our study. In Falmado, rains
occurring during the wet season ensure that both the permanent
and temporary ponds surrounding the village are ﬁlled up, facilitat-
ing transmission of schistosomiasis. However, prior to the present
study, the village of Falmado was never targeted for either prazi-
quantel or albendazole treatment. We proceeded to an exhaustive
sampling of all the households having a child of less than 5 years
after census to participate to the study.2.2. Ethical consideration and treatment
Ethical clearance was obtained from the Niger National Ethical
Committee (Niamey, Niger) and from the NHS-LREC review board
ea in western Niger.
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f St Mary’s Hospital, Imperial College (London, UK) application
3.36. In the ﬁeld, the objectives of the study were explained to the
ocal village chiefs and political and religious authorities who gave
heir consent to conduct the study.
All the mothers with children under 5 years of age were invited
o participate in the study. The objectives, procedures and poten-
ial risk and beneﬁts were explained prior to data collection.
nce the mothers gave their oral informed consent (illiteracy
ate is very high, hence we opted for oral rather than written
nformed consent), their children were included in the study. The
hole population of the two villages were treated immediately
fter the study with praziquantel (single 40mg/kg oral dose) and
lbendazole (single 400mg oral dose), using crushed tablets for
he youngest children by the national schistosomiasis and soil-
ransmitted helminthiasis control programme during their mass
reatment campaign. Praziquantel and albendazole tablets were
rushed between two spoons, diluted with water and given to the
hild by the mother generally accustomed to give drugs in this
ay to their children. Drugs administered in this way were well
olerated.
.3. Questionnaire survey
A questionnaire assessing risks for early childhood schistosome
nfections was administered to participating mothers in Diambala,
he village characterized by a mixed focus of S. haematobium and
. mansoni. We employed a standardised, pre-tested questionnaire
hat has been successfully used before (Beidou, 2006) in the local
anguage (Zarma)by trainedﬁeld investigators. Socio-demographic
ata (e.g. age, sex, profession and educational attainment), knowl-
dge and attitude towards water contact patterns, means of
revention,water supply, availability of latrines, and recent history
f treatment with anthelminthic drugs were collected.
.4. Parasitological survey
Urine collection containers (and in Diambala also stool col-
ection containers) with unique identiﬁers were handed out to
he participating mothers and their young children. Each subject
ncluded in the study underwent two parasitological examina-
ions of their urine on consecutive days. For the collection of the
rine samples, from a few very young children, plastic potties were
iven out to facilitate collection of urine. Urine specimens were
ollected between 10:30 and 14:00h and the standard urine ﬁltra-
ion method was employed (WHO, 1985). In brief, urine samples
able 1
haracteristics of the study population in the two villages of Diambala and Falmado in w
Characteristics Village
Number of participants (%) Diambala
Falmado
Total
Mean age (SD) Diambala
Falmado
Total
History of treatment with praziquantel in % (95% CI) Diambala
Falmado
History of treatment with albendazole in % (95% CI) Diambala
Falmado115 (2010) 212–219
were vigorously shaken, and 10ml were ﬁltered using nucleopore
ﬁlters. The ﬁlters were placed on a microscope slide, a drop of
Lugol’s iodine was added and the slides were examined under a
microscope by experienced laboratory technicians. The number of
S. haematobium eggs per slide were counted and recorded for each
individual separately. Additionally, urine specimens were exam-
ined for macrohaematuria (visible blood in urine). Only the ﬁrst
day urine sample was subjected to microhaematuria testing, using
Hemastix® strip (Bayer; Leverkusen, Germany).
A single stool specimen collected from participating mothers
and their young children in Diambala was subjected to the Kato-
Katz technique (Katz et al., 1972) with duplicate thick smears
prepared from each sample. We also recorded the consistency of
stools (liquidity and presence of blood). Other intestinal parasites
detected under the microscope were also recorded.
We classiﬁed intensity of schistosome infections according to
guidelines put forth by the World Health Organization (WHO,
2002). For S. haematobium, we determined between light infection
(1–49 eggs/10ml of urine), and heavy infection (≥50 eggs/10ml of
urine). The intensity of S. mansoni infection was classiﬁed into light
infection (1–99 eggs per gram of stool (EPG)), moderate infection
(100–399 EPG) and heavy infection (≥400 EPG).
2.5. Statistical analysis
All datawere entered into an Excel spreadsheet, transferred into
EpiInfo version 6.04d (Centers for Disease Control and Prevention;
Atlanta, USA) and analysed with the latter software. We calculated
the various proportions of interest and made comparisons using
the Pearson 2 test, or the Yates’ corrected 2 test, as appropriate.
For statistical signiﬁcance, we use a threshold of 5%.
3. Results
3.1. Characteristics of study population
Table1 summarises thedemographic characteristics of the stud-
ied population, stratiﬁed by village. Overall, 282 children and 224
mothers participated in the study. The average age of the whole
surveyed preschool-aged children group was 2.6 years with a stan-
dard deviation (SD) of 1.1 years. There were more girls than boys
in both villages with a sex ratio of male to female of 0.89. The age
of the mothers ranged from 15 to 50 years, with an average of 30.1
(SD=8.6) years.
estern Niger and prior treatment history with praziquantel and albendazole.
Children (< 5 years) Mothers
Male 84 (45.4)
Female 101 (54.6)
Total 185 (100) 143
Male 49 (50.5)
Female 48 (49.5)
Total 97 (100) 81
Male 133 (47.2)
Female 149 (52.8)
Total 282 (100) 224
2.7 (1.0) 31.4 (8.7)
2.6 (1.2) 27.8 (7.9)
2.6 (1.1) 30.1 (8.6)
1.1 (0.1–3.9) 72.3 (64.2–79.5)
0.0 (0.0–3.7) 0.0 (0.0–4.4)
97.8 (94.5–99.4) 0.0 (0.0–2.6)
0.0 (0.0–3.7) 0.0 (0.0–4.4)
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Table 2
Prevalence of S. haematobium infection and morbidity indicators among children aged below 5 years and their mothers in the two study villages of Diambala and Falmado,
western Niger.
Characteristics Village n Children (<5 years) n Mothers
S. haematobium infection prevalence in % (95% CI)
Diambala 185 60.5 (53.1–67.6) 143 72.2 (64.2–79.4)
Falmado 97 50.5 (39.2–59.8) 81 55.6 (44.1–66.6)
Prevalence of heavy S. haematobium infections (≥50 eggs/10ml of urine) in % (95% CI)
Diambala 0.0 (0.0–1.9) 0.0 (0.0–2.5)
Falmado 6.2 (2.3–13.0) 8.6 (3.5–17.0)
Arithmetic mean eggs of S. haematobium per 10ml of urine (SD)
Diambala 4.3 (6.3) 6.8 (7.69)
Falmado 9.4 (31.2) 12.9 (28.9)
Macrohaematuria in % (95% CI)
Diambala 2.2 (0.6–5.4) 2.1 (0.4–6.0)
Falmado 5.2 (1.7–11.6) 8.6 (3.5–17.0)
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Falmado
In Diambala, 97.8% of the surveyed children had a history of
reatment with albendazole and 1.1% had a history of treatment
ith praziquantel. Almost three quarters of the mothers (72.3%)
eported to have previously received praziquantel. In Falmado, no
revious treatmentwas reportedwith either drug, neither inmoth-
rs nor in children.
.2. Infection with S. haematobium
Table 2 summarises the results of S. haematobium infection in
oth children aged below 5 years and their mothers. The preva-
ence of S. haematobium among children was 60.5% in Diambala
nd 50.5% in Falmado. There is no difference between girls and
oys (2 =0.01, P=0.9). The prevalence of heavy infection of
. haematobium (≥50 eggs/10ml of urine) was 6.2% in the children
f Falmado. The prevalence of macrohaematuria and microhaema-
uria among preschool-aged children was respectively 5.2% and
0.5% in Falmado, and 2.2% and 38.9% in Diambala. The preva-
ence of both macrohaematuria and microhaematuria was higher
n Falmado compared to Diambala, but the difference was not
tatistically signiﬁcant (2 =1.00, P=0.316 for macrohaematuria;
2 = 3.49, P=0.061 for microhaematuria).
Among mothers, the prevalence of S. heamatobium was 55.6% in
almado and 72.2% in Diambala. The prevalence of heavy infection
as high in Falmado (8.6%). The prevalence of macrohaematuria
nd microhaematuria among mothers was respectively 8.6% and
1.7% in Falmado, and 2.1% and 52.4% in Diambala.
able 3
revalence and intensity of S. mansoni infection, other helminth infections and stool co
iambala, western Niger.
Characteristics
Number of individuals examined
Prevalence of S. mansoni in % (95% CI)
Prevalence of mixed infection with S. mansoni and S. haematobium in % (95% CI)
Mean infection intensity in EPG (SD)
Infection intensity classes in % (95% CI)
No infection
Light infection (1–99 EPG)
Moderate infection (100–399 EPG)
Heavy infection (≥400 EPG)
Liquid stools in % (95% CI)
Blood in stool in % (95% CI)
Enterobius vermicularis in % (95% CI)
Hookworm in % (95% CI)
Hymenolepis nana in % (95% CI)38.9 (31.8–46.3) 52.4 (43.9–60.8)
50.5 (40.1–60.8) 61.7 (50.2–72.3)
3.3. Infection with S. mansoni
The results of the infection with S. mansoni and other intesti-
nal parasites in Diambala are presented in Table 3. Overall, the
prevalence of S. mansoni in children below5 years of agewas 43.8%.
There was no statistically signiﬁcant difference in infection preva-
lence among boys and girls. 17.3% of the children presented light
infections (1–99 EPG), 23.8% moderate infections (100–399 EPG),
whereas 2.7% of the childrenwere heavily infected (≥400 EPG). The
proportion of both liquid stools and blood in stool was 3.2%.
In the mothers group, the prevalence of S. mansoni was 52.1%.
Stratiﬁcation by infection intensity revealed 13.4%, 29.6% and 9.2%
light,moderate andheavy infections, respectively. Themacroscopic
characteristic of the stools from the mothers showed that 18.3%
contained blood and that 2.1% were liquid.
3.4. Co-infection with S. haematobium and S. mansoni
In Diambala, more than a quarter (28.6%) of the preschool-aged
children were co-infected with S. mansoni and S. haematobium.
The respective prevalence of co-infection with both S. mansoni and
S. haematobium among mothers was 37.3%.3.5. Risks factors for early childhood schistosome infections
Table 4 summarises the results obtained with the questionnaire
administered to themothers in Diambala. Themothers knew about
nsistency in children below the age of 5 years and their mothers in the village of
Children (<5 years) Mothers
185 143
43.8 (36.5–51.3) 52.1 (43.6–60.6)
28.6 (22.3–35.7) 37.3 (29.4–45.8)
80.7 (132.6) 151.4 (263.5)
56.2 (48.7–63.5) 47.9 (39.4–56.4)
17.3 (12.1–23.5) 13.4 (8.3–20.1)
23.8 (17.8–30.6) 29.6 (22.2–37.8)
2.7 (0.9–6.2) 9.2 (5.0–15.1)
3.2 (1.2–6.9) 2.1 (0.4–6.0)
3.2 (1.2–6.9) 18.3 (12.3–25.7)
8.6 (5.0–13.7) 2.8 (0.8–7.0)
2.7 (0.9–6.2) 4.9 (2.0–9.9)
0.0 (0.0–1.9) 2.1 (0.4–6.0)
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Table 4
Mothers’ knowledge and awareness of schistosomiasis in Diambala, western Niger
(number of mothers interviewed=147).
Knowledge and awareness Positive responders (%)
Know about schistosomiasis 142 (96.6)
Know a place where one becomes infected 142 (96.6)
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disease
135 (90.5)
Know at least one symptom of schistosomiasis 140 (95.5)
chistosomiasis, its symptoms, and the role of water contact in the
ransmission of the disease. Fig. 2A shows that the irrigation canal,
hich is themainwater contact site for villagers, was also the prin-
ipal source of water utilized by the women. The availability of
atrines in the households was low (18.9%), and hence open defeca-
ion (“in the bush”) was practiced by four out of ﬁve of the villagers
Fig. 2B).
Most of the mothers (69.8%) stated they brought infants
ounger than 1 year of age to the irrigation canal (Fig. 2C), thus
hildren were put in contact with the transmission sites very
arly in their life. The water of the canal was used by 75.3% of the
others to wash their children, while the water from the well or
rilling was used by only 30.2% of the women (Fig. 2D). As shown
n Fig. 2E, three-quarter of the mothers said that they washed their
hildren directly in the canal (Fig. 3), and 51.3% said they used a
ucket for bathing (Fig. 4). With the exception of one mother, all
eported to use soap while washing their children.
. DiscussionThis epidemiological survey in the western part of Niger has
evealed that children below the age of 5 years are at signiﬁcant
isk of schistosomiasis. Moreover, it is also evident that in one of
he two study villages presenting as a mixed infection focus of
. haematobium and S. mansoni, young children have contracted
ig. 2. Frequency in % of (A) water sources used by the mothers; (B) disposal sites of the
ater used to clean infants and preschool-aged children; and (E) cleaning practices of theFig. 3. A mother with her 1-year and 3-year-old children in the canal in Diambala,
western Niger.
both forms of schistosomiasis. Our study population consisted
of 282 infants and preschool-aged children, and their mothers
(n=224). To our knowledge, this is the largest study carried out
to date for investigation of schistosomiasis among infants and
preschool-aged children. In previous studies, Perel et al. (1985)
examined 142 preschool-aged children also in Niger, Odogwu et
al. (2006) studied 136 young children in Uganda, whereas Maﬁana
et al. (2003) examined 209 young children, and Opara et al. (2007),
another 126 preschool-aged children in Nigeria. Furthermore, our
ﬁndings showed that co-infection with both S. haematobium and
S. mansonialreadyoccurs at veryyoungage, sincemore thanaquar-
terof the surveyed infants andpreschool-agedchildren inDiambala
were co-infected, an issue that has been neglected thus far.
human excreta; (C) age of the infants at ﬁrst exposure to contamination sites; (D)
infants by the mothers.
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re playing in the pond.
While we found a prevalence of S. haematobium of 50.5% and
0.5% in Falmado and Diambala, respectively, and a prevalence of
3.8% for S. mansoni in Diambala in our group of young children
n western Niger, prevalence ranging from 3.9% to 71.8%, and
rom 7% to 47.4% were found for S. haematobium and S. mansoni,
espectively, in the other settings (Perel et al., 1985; Maﬁana et
l., 2003; Bosompem et al., 2004; Odogwu et al., 2006; Opara et
l., 2007; Sousa-Figueiredo et al., 2008). It should be noted that
he prevalence of S. mansoni reported by Odogwu et al. (2006)
n Uganda was 47.4%, however this was only after carrying out a
otal of six Kato-Katz thick smear readings (three stool samples
ith duplicate Kato-Katz examinations), while only a duplicate
ato-Katz examination was conducted in our study using a single
tool sample. Furthermore, the Odogwu et al. (2006) study con-
isted of a sample size of only 19 preschool-aged children where
uch exhaustive conﬁrmatory parasitological examinations were
ndertaken, with the remainder of the child cohort examined by
ingle Kato-Katz but bolstered with urine-circulating cathodic
ntigen (CCA) rapid diagnostic test. Without doubt, we would
ave found a higher prevalence if we had carried out several
ato-Katz examinations on multiple stool samples, coupled with
rine-CCA tests. Hence the true S. mansoni prevalence in our study
ight be considerably higher than reported here, because of the
ower sensitivity of a duplicate Kato-Katz thick based on a single
tool sample when compared to multiple Kato-Katz thick smears
btained from multiple stool samples (de Vlas and Gryseels, 1992;
tzinger et al., 2001; Booth et al., 2003; Bergquist et al., 2009).
The high prevalence of S. mansoni both among young children
nd their mothers in Diambala reﬂects the expansion of intestinal
chistosomiasis in theNRVupstream fromTillabéri. The intermedi-
te host snail of S. mansoni, Biomphalaria pfeifferi, was found in ﬁve
ut of eight irrigated areas (Namarigoungou, Diambala, Bonféba,
oula and Daikaina) surveyed upstream and in the surrounding
rea of Tillabéri (Labbo et al., 2003). A previous investigation by
arba et al. (2004a,b) found human infection with S. mansoni
nly in the village of Namarigoungou where a prevalence of 5.9%
as observed. This constitutes a major health risk for the local
opulation, which might be further exacerbated once the Kandadji
am construction is completed as noted before (Hunter et al., 1993;
ecsult, 2006). The Kandadji dam is located 187km upstream of
iamey on the Niger River and the construction commenced in
ugust 2008. The area for which major environmental, health and
ocial impacts are predicted extends over approximately 4500km2.
he dam itself will be an earth embankment with a length of115 (2010) 212–219 217
8.78km and a peak height of 231m. The water surface is estimated
at 282km2 extending over a length of 60km. The dam will be used
for hydropower production (565GWh) and irrigated agriculture
(31,000ha). Impoundment of the water reservoir will result in
forced resettlement of approximately 35,000 people. The micro-
climate, which will result from the dam lake, will probably lead to
an increase in the distribution area and the number of B. pfeifferi.
Moreover, the migration phenomenon brought on by the arrival
of workers for the dam construction and the forced resettlement
of resident population, and also the introduction of new irrigated
areas will increase the number of people at risk and those who will
become infected (Lerer and Scudder, 1999; Steinmann et al., 2006).
Urinary schistosomiasis is highly endemic in the two villages
studied here. Indeed, the prevalence of S. haematobium in each
village exceeded 50%, the threshold recommended for large-scale
administration of praziquantel (WHO, 2002). To our knowledge,
our study is the ﬁrst to highlight such a high prevalence of
S. haematobium in children below the age of 5 years in Niger. In
a previous study conducted by Perel et al. (1985) in the village of
Liboré (located near an irrigated zone of the Niger River) and in the
village of Zarmeye (located near a temporary pond), a prevalence
of 14.1% and 4.6%, respectively, was found.
In a study in Ghana, Bosompem et al. (2004) found a preva-
lence of 11.2% among children aged 2 months to 5 years with
the youngest infected child only 4 months old, as assessed by
the urine sediment method. This technique is known to be less
sensitive than urine ﬁltration used in our study. By employing an
immunological test, Bosompem et al. (2004) found a prevalence of
30% in the same study population. In a previous study carried out
in Niger, the youngest infected child was 6 months old (Perel et al.,
1985), as in the current study. In Nigeria, Opara et al. (2007) found
a prevalence of 19.8% and Maﬁana et al. (2003) found a prevalence
of 71.8% in children younger than 5 years. The high prevalence
observed in our study highlight the intense transmission of urinary
schistosomiasis in the NRV. We did not observe a statistically
signiﬁcant difference between the prevalence according to age,
even though previous studies showed infection may start at a very
early age (Perel et al., 1985; Bosompem et al., 2004).
Detection of 50 or more S. haematobium eggs per 10ml of urine
is regarded as an indicator of risk for morbidity, as is macrohaema-
turia (WHO, 2002), which is used by several control programmes
as an indicator for the monitoring and for the identiﬁcation
of endemic communities warranting treatment. In Diambala,
although the prevalence of infection was high, we did not ﬁnd any
heavily infected children and the prevalence of macrohaematuria
was low (2.2%). On the other hand, in Falmado, 6.2% of the children
were heavily infected and 5.2% had macrohaematuria. This reveals
that not only can the prevalence of S. haematobium be very high
in the children below 5 years of age, but also that they can be
heavily infected and therefore are at risk of developing morbidity
very early in life. In Ebonyi Benue River Valley of Nigeria, Anosike
et al. (2003) found a prevalence of 27.6% in children younger
than 5 years. The children also had a very high mean arithmetic
eggs count of 298.4 per 10ml of urine. The high S. haematobium
prevalence that we found in Falmado can be explained by the
intensive transmission and by the fact that the village was never
subjected to praziquantel administration prior to our study.
Inmothers ofDiambala, the overall prevalenceof S. mansoniwas
52.1%. The prevalence of moderate infection and heavy infection
were 29.6% and 9.2%, respectively. This reﬂects the high morbidity
in women of childbearing age and justify the extension of large-
scale drug administration campaigns to this target by WHO (Allen
et al., 2002; Ajanga et al., 2006; Friedman et al., 2007).
The overall prevalence of S. haematobium in mothers was 72.2%
in Diambala, constituted by only light infections. The absence
of heavy infection intensities is probably due to the impact
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f the previous mass treatment campaigns carried out by the
ational schistosomiasis and soil-transmitted helminthiasis con-
rol programme. Mass treatment campaigns with praziquantel and
lbendazole, targeting all school-aged children and the total pop-
lation in highly endemic areas, have been carried out in NRV in
004 and 2005. Children under 5 years of age were treated with
lbendazole during integrated deworming and poliomyelitis vac-
ination campaigns inDecember 2006 for Falmado andMarch 2007
or Diambala with estimated coverage rates in excess of 90%.
Since the main objective of the national schistosomiasis control
rogramme is to control morbidity, it can therefore be concluded
hat a signiﬁcant reductionofmorbiditywasobtained in the treated
reas. In Falmado, a village that had not been targeted during the
ass treatment campaigns, the prevalence of S. haematobium was
5.6% with a prevalence of 8.6% being heavy infections.
In high schistosomiasis transmission areas, infants would be
xposed to the risk of obvious infection, especially if they accom-
any their mothers to transmission sites or if they bathe regularly.
nDiambala, 99.3%of themothersquestionedprovided information
n water contact related to their domestic activities and the expo-
ure of their children to the risks of transmission. The proportion
f mothers with a latrine in their house was low (18.9%), therefore
he majority of human waste was disposed outside the village, in
he bush and temporary ponds. The water of the irrigation canals
as used for domestic activities by two-third of the mothers. In
ur study the majority of the mothers (76.3%) were accompanied
y their children to the canal or the pond and washed them with
he contaminatedwater.Mothers brought their childrenwith them
ecause they did not have suitable guardian to watch over the chil-
ren while they conducted their daily activities or because they
lanned on bathing their children in a bucket (51.8%) or directly in
he water (52.8%) once their activities were complete.
Bosompem et al. (2004) observed that 29.2% of the mothers
ash their children directly in the irrigation canal. In our study
he average time that a child spent in the water was 15min
SD=8min). Our results are comparable with those of Odogwu et
l. (2006) in Uganda where 71.4% of the mothers conﬁrmed wash-
ng their childrenwith lakewater for an average duration of 28min
SD=15min), hence considerably longer than in our study. Expo-
ure time for the children when they accompanied their mothers
as a determining factor in the transmission of schistosomiasis
nfection and intensity. Thehigh rates of prevalence and intensity of
nfection found in school-aged children, the reason for which they
re the priority targets of most control programmes, results from
he fact that the infection accumulates fromanearly age.Due to this
ehaviour, school-aged children in hyperendemic zones are likely
o develop severe clinical signs of schistosomiasis if they are left
ntreated. The harmful behaviour of the mothers with respect to
ot preventing their children from coming in contact with infested
ater could be explained by their ignorance of schistosomiasis pre-
ention and transmission although in Diambala our results show
hat 90.5% of the mothers were aware that schistosomiasis is a
ater-related disease. Hence, it is possible that the lack of accessi-
le clean water combined with the necessity of taking their infants
ith them when performing their household chores could explain
he persistence of such risk associated behaviour.
The use of soap, although claimed by the majority of the
others, did not seem to be convincing with regard to impeding
ercariae from penetrating the unbroken skin. During our study,
e observed mothers placing their children into the canals or in
uckets for long periods of time for the children to play and the
others to conduct their daily activities. The amount of time the
hildren were in the contaminated water was largely sufﬁcient for
he child to become infected.
In conclusion, the present study revealed the extent of
. mansoni and S. haematobium (co-)infection in children aged less115 (2010) 212–219
than 5 years in two hyperendemic villages in Niger and high-
lights these infections as an important, yet neglected public health
issue for schistosomiasis control. As S. mansoni is spreading in the
NRV in the hydro-electric Kandadji dam area, it is conceivable that
schistosomiasis in younger children will continue to increase, and
thus to more accurately monitor and assess this issue, additional
surveys are urgently needed to conﬁrm and better quantify this
geographical zone of infection. It is important to note that there
is a persistence of risky behaviours within the study populations.
More than80%of thewomenhadnoaccess to latrines and therefore
disposed of their waste in nature and two-third of the women used
the irrigation canals for both their water supply and to wash their
children. We noticed a positive impact of the prior praziquantel
administration on morbidity as the number of light infections was
higher and in addition no severe infection was found in mothers in
treated zones. This indicates that the high infection responsible for
gross morbidity is preventable through regular treatment. Because
of the safety of praziquantel, women of childbearing age should
be given this drug during mass treatment campaigns and also on a
routine basis in maternal health clinics. In order to reduce or pre-
vent the development of morbidity in this very young age group, it
is imperative that a system to determine where children of a young
age are heavily infected is created and then these children aged
less than 5 years should be targeted for treatment in future mass
treatment campaigns. The need for a suitable formulation of prazi-
quantel (e.g. syrup) must be emphasised, which will help to readily
administer praziquantel to this age group.
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The impact of single versus mixed schistosome
species infections on liver, spleen and bladder
morbidity within Malian children pre- and
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Abstract
Background: In the developing world co-infections and polyparasitism within humans appear to be the rule rather
than the exception, be it any combination of inter-specific and/or inter- and intra-Genera mixed infections. Mixed
infections might generate synergistic or antagonistic interactions and thereby clinically affect individuals and/or
impact parasite epidemiology.
Methods: The current study uniquely assesses both Schistosoma mansoni- and Schistosoma haematobium-related
morbidity of the liver and the bladder as assessed by ultrasound as well as spleen and liver morbidity through
clinical exams. The impact of praziquantel (PZQ) treatment on such potential inter-specific schistosome interactions
and resulting morbidity using uniquely detailed longitudinal data (pre- and one year post-PZQ treatment) arising
from the National Schistosomiasis Control Program in three areas of Mali: Ségou, Koulikoro and Bamako, is also
evaluated. At baseline, data were collected from up to 2196 children (aged 7-14 years), 844 of which were infected
with S. haematobium only, 124 with S. mansoni only and 477 with both. Follow-up data were collected from up to
1265 children.
Results: Results suggested lower liver morbidity in mixed compared to single S. mansoni infections and higher
bladder morbidity in mixed compared to single S. haematobium infections. Single S. haematobium or S. mansoni
infections were also associated with liver and spleen morbidity whilst only single S. haematobium infections were
associated with bladder morbidity in these children (light S. haematobium infection OR: 4.3, p < 0.001 and heavy
S. haematobium infection OR: 19, p < 0.001). PZQ treatment contributed to the regression of some of the forms of
such morbidities.
Conclusions: Whilst the precise biological mechanisms for these observations remain to be ascertained, the results
illustrate the importance of considering mixed species infections in any analyses of parasite-induced morbidity,
including that for the proposed Disability Adjusted Life Years (DALYs) revised estimates of schistosomiasis
morbidity.
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Background
In the developing world co-infections and polyparasit-
ism within humans appear to be the rule rather than
the exception. New integrated control programmes
acknowledge this, with for instance combined mass
drug administration (MDA) for schistosomiasis, lym-
phatic filariasis, onchocerciasis, trachoma and soil-
transmitted helminths being initiated throughout parts
of sub-Saharan Africa [1]. However, within-Genera
polyparasitism must also be fully acknowledged. More-
over, synergistic or antagonistic interactions resulting
from such co-infections may be predicted to clinically
affect individuals and/or impact parasite epidemiology
[2].
Schistosomiasis is a chronic and debilitating disease
which affects millions of people, particularly the rural
poor in the developing world. Of some 600 million peo-
ple at risk, an estimated 200 million are infected, more
than half of which are symptomatic and at least 20 mil-
lion exhibit severe disease manifestations [3]. Schisto-
somes, the causative agents, are parasitic bloodflukes
(Phylum: Platyhelminth; Class: Trematoda) with indir-
ectly transmitted life-cycles involving obligatory alterna-
tion of generations between sexual reproduction in a
mammalian host and asexual reproduction within a
molluscan (freshwater snail) host. The clinical manifes-
tations of schistosomiasis are classically associated with
the species-specific ovipositioning (egg-laying) sites; the
mesenteric venous systems for Schistosoma mansoni
(prevalent in sub-Saharan Africa and South America)
leading to chronic hepatic and intestinal fibrosis and the
vesical venous plexus of the urogenital system for Schis-
tosoma haematobium (prevalent in sub-Saharan Africa)
associated with ureteral and bladder fibrosis, calcifica-
tion of the urinary tract and bladder cancer [4].
Co-infections between S. mansoni and S. haemato-
bium have been reported in an increasing number of
foci across Africa [5-9]. Furthermore, studies in Camer-
oon and Senegal have revealed that in areas of overlap,
S. mansoni-shaped eggs may be excreted in urine as
opposed to the usual faecal route [10]. Studies on schis-
tosomiasis-associated morbidity tend to, nevertheless,
always consider single species infections individually [3].
In addition to affecting the prevalence and intensity of
human infections, inter-specific parasite interactions
during mixed species infections may, however, also be
predicted to impact host morbidity directly. In one of
the few studies to consider this, Cunin et al. (2003) in
Cameroon, for example, reported an apparent lowering
of S. mansoni-induced morbidity (hepatomegaly and
splenomegaly morbidity, as determined through clinical
palpation) in mixed infections with S. haematobium
relative to that observed for S. mansoni single infections
[6]. The authors suggested that this lowering effect on
liver morbidity could be due to S. haematobium males
mating with S. mansoni females (which cannot success-
fully hybridize) and the subsequent eggs produced from
such couplings passing to the urinary oviposition site,
thereby reducing the amount of classical S. mansoni-
induced morbidity. Laboratory rodent model studies
have confirmed these observations [11].
Preventive mass drug administration (MDA) interven-
tions, as are recently being employed across parts of
sub-Saharan Africa [12,13], may be further predicted to
have an impact on such complex inter-specific interac-
tions, especially if the selection pressure differs between
the parasite species, as may be plausible for S. mansoni
and S. haematobium [14]. For example, S. mansoni and
S. haematobium differ in their generation times/length
of time to maturation, and as juvenile schistosomes are
not susceptible to PZQ, this could potentially lead to
differences between these two species in terms of their
responses to MDA within individual hosts. Such differ-
ences could also subsequently affect the order of estab-
lishment of the parasites within their human hosts (a
factor known to be very important in determining the
outcome of inter-specific competition and subsequent
parasite-induced host morbidity [15,9]).
However, despite the theoretical and applied interest
of mixed schistosome species interactions on human
host morbidity under differing selective pressures, few
studies appear to have focused upon this. Indeed, to the
authors knowledge, no studies have yet examined the
potential consequence of S. haematobium-associated
bladder pathology in mixed species infections, nor the
potential impact of MDA on hepatic and urinary-asso-
ciated morbidity of mixed schistosome species
infections.
The aim of the current study was to test if the
hypothesis that liver morbidity in mixed schistosome
species infections is lower relative to that observed for
S. mansoni single infections [6], can be generalized in
different environmental settings within sub-Saharan
Africa such as Mali. Furthermore, while previous studies
were restricted to clinical examination and palpation of
hepatomegaly and splenomegaly, the present study also
incorporates detailed ultrasonography (US) to determine
schistosome-specific morbidity in the liver and bladder.
Finally, the current study also evaluates the impact of
PZQ treatment on such potential inter-specific schisto-
some interactions and resulting morbidity using
uniquely detailed longitudinal data (pre- and one year
post-praziquantel (PZQ) treatment) arising from
the National Schistosomiasis Control Program in three
areas of Mali: Ségou, Koulikoro and Bamako. The
results obtained should have theoretical and applied
Koukounari et al. BMC Infectious Diseases 2010, 10:227
http://www.biomedcentral.com/1471-2334/10/227
Page 2 of 14
implications regarding inter-specific schistosome inter-
actions and human morbidity.
Methods
Study design
The schools included in these surveys were randomly
selected from all schools known a priori to be places
where schistosomiasis is highly endemic: Ségou, Bamako
and Koulikoro. Details concerning sample-size calcula-
tions and cohort design have been described elsewhere
[16]. We would like to acknowledge that this study
describes data from an ongoing MDA control pro-
gramme and not a double-blind placebo randomized
clinical trial study.
Initially 2196 children (aged 7 to 14 years) from 29
schools were recruited with US and parasitological data
on both schistosome species infections. Of these, 844
children were infected with S. haematobium only, 124
with S. mansoni only and 477 with both. Clinical exami-
nations (i.e. liver and spleen palpations) were performed
on 2128 of these children, as part of the baseline survey
(of these, 821 children were infected with S. haemato-
bium only, 117 with S. mansoni only and 463 with
both).
Only 23 of the 29 schools surveyed at baseline were
visited at the second survey, due to financial and time
constraints. All subsequent analyses here of the follow-
up (second survey) data exclude baseline data from the
6 schools that were not followed up. Follow-up data
were collected from 1265 children from 23 schools (76%
of the 1670 children recruited from these schools at
baseline) but only 853 children had complete clinical,
US and parasitological data on both schistosomiasis
infections. Follow-up rates following the first survey
were much higher for children under 13 years of age, as
is common in such sub-Saharan regions where primary
school children leave for reasons such as work or early
marriage [17].
Baseline surveys took place in the Ségou area in
March and April of 2004 while the follow-up surveys
were performed just over one year later (i.e. in May
2005). By the second survey children in the schools of
this area had received two MDA treatments with PZQ:
a) one just after baseline data collection (in March-April
2004) and b) another during preventive chemotherapy
intervention (in February 2005). In Bamako baseline sur-
veys took place in July 2004 while the majority of the
follow-up surveys were performed almost two years
later (i.e. in April-May 2006) with the remaining three
schools in this area to be visited in October 2006. A sin-
gle round of MDA took place in 2005 (i.e. in May, June
and November). Finally baseline surveys took place in
Koulikoro during June-August 2004 while the follow-up
surveys took place almost two years later (i.e. in May
2006). The children would have received one PZQ treat-
ment during the MDA in August 2005.
Clinical, ultrasound and parasitological examination
Clinical examination was performed on each child by
experienced clinical nurses who were blind to parasito-
logical results. The following measurements were
recorded: the excursion in centimeters of the spleen
below the rib cage in the left mid-clavicular line (MCL)
and left mid-axillary line (MAL); liver tenderness; the
excursion in centimeters of the left liver lobe beneath
the sternum in the mid-sternal line (MSL); the excur-
sion of the right liver lobe beneath the rib cage in the
right MCL. The consistency of the liver and spleen were
also graded as follows: not palpable, soft, firm and hard.
The presence of physical abnormalities such as ascites
or other abdominal swelling, umbilical collaterals and
scars were recorded as being present or absent, and
finally, the presence of liver tenderness or febrility were
noted [18].
Ultrasound (US) examination was performed with a
portable ultrasonography device (SSD-500; Aloca,
Tokyo, Japan). For parasitologic examinations, a filtra-
tion method was used to determine S. haematobium
infection intensity, whilst the Kato-Katz (KK) technique
was employed to define S. mansoni infection intensity.
Further details have been described elsewhere for both
US and KK [16].
Ethics statement
Ethical approval was obtained from the St Mary’s Hospi-
tal Local Ethics Research Committee, R&D office (part
of the Imperial College, London Research Ethics Com-
mittee (ICREC)) in combination with the ongoing Schis-
tosomiasis Control Initiative (SCI) activities, in areas
where SCI is physically based. Within Mali, all aspects
of Monitoring and Evaluation were carried out in the
framework of the disease control activities implemented
and approved by the Ministry of Health (MOH) and
adopted by regional and local administrative and health
authorities. The communities of the selected villages
were informed about the objectives, the methodology of
the study and the advantages. A meeting was organized
with the population and verbal community consent was
obtained for each selected village. Where the study was
performed within the schools, verbal consent was also
obtained from school teacher’s directors and teachers,
prior to the recruitment of the children. Within Mali,
for cultural reasons, obtaining verbal consent from the
community leaders/heads of villages (via community
forum), and teachers’ directors, is the most accepted
procedure, and hence the practice we followed here.
The results of the different diagnostic procedures per-
formed on children were briefly explained to the
Koukounari et al. BMC Infectious Diseases 2010, 10:227
http://www.biomedcentral.com/1471-2334/10/227
Page 3 of 14
children themselves. If any pathology was discovered,
this was reported to the parents or guardians, or, if this
was not possible, carefully explained to the teachers for
them to brief the children’s parents or guardians. The
health officer responsible for the nearest medical post,
who was usually present on spot at the time of the
examinations, was also informed about the pathology of
the children and asked to take care of them, according
to the practices and procedures of the national health
system of Mali.
Statistical Analyses
Baseline (pre-MDA) data were used to investigate
whether or not there was an association between schis-
tosomiasis infection status and pathological manifesta-
tions as determined by US examinations for liver and
bladder morbidity as well as by clinical examinations for
liver and spleen morbidities. Univariate analyses were
performed using chi-square tests for associations
between schistosomiasis infection status and the various
pathological manifestations.
In order to study simultaneously the impact of several
covariates on the pathological manifestations at baseline,
logistic regression models with random effects at the
school level (i.e. multilevel logistic regressions) were
fitted using the PROC NLMIXED command in SAS ver-
sion 9.1 (SAS Institute Inc., Cary, NC). Schistosomiasis
infections were classified on the basis of intensities
using WHO standards (see S1a in Additional file 1), and
these intensity classes were included as covariates. The
assumption of linear effects of age was tested through
comparison with models including categorical effects for
each year of age. The assumption of linear effects of
infection intensity classes was tested using the Akaike
information criterion (AIC) to compare models assum-
ing linear effects (with and without an interaction of
those linear effects) with models fitting separate effects
for each combination of S. mansoni and S. haemato-
bium intensity classes. The intensity classes for S. hae-
matobium infection were assigned 0 for ‘not infected’
(0e/10 ml), 1 for ‘light’ (< 50e/10 ml) and 2 for ‘heavy’
(> 50e/10 ml) while the intensity classes for S. mansoni
infection were assigned 0 for ‘not infected’ (0 epg), 1 for
‘light’ (1-99 epg), 2 for ‘medium’ (100-399 epg) and 3
for ‘heavy’ (> 400 epg).
Differences in baseline characteristics were tested
between children successfully and unsuccessfully fol-
lowed up by univariate analysis using a Wilcoxon 2-
sample test for means and a chi-square test or Fisher’s
exact test if there were small values for proportions.
The data were further analyzed excluding data from 13-
and 14-year-old children because children in these age
groups would be more likely to have left school during
interval between baseline and follow-up assessments.
Statistical analysis for the effect of MDA (i.e. post
PZQ treatment, one year follow-up) was restricted to
children with complete records on all outcomes of inter-
est here (i.e. parasitological, US and clinical exam data)
from both baseline and follow-up surveys. Differences in
baseline and separately follow-up health characteristics
of children between pairs of the three surveyed areas of
the country were performed using two-proportion
z-tests of unequal variances. Such comparisons were
performed as different treatment strategies had been fol-
lowed between these regions.
Changes of the health characteristics of children
between the two time points of the study in relation to
their baseline schistosomiasis infection status, adjusting
at the same time for age and sex, were analyzed using
generalized logit multinomial models for all three areas
and for each morbidity measure using the PROC
LOGISTIC command in SAS version 9.1 (SAS Institute
Inc., Cary, NC). In these models schistosome infection
status was characterized as simply infected or not
infected, rather than by the intensity of infection, based
on model fits with prevalence and linear effects of inten-
sity (see S3 in Additional File 1 for further details).
Finally, in these models the response variable was a
new categorical variable with four levels indicating the
following: a) no pathological manifestation of each mor-
bidity measure at both time points, b) pathological man-
ifestation of each morbidity measure at baseline but
cured at final point of the study, c) no pathological
manifestation of each morbidity measure at baseline and
pathological manifestation of each morbidity measure at
final point of the study, or d) pathological manifestation
of each morbidity measure at both time points.
Results
The ages of children were found to be approximately
matched between infection status groups. The mean
ages were: for the uninfected children 10.13 years old;
for the children with single S. haematobium infection
10.52 years old; for the children with single S. mansoni
infection 10.96 years old; for those children who were
co-infected with both schistosomes species the mean
age was 10.64 years old.
Univariate analysis for the association between
schistosomiasis infection status and pathological
manifestations at baseline
Figure 1 presents baseline prevalence levels of liver or
spleen morbidity as determined by US or clinical exami-
nations and bladder morbidity as determined by US
examination for those with single and both schistosome
species infections as well as those who were uninfected.
Chi-square tests revealed that the prevalence of liver
and spleen morbidity (pathology characteristics 1 to 7 in
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Figure 1) did not differ significantly in children with
S. mansoni infection only compared with co-infected
children. Similarly, the bladder morbidity (pathology
characteristic 8, in Figure 1) did not differ significantly
in children with S. haematobium infection only com-
pared with co-infected children.
However, the prevalence levels of liver morbidity in
the forms of portal hypertension and hepatomegaly, as
assessed both by US, were significantly higher among
children infected with S. haematobium only than among
uninfected children (p = 0.017 & p = 0.002 respectively
for pathology characteristics 2 and 3 in Figure 1). Simi-
larly, clinical examination revealed significantly higher
prevalence levels of liver morbidity among children
infected with S. haematobium only than among unin-
fected children (p = 0.001 and p = 0.010 respectively for
pathology characteristics with numbers 4 and 5 in
Figure 1).
Clinical examination revealed significantly higher pre-
valence levels of spleen morbidity among children
infected with S. haematobium only than among unin-
fected children (p < 0.001 for both pathology character-
istics 6 and 7 in Figure 1). Finally, the prevalence level
of bladder morbidity was significantly higher among
children infected with S. haematobium only than among
uninfected children (p < 0.001 for pathology characteris-
tic 8 in Figure 1).
Multivariate analyses for the association between the
intensity of schistosomiasis infection status and
pathological manifestations at baseline
Models with linear effects of intensities yielded better fit
through AIC comparisons and these are the results that
are presented here (see S1b in Additional File 1). The
adjusted odds ratios (ORs) for gender and age from
multilevel multivariate logistic regression models for the
Figure 1 Univariate analysis for association between single and mixed schistosomiasis infections with liver, bladder and spleen
pathology as assessed by US and clinical examination at baseline (n = 2128 children). Numerical coding for pathology characteristics in
the horizontal axis of Figure 1 represent the following: 1: Abnormal liver image patterns as assessed by US examination; 2: Portal Hypertension
(as determined by positive PVD scores from US examination); 3: Hepatomegaly as determined by positive PSL scores from US examination; 4:
Hepatomegaly as determined by MSL>2 cm from clinical examination; 5: Hepatomegaly as determined by MCL>2 cm from clinical examination;
6: Splenomegaly as determined by MCL>2 cm from clinical examination; 7: Splenomegaly as determined by MAL>2 cm from clinical
examination; 8: Bladder pathology (as determined by positive global scores from US examination). US, ultrasound; PVD, portal vein diameters:
PSL, parasternal line; MSL, mid-sternal line; MCL, mid-clavicluar line; MAL, mid-axillary line.
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liver pathology outcomes, as assessed by US examina-
tion, are shown in Table 1. Estimates for the risk of hav-
ing an abnormal liver image pattern indicated that
children infected with S. mansoni only (light, medium
and heavy intensities) were significantly more likely to
have an abnormal liver image pattern compared to
uninfected children (OR: 1.6, p = 0.008; OR: 2.5, p =
0.008 and OR:3.9, p = 0.008 respectively), while the data
indicated that co-infected children were at lower risk of
liver morbidity, in the form of an abnormal liver image
pattern, than children with single S. mansoni species
infections of the same intensity. Furthermore, there
Table 1 Multivariate logistic regressions for liver pathology as assessed by US examination at baseline (n = 2128)
Estimates from multilevel logistic regressions for liver pathology as assessed by US
Adjusted ORs for gender and age (95% CI) and p-values for the risk of having
abnormal liver image pattern
Type of schistosomiasis infection intensity related variables For S. mansoni
For S. haematobium none light medium heavy
none 1 1.569 2.463 3.866
(1.123 to 2.194) (1.261 to 4.812) (1.416 to 10.556)
p = 0.008 p = 0.008 p = 0.008
Light 0.526 0.825 1.295 2.033
(0.343 to 0.807) (0.520 to 1.309) (0.654 to 2.565) (0.769 to 5.374)
p = 0.003 p = 0.415 p = 0.458 p = 0.153
Heavy 0.277 0.434 0.681 1.069
(0.117 to 0.651) (0.190 to 0.990) (0.271 to 1.715) (0.350 to 3.267)
p = 0.003 p = 0.047 p = 0.415 p = 0.907
Adjusted ORs for gender and age (95% CI) and p-values for the risk of having
portal hypertension as assessed by positive PVD scores
For S. mansoni
For S. haematobium none light medium heavy
None 1 0.882 0.778 0.686
(0.655 to 1.187) (0.429 to 1.410) (0.281 to 1.674)
p = 0.408 p = 0.408 p = 0.408
Light 1.013 0.893 0.788 0.695
(0.698 to 1.470) (0.582 to 1.372) (0.417 to 1.489) (0.284 to 1.703)
p = 0.946 p = 0.606 p = 0.463 p = 0.426
Heavy 1.026 0.905 0.798 0.704
(0.487 to 2.161) (0.429 to 1.908) (0.339 to 1.881) (0.248 to 2.000)
p = 0.946 p = 0.793 p = 0.606 p = 0.510
Adjusted ORs for gender and age (95% CI) and p-values for the risk of having
of hepatomegaly as assessed by positive PSL scores
For S. mansoni
For S. haematobium none light medium heavy
None 1 4.583 21.006 96.274
(1.517 to 13.844) (2.301 to 191.788) (3.490 to 2656.018)
p = 0.007 p = 0.007 p = 0.007
Light 3.409 4.705 6.494 8.964
(1.273 to 9.125) (1.201 to 18.425) (0.777 to 54.292 (0.453 to 177.253)
p = 0.015 p = 0.026 p = 0.084 p = 0.150
Heavy 11.619 4.83 2.008 0.835
(1.621 to 83.261) (0.536 to 43.480) (0.077 to 52.677) (0.008 to 85.355)
p = 0.015 p = 0.160 p = 0.676 p = 0.939
The categories for the intensity of S. haematobium infection were defined according to WHO guidelines as: none: 0 e/10 ml; light: < 50 e/10 ml and heavy: ≥ 50
e 10 ml.
The categories for the intensity of S. mansoni infection were defined according to WHO guidelines as: none: 0 epg; light: 1-99 epg; moderate: 100-399 epg; and
heavy: ≥ 400 epg
e/10 ml, eggs/10 milliliters & epg, eggs per gram
These categorizations for both schistosomes species apply for all tables presented beyond this point.
ORs, Odds Ratios; 95% CIs, 95% Confidence Intervals
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were no significantly increased risks of liver morbidity,
in the form of an abnormal liver image pattern, among
the co-infected children than among the uninfected chil-
dren. Children infected with S. haematobium only (both
light and heavy intensities) were significantly less likely
to have an abnormal liver image pattern compared to
uninfected children (OR: 0.5, p = 0.003 and OR: 0.3, p =
0.003 respectively).
As regards the risk of having portal hypertension,
the multilevel multivariate logistic regression model
(Table 1) did not yield any significant associations with any
of the intensities of the single or mixed schistosome
species.
Regarding the risk of having hepatomegaly as assessed
by positive PSL scores, children with single infections (S.
mansoni only or S. haematobium only) were more likely
to have this marker of liver morbidity than uninfected
children (with children with medium and heavy intensity
S. mansoni infections only being at particularly high risk:
OR: 21, p = 0.007 and OR = 96, p = 0.007, respectively).
The data indicated that children with medium and high
intensity S. mansoni infections, but no S. haematobium
infection, were at substantially higher risk of liver morbid-
ity of this form than co-infected children with medium
and high intensity S. mansoni infections. Furthermore,
there were no significantly increased risks of liver morbid-
ity, as assessed by positive PSL scores, among the co-
infected children with medium and high intensity S. man-
soni infections than among the uninfected children.
The risk of having hepatomegaly as assessed by
MSL>2 cm (Table 2) appeared to depend only upon the
intensity of the S. mansoni infection (risk was lowest
with no infection and increased with increased S. man-
soni intensity), with no effect of any S. haematobium
infection. Similarly, the risk of having hepatomegaly as
assessed by MCL>2 cm (Table 2) appeared to depend
only upon the intensity of the S. mansoni infection (risk
was lowest with no infection and increased with
increased S. mansoni intensity), with no effect of any S.
haematobium infection.
The risk of having splenomegaly as assessed once by
MCL>2 cm and then by MAL>2 cm did not depend on
the presence, or intensity of single or mixed S. mansoni
infection but it was slightly reduced in the presence of
single S. haematobium infection (Table 2).
The risk of bladder pathology as assessed by US exam-
ination (Table 3) did not depend on the presence, or
intensity of single S. mansoni infection but was much
increased in the presence of single S. haematobium
infection (light S. haematobium infection OR: 4.3, p <
0.001 and heavy S. haematobium infection OR: 19, p <
0.001 for children uninfected with S. mansoni in both
cohorts) and even further in the presence of mixed
infections.
Drop out rates at follow-up
There were significant differences in the ages of the 853
children successfully followed up and the 817 children
who dropped out during the follow-up (p < 0.001); chil-
dren who dropped out were older on average than chil-
dren who were successfully followed up (i.e. 11.25 years
versus 9.62 years). There were also significant differ-
ences between these two groups of children with refer-
ence to the prevalence of abnormal liver image patterns
(p = 0.024) and the bladder pathology (p = 0.010), as
determined by US examination, as well as the preva-
lence of hepatomegaly and splenomegaly as determined
by clinical examination (p = 0.020 and p = 0.003 respec-
tively). These indicators of morbidity were significantly
lower at baseline among children that dropped out than
in children who were successfully followed up. For all
other pathological manifestations considered, there were
no significant differences between these two groups of
children: those who dropped out and those who were
successfully followed up.
Excluding data from children aged 13 and 14 years at
baseline, the only significant follow-up differences were
that the prevalences of mixed schistosome species infec-
tions and bladder pathology were significantly lower in
those children who dropped out compared to those who
were successfully followed up. The observation that
most features examined were similar in children that
were successfully followed up and children who dropped
out during the follow-up suggested that results obtained,
after appropriate adjustment for age, were largely repre-
sentative of the population from which the sample had
been selected (see S2 in Additional File 1 for further
details).
Impact of MDA
Both at baseline and at follow-up the heaviest intensities
of S. haematobium infection were observed in Ségou
while the heaviest intensities of S. mansoni infection
were observed in Koulikoro (Table 4). However, in all
three areas and for both schistosome species, there were
observed significant decreases from baseline to follow-
up in the classes of heavy intensities with the exception
of Bamako area and the heavy intensity of S. mansoni
infection. It should be noted though that the latter was
very low at baseline and thus even if there was a signifi-
cant drop post treatment, it was unlikely to have been
detected with this small sample size. Co-infections also
decreased significantly in all three areas at follow-up
relative to baseline.
There were no substantial changes in the prevalence
of abnormal liver image patterns from baseline to fol-
low-up in all three areas (Table 4). Only hepatomegaly
in Ségou was observed to decrease significantly from
baseline to follow-up. Likewise, the prevalence of
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Table 2 Multivariate logistic regressions for liver and spleen pathology as assessed by clinical examination at baseline
(n = 2128)
Estimates from multilevel logistic regressions
Adjusted ORs for gender and age (95% CI) and p-values for the risk of having
hepatomegaly as assessed by MSL >2 cm
Type of schistosomiasis infection intensity related variables For S. mansoni
For S. haematobium none light medium heavy
None 1 1.431 2.049 2.932
(1.008 to 2.033) (1.016 to 4.132) (1.024 to 8.399)
p = 0.045 p = 0.045 p = 0.045
Light 0.995 1.425 2.039 2.919
(0.614 to 1.612) (0.839 to 2.419) (0.956 to 4.349) (1.016 to 8.383)
p = 0.985 p = 0.190 p = 0.065 p = 0.047
Heavy 0.991 1.418 2.03 2.905
(0.377 to 2.600) (0.548 to 3.667) (0.704 to 5.850) (0.825 to 10.230)
p = 0.985 p = 0.471 p = 0.190 p = 0.097
Adjusted ORs for gender and age (95% CI) and p-values for the risk of having
hepatomegaly as assessed by MCL>2 cm
For S. mansoni
For S. haematobium none light medium heavy
None 1 1.446 2.092 3.025
(1.006 to 2.078) (1.013 to 4.320) (1.019 to 8.979)
p = 0.046 p = 0.046 p = 0.046
Light 1.057 1.529 2.211 3.198
(0.652 to 1.713) (0.895 to 2.611) (1.017 to 4.805) (1.078 to 9.484)
p = 0.822 p = 0.120 p = 0.045 p = 0.036
Heavy 1.117 1.616 2.337 3.38
(0.425 to 2.934) (0.623 to 4.189) (0.801 to 6.815) (0.937 to 12.196)
p = 0.822 p = 0.323 p = 0.120 p = 0.063
Adjusted ORs for gender and age (95% CI) and p-values for the risk of having
splenomegaly as assessed by MCL>2 cm
For S. mansoni
For S. haematobium none light medium heavy
None 1 1.068 1.142 1.22
(0.864 to 1.321) (0.747 to 1.745) (0.645 to 2.306)
p = 0.541 p = 0.541 p = 0.541
Light 0.768 0.82 0.876 0.936
(0.594 to 0.992) (0.607 to 1.108) (0.557 to 1.378) (0.494 to 1.776)
p = 0.044 p = 0.197 p = 0.568 p = 0.840
Heavy 0.589 0.629 0.673 0.719
(0.352 to 0.985) (0.375 to 1.057) (0.368 to 1.228) (0.343 to 1.505)
p = 0.044 p = 0.080 p = 0.197 p = 0.381
Adjusted ORs for gender and age (95% CI) and p-values for the risk of having
splenomegaly as assessed by MAL>2 cm
For S. mansoni
For S. haematobium none light medium heavy
None 1 1.099 1.207 1.326
(0.879 to 1.373) (0.773 to 1.886) (0.679 to 2.591)
p = 0.408 p = 0.408 p = 0.408
Light 0.754 0.829 0.911 1.001
(0.576 to 0.988) (0.604 to 1.139) (0.565 to 1.468) (0.510 to 1.965)
p = 0.041 p = 0.247 p = 0.701 p = 0.998
heavy 0.569 0.625 0.687 0.755
(0.332 to 0.977) (0.362 to 1.079) (0.364 to 1.296) (0.346 to 1.646)
p = 0.041 p = 0.092 p = 0.247 p = 0.480
ORs, Odds Ratios; 95% CIs, 95% Confidence Intervals
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bladder pathology decreased significantly only in Ségou
at follow-up relative to baseline. In the other two areas,
follow-up results indicated significant increases relative
to baseline. Within both time points, differences in
these proportions were statistically significant when
comparing Ségou with the other two areas (Table 4).
Results of clinical examinations suggested significant
decreases in the prevalence of splenomegaly in Kouli-
koro and Ségou from baseline to follow-up. The preva-
lence of splenomegaly in Bamako between the two time
points of the study was similar. For the prevalence of
hepatomegaly, there was a significant decrease between
the two time points of the study only in Ségou whilst in
the other two surveyed areas this was similar.
As the descriptive analysis of the results of clinical and
US examinations indicated very low prevalences of
pathology in Bamako and Koulikoro, the fitting of multi-
nomial models for the changes of pathological manifes-
tations was restricted to the data of children from
Ségou. Even within the Ségou area, the fitting algorithm
converged only for four outcome variables: liver image
patterns, portal hypertension as determined by positive
PVD scores from US examination, splenomegaly as
assessed by MCL exceeding 2 cm from clinical examina-
tion and splenomegaly as assessed by MAL exceeding
2 cm from clinical examination (see Table 5 for results).
In addition valid results were obtained only when the
schistosome infection status was characterized as simply
infected or not infected (see S3 in Additional File 1 for
further details).
Considering liver image patterns, children with S.
mansoni infection at baseline compared to those without
were more likely to have liver image pathology at one or
both time points. In addition, among those children
with liver pathology at baseline, those with S. mansoni
infection at baseline were much more likely than
children without to have liver pathology at follow-up
(OR for pathology at both time points: 34.6 was much
greater than OR for pathology at baseline but no pathol-
ogy at follow-up: 3.1).
The regression model for portal hypertension from US
showed that children with S. mansoni infection at base-
line would have such pathology at baseline but it did
not enable us to predict what is going to happen after
treatment (OR for pathology at both time points: 2.8
was similar to the OR for pathology at baseline but not
at follow-up: 3.1).
Children with S. mansoni infection at baseline com-
pared to those with no S. mansoni infection were most
likely to have splenomegaly as assessed by clinical exam-
ination at both examined time points of interest (OR =
2.9, p = 0.002).
Finally, those children infected with S. haematobium
at baseline proved significantly less likely than those
without S. haematobium to have liver pathology at both
time points of study (OR = 0.2, p = 0.015; OR = 0.4, p
= 0.046 for the risk of portal hypertension and spleno-
megaly, respectively); those children infected with S.
haematobium at baseline proved also significantly less
likely than those without S. haematobium to have liver
pathology at baseline and being cured from such mor-
bidity at follow up.
Discussion
Both S. mansoni and S. haematobium schistosome spe-
cies infections are prevalent in much of sub-Saharan
Africa and are known to be co-endemic in several coun-
tries, such as Mali under study here, with currently
available studies contributing useful information with
regards to the epidemiology and immunology of each of
these separate specific parasitic infections [19-27]. In
contrast, however, very little is yet known about
Table 3 Multivariate logistic regression of bladder pathology as assessed by US at baseline (n = 2128)
Estimates from multilevel logistic regressions
Adjusted ORs for gender and age (95% CI) and p-values for the risk of having
bladder pathology as assessed by positive global scores
Type of schistosomiasis infectionintensity related variables For S. mansoni
For S. haematobium none light medium heavy
None 1 1.166 1.36 1.587
(0.923 to 1.473) (0.853 to 2.170) (0.787 to 3.198)
p = 0.197 p = 0.197 p = 0.197
Light 4.347 5.07 5.914 6.898
(3.232 to 5.847) (3.560 to 7.220) (3.513 to 9.955) (3.339 to 14.251)
p < 0.001 p < 0.001 p < 0.001 p < 0.001
Heavy 18.897 22.041 25.708 29.985
(10.446 to 34.186) (11.986 to 40.531) (12.677 to 52.134) (12.702 to 70.783)
p < 0.001 p < 0.001 p < 0.001 p < 0.001
ORs, Odds Ratios; 95% CIs, 95% Confidence Intervals
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potential interactions of concurrent infections, nor as
the associated clinical impact of mixed schistosome
infections on the human host. Further understanding of
polyparasitic interactions is essential in order to guide
public health measures in endemic areas [28]. To our
knowledge, our study represents the first which uses not
only clinical examination but also precise and detailed
ultrasonography in order to examine the impact of sin-
gle versus mixed schistosome species infections on
human hosts’ liver, spleen and bladder morbidity at the
same time, both pre- and post-chemotherapy.
We have demonstrated here that, in general, the risk
for baseline liver morbidity amongst these 7-14 year old
children, in the form of an abnormal liver image pattern
and hepatomegaly, as assessed by positive PSL scores,
was lower for co-infections if compared to single
S. mansoni infections of the same intensity. This finding
from Mali agrees with previous results of decreased
hepatomegaly, as determined by palpation, in co-infec-
tions from Cameroon [6]. Furthermore, our study has
also indicated through univariate analysis that at base-
line significantly more children with S. haematobium
only, compared to uninfected children, had liver mor-
bidity (i.e. portal hypertension and hepatomegaly-as
assessed by both US and clinical examination) or spleen
morbidity as assessed by clinical examination; baseline
results from multivariate analysis yielded significant
increased risks of hepatomegaly as assessed by positive
PSL scores for children with single S. haematobium
infections compared to uninfected children (ORs for
Table 4 Health characteristics of schoolchildren successfully retraced (i.e. pre and post treatment-n = 853)
Baseline Post-treatment
Bamako Koulikoro Ségou Bamako Koulikoro Ségou
(n = 273) (n = 153) (n = 427) (n = 273) (n = 153) (n = 427)
Parasitology
% Uninfected 45.05 (< 0.001)a 14.38 (< 0.001)b 8.90 (< 0.001)c 64.10 (< 0.001)d ** 32.68 (0.010)e ** 40.05 (< 0.001)f **
% Infected with
S. haematobium
43.96 (< 0.001)a 3.92 (< 0.001)b 57.38 (< 0.001)c 26.37 (< 0.001)d ** 5.23 (< 0.001)e 35.36 (0.011) f **
% Infected with S. mansoni 1.10 (< 0.001)a 24.84 (< 0.001)b 4.22 (0.007)c 4.03 (< 0.001)d ** 40.52 (< 0.001)e ** 14.05 (< 0.001)f **
% Co-infected 9.89 (< 0.001)a 56.86 (< 0.001)b 29.51 (< 0.001)c 5.49 (< 0.001)d ** 21.57 (0.002)e ** 10.54 (0.013)f **
% Heavy S. haematobium
infections
13.19 (0.040) a 7.19 (< 0.001) b 39.58 (< 0.001) 2.20 (0.161)c ** 0.65 (< 0.001) e ** 7.73 (< 0.001) f **
% Heavy S. mansoni infections 0.73 (< 0.001) 22.88 (0.005) 12.41 (< 0.001) 0.00 (< 0.001) 10.46 (0.003) ** 2.81 (< 0.001) **
Liver Pathology as assessed by ultrasound (US) examination
% with abnormal liver image
patterns
0.37 (0.316)a 0.00 (< 0.001)b 12.18 (< 0.001)c 0.37 (0.316)d 0.00 (< 0.001)e 12.88 (< 0.001)f
% with portal hypertension
(as determined by positive PVD
scores)
0.73 (0.585)a 1.31 (< 0.001)b 9.60 (< 0.001)c 5.49 (0.013)d ** 13.07 (0.076)e ** 7.73 (0.237)f
% with hepatomegaly (as
determined by positive PSL
scores from US)
0.37 (0.701)a 0.65 (0.085)b 2.34 (0.085)c 0.00 (0.316)d 0.65 (0.545)e 0.23 (0.317)f **
Liver + spleen pathology as assessed by clinical examination
% with hepatomegaly as
assessed by MSL>2 cm
0.00 (0.316)a 0.65 (< 0.001)b 9.84 (< 0.001)c 0.00 (0.080)d 1.96 (0.291)e 0.70 (0.082)f **
% with hepatomegaly as
assessed by MCL>2 cm
0.00 (0.316)a 0.65 (< 0.001)b 8.67 (< 0.001)c 0.00 (0.080)d 1.96 (0.291)e 0.70 (0.082)f **
% with splenomegaly as
assessed by MCL>2 cm
0.73 (< 0.001)a 12.42 (< 0.001)b 27.17 (< 0.001)c 0.00 (0.023)d 3.27 (0.009)e ** 8.43 (< 0.001)f **
% with splenomegaly as
assessed by MAL>2 cm
0.73 (< 0.001)a 8.50 (< 0.001)b 25.06 (< 0.001)c 0.00 (0.043)d 2.61 (0.010)e ** 7.26 (< 0.001)f **
Bladder Pathology as assessed by US examination
Bladder pathology (as
determined by positive global
scores from US)
8.42 (0.194)a 5.23 (< 0.001)b 22.95 (< 0.001)c 22.34 (0.057)d ** 15.03 (< 0.001)e ** 3.98 (< 0.001)f **
ap-values comparing proportions reported between Bamako and Koulikoro at baseline in parentheses; b p-values comparing proportions reported between
Koulikoro and Ségou at baseline in parentheses; c p-values comparing proportions reported between Bamako and Ségou at baseline in parentheses; d p-values
comparing proportions reported between Bamako and Koulikoro at follow-up in parentheses; e p-values comparing proportions reported between Koulikoro and
Ségou at follow-up in parentheses; f p-values comparing proportions reported between Bamako and Ségou at follow-up in parentheses; ** significant differences
at a = 0.05 between baseline and post treatment paired proportions as indicated by McNemar’s test
US, ultrasound; PVD, portal vain diameters; PSL, parasternal line; MSL, mid-sternal line; MCL, mid-clavicular line; MAL, mid-axillary line
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light and heavy intensities of S. haematobium infection
were estimated respectively as 3.4 and 11.6 in Table 1).
Such findings suggest that urinary schistosomiasis alone
might also lead to liver and spleen abnormalities, and
hence, where possible, potential liver morbidity para-
meters in S. haematobium infections should also be
examined during MDA monitoring and evaluation [29].
Indeed, to our knowledge, with the exception of com-
munity and hospital surveys performed in Egypt [30,31],
there are very few studies that have examined human
liver morbidity by US and clinical examinations in S.
haematobium infection, and our results here may imply
that such findings should also be taken into account in
the revised assessments of schistosomiasis morbidity
and disability adjusted life years (DALYS) [3].
The precise causation of such S. haematobium-asso-
ciated liver and spleen morbidity here remains, however,
unclear. One could speculate that children with single S.
Table 5 Multivariate multinomial logistic regressions for the changes of liver image patterns for Ségou area (n = 427)
Estimates from multinomial model with dependent variable indicating the change of liver image patterns during the 2 time points of the
study
(Adjusted ORs for gender and age, 95% CIs & p-values)
Dependent variable: the
risk of having pathology
at both time points
Dependent variable: the risk of having
no pathology at baseline and having
pathology at final point of the study
Dependent variable: the risk of
having pathology at baseline but
cured at final point of the study
Risk factors-Independent
variables at baseline(Reference
category)
Type of schistosomiasis
infection related variables at
baseline
Infected with S. haematobium
(Not infected with S.
haematobium)
0.353 (0.080 to 1.560)
p = 0.1691
2.339 (0.525 to 10.423) p = 0.2651 0.245 (0.110 to 0.544) p < 0.0011
Infected with S. mansoni (Not
infected with S. mansoni)
34.591 (4.315 to 277.268)
p < 0.0011
7.139 (3.513 to 14.506) p < 0.0011 3.081 (1.514 to 6.267) p = 0.0021
Estimates from model with dependent variable indicating the change of portal hypertension from ultrasound during the 2 time points of
the study
Type of schistosomiasis
infection related variables at
baseline
Infected with S. haematobium
(Not infected with
S. haematobium)
0.157 (0.036 to 0.695)
p = 0.0151
1.541 (0.346 to 6.865) p = 0.5711 0.612 (0.230 to 1.631) p = 0.3271
Infected with S. mansoni (Not
infected with S. mansoni)
2.792 (0.611 to 12.753)
p = 0.1851
0.188 (0.043 to 0.813) p = 0.0251 3.076 (1.460 to 6.482) p = 0.0031
Estimates from model with dependent variable indicating the change of splenomegaly from clinical examination and MCL>2 during the
2
time points of the study
Type of schistosomiasis
infection related variables at
baseline
Infected with S. haematobium
(Not infected with
S. haematobium)
0.356 (0.129 to 0.983)
p = 0.0461
1.105 (0.136 to 9.009) p = 0.9261 0.482 (0.253 to 0.919) p = 0.0271
Infected with S. mansoni (Not
infected with S. mansoni)
2.946 (1.267 to 6.848)
p = 0.0121
0.915 (0.235 to 3.562) p = 0.8991 1.479 (0.900 to 2.432) p = 0.1231
Estimates from model with dependent variable indicating the change of splenomegaly from clinical examination and MAL>2 during the
2 time points of the study
Type of schistosomiasis
infection related variables at
baseline
Infected with S. haematobium
(Not infected with
S. haematobium)
0.505 (0.155 to 1.647)
p = 0.2571
1.028 (0.125 to 8.474) p = 0.9791 0.487 (0.256 to 0.929) p = 0.0291
Infected with S. mansoni (Not
infected with S. mansoni)
4.353 (1.681 to 11.272)
p = 0.0021
0.953 (0.238 to 3.810) p = 0.9461 1.140 (0.681 to 1.908) p = 0.6191
Note: The comparison group for the dependent variable is ‘no pathology at both time points’
ORs, Odds Ratios; 95% CIs, 95% Confidence Intervals
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haematobium infections may have had active S. mansoni
infections in the past, particularly in such co-endemic
regions, which could account for the classic S. mansoni-
associated liver and splenic morbidity observed in S.
haematobium infected individuals. However, the
approximately matched ages of children between infec-
tion status groups sampled here may warrant against
this as a sufficient potential explanation, although we
admittedly cannot fully discount the possibility of some
very light current S. mansoni infections being missed
during the single Kato Katz examinations. An alternative
plausible explanation, therefore, may be related to the
fact that S. haematobium eggs are found in the liver and
do cause granulomas, albeit to a lesser extent than S.
mansoni, as both of these schistosome species involve a
hepatic portal system migration phase during their life-
cycles [32,33], which could plausibly result in some
pathology. In any case, further research into this poten-
tially very important observation, of liver pathology in S.
haematobium infections (urinary schistosomiasis), and
not only S. mansoni infections (intestinal schistosomia-
sis) is warranted.
As regards the bladder morbidity examined here, our
results indicated that at baseline children with single
and mixed schistosome species infections were signifi-
cantly more likely to have this risk. Moreover, the risk
of having such morbidity was greater in mixed infec-
tions than in single S. haematobium infections of the
same intensity. Once again the mechanisms behind such
increased bladder morbidity in mixed as compared to
single species infections is uncertain. As we predicted
from the results of the Cameroon study in humans
[5,6], combined with that know from laboratory mixed
species studies in mice [11], synergistic or antagonistic
interactions resulting from mixed species infections, and
in particular potential interspecific S. mansoni: S. hae-
matobium pairings, might be likely to lead to bladder
abnormalities as observed by US. In part, mixed species
infections within a single host may compete, and
increase their individual egg output and subsequent
virulence to their host, relative to that produced under
single species infections [34]. Indeed, it has been
observed in very high infection intensities cases, eggs
from either species can be found in a range of ‘addi-
tional’ internal organs [32], although the current ana-
lyses controlled for infection intensity and so this alone
is unlikely to fully explain the results here. More plausi-
bly the observed results may indicate S. haematobium
males mating with S. mansoni females and the subse-
quent (infertile) eggs produced from such couplings pas-
sing to the urinary oviposition site, thereby reducing the
amount of classical S. mansoni-induced morbidity whilst
increasing the classic S. haematobium-associated bladder
morbidity. Furthermore, it may be plausible that the
infertile, and immunogenically novel, hybrid eggs pro-
duced from such female S. mansoni and male S. haema-
tobium heterologous pairs in the urinary tract may not
be as adept at transversing the urinary tract wall, relative
to their pure-bred single species counterparts, and hence
may more frequently become trapped, and cause granu-
loma-related morbidity, in the urinary tract and bladder
tissues. Whatever the precise aetiology, the results indi-
cate again that any consideration of schistosome-asso-
ciated morbidity in the human hosts should examine
further than the traditional single species ‘liver/spleen’
for S. mansoni and bladder/urinary tract for S.
haematobium.
When pre- and post-MDA data were analyzed we
found that at baseline the highest prevalence of S. hae-
matobium infection was observed in Ségou while the
highest prevalences of S. mansoni infection and co-
infections were both found in Koulikoro. At follow-up,
prevalences of single and mixed S. haematobium infec-
tions significantly decreased with the exception of Kouli-
koro where prevalence of single S. haematobium
infections significantly increased. Furthermore, the pre-
valence of S. mansoni infection after PZQ treatment sig-
nificantly increased in all three areas in Mali, as has
been reported in Senegal and Egypt [8,9]. Heavy intensi-
ties for both S. haematobium and S. mansoni infections
have both significantly decreased in Koulikoro and
Segou after PZQ treatment. At follow-up there were sig-
nificant decreases in liver/spleen and bladder patholo-
gies in the Ségou area while in Bamako and Koulikoro
areas there were observed significant increases in blad-
der pathology. This finding does, as we predicted, high-
light the importance of looking at both liver and bladder
when assessing morbidity, particularly in areas of mixed
foci.
Moreover, multivariate analysis on the two years’ data
from Ségou area highlighted the causative role of S.
mansoni infections compared to absence of infection
with S. mansoni with respect to chronic liver morbidity,
both before and after PZQ treatment. More precisely,
we found that those children who were infected with S.
mansoni only compared to those uninfected at baseline
were significantly more likely to have liver morbidity at
follow-up. For those children who were infected with S.
haematobium only compared to those uninfected at
baseline, they were found significantly less likely to have
changes in their liver morbidity during the two years of
study. However, intensities of infection were not
included in this part of the analysis and further research
here is therefore warranted.
We do recognize the inherent limitations of this study,
where treatments provided could not be randomized
because of ethical reasons associated with a national
schistosomiasis control program, in addition to the a
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priori well-known focality of disease in the baseline
results of this study and the different number of treat-
ments delivered in each of the three study areas. Other
potentially confounding factors such as additional con-
current parasitic diseases, for example malaria, could
complicate the interpretation of results, and further
research to elucidate these complicating factors is war-
ranted. Nevertheless, we still believe that the results of
this study add important insights into polyparasite inter-
actions and their implications to the human host.
Conclusions
To conclude, this study found decreased liver morbidity
in mixed schistosome species infections compared to
single S. mansoni infections and increased bladder mor-
bidity in mixed schistosome species infections compared
to single S. haematobium infections. Single S. haemato-
bium or S. mansoni infections were also associated with
liver and spleen morbidity, while only single S. haemato-
bium infections were associated with bladder morbidity
in these children. PZQ treatment contributed to the
regression of some of the forms of such morbidities.
The precise biological mechanisms for these observa-
tions remain to be fully ascertained but, at least, the
estimates of schistosomiasis morbidity DALYs should
take the current findings into account.
Additional material
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analysis that supports the methodology finally used.
Acknowledgements
We thank the field and technical staff of the Malian Ministry of Health
(Institut National de Recherche en Santé Publique and Programme National de
Lutte contre la Schistosomiase et les Géohelminthiases) for their collaboration.
We also thank Professor Sir Roy Anderson for helpful discussions. A special
thank to the headteachers, staff and children for their willingness to
participate in the survey. This work was funded by the Bill & Melinda Gates
foundation. CAD thanks the MRC for Centre funding.
Author details
1Schistosomiasis Control Initiative, Department of Infectious Disease
Epidemiology, Faculty of Medicine, Imperial College London, UK. 2MRC
Centre for Outbreak Analysis and Modelling, Department of Infectious
Disease Epidemiology, Imperial College London, London, UK. 3Institut
National de Recherche en Santé Publique, Ministère de la Santé, Bamako,
Mali. 4Service de la Radiologie, Hôpital National du Point G, Bamako, Mali.
5Programme National de Lutte contre la Schistosomiase et les
Géohelminthiases, Direction Nationale de la Santé, Ministère de la Santé,
Bamako, Mali. 6Department of Control of Neglected Tropical Diseases, World
Health Organization, CH-1211 Geneva 27, Switzerland.
Authors’ contributions
AF obtained funding and AF & JPW were the principal investigators. JPW,
AF, and AFG participated in the design of data collection. MS, ADK, AL, RD,
EBO & AFG participated in data collection. AK (with JPW) drafted the
manuscript. AK carried out statistical analysis. All authors contributed to the
critical revision of the manuscript for important intellectual content and
agreed on submission.
Competing interests
The authors declare that they have no competing interests.
Received: 5 March 2010 Accepted: 29 July 2010 Published: 29 July 2010
References
1. Hotez P, Raff S, Fenwick A, Richards F Jr, Molyneux DH: Recent progress in
integrated neglected tropical disease control. Trends Parasitol 2007,
23(11):511-514.
2. Keusch GT, Migasena P: Biological implications of polyparasitism. Rev
Infect Dis 1982, 4(4):880-882.
3. King CH, Dickman K, Tisch DJ: Reassessment of the cost of chronic
helmintic infection: a meta-analysis of disability-related outcomes in
endemic schistosomiasis. Lancet 2005, 365(9470):1561-1569.
4. Vennervald BJ, Dunne DW: Morbidity in schistosomiasis: an update. Curr
Opin Infect Dis 2004, 17(5):439-447.
5. Cunin P, Griffet A, Poste B, Djibrilla K, Martin PM: Epidemic Schistosoma
mansoni in a known S. haematobium area. Trans R Soc Trop Med Hyg
2000, 94(6):657-660.
6. Cunin P, Tchuem Tchuente LA, Poste B, Djibrilla K, Martin PM: Interactions
between Schistosoma haematobium and Schistosoma mansoni in
humans in north Cameroon. Trop Med Int Health 2003, 8(12):1110-1117.
7. Garba A, Labbo R, Tohon Z, Sidiki A, Djibrilla A: Emergence of Schistosoma
mansoni in the Niger River valley Niger. Trans R Soc Trop Med Hyg 2004,
98(5):296-298.
8. Abdel-Wahab MF, Yosery A, Narooz S, Esmat G, el Hak S, Nasif S,
Strickland GT: Is Schistosoma mansoni replacing Schistosoma
haematobium in the Fayoum? Am J Trop Med Hyg 1993, 49(6):697-700.
9. Ernould JC, Ba K, Sellin B: Increase of intestinal schistosomiasis after
praziquantel treatment in a Schistosoma haematobium and Schistosoma
mansoni mixed focus. Acta Trop 1999, 73(2):143-152.
10. Ratard RC, Ndamkou CN, Kouemeni LE, Ekani Bessala MM: Schistosoma
mansoni eggs in urine. J Trop Med Hyg 1991, 94(5):348-351.
11. Webster BL, Southgate VR, Tchuem Tchuente LA: Mating interactions
between Schistosoma haematobium and S. mansoni. J Helminthol 1999,
73(4):351-356.
12. Garba A, Toure S, Dembele R, Bosque-Oliva E, Fenwick A: Implementation
of national schistosomiasis control programmes in West Africa. Trends
Parasitol 2006, 22(7):322-326.
13. Kabatereine NB, Fleming FM, Nyandindi U, Mwanza JC, Blair L: The control
of schistosomiasis and soil-transmitted helminths in East Africa. Trends
Parasitol 2006, 22(7):332-339.
14. Southgate VR, Rollinson D, Tchuem Tchuente LA, Hagan P: Towards
control of schistosomiasis in sub-Saharan Africa. J Helminthol 2005,
79(3):181-185.
15. Cosgrove CL, Southgate VR: Mating interactions between Schistosoma
mansoni and S. margrebowiei. Parasitology 2002, 125(Pt 3):233-243.
16. Koukounari A, Sacko M, Keita AD, Gabrielli AF, Landoure A, Dembele R,
Clements AC, Whawell S, Donnelly CA, Fenwick A, et al: Assessment of
ultrasound morbidity indicators of schistosomiasis in the context of
large-scale programs illustrated with experiences from Malian children.
Am J Trop Med Hyg 2006, 75(6):1042-1052.
17. Mukudi E: Nutrition status education participation and school
achievement among Kenyan middle-school children. Nutrition (Burbank,
Los Angeles County Calif) 2003, 19(7-8):612-616.
18. Lambertucci JR, Cota GF, Pinto-Silva RA, Serufo JC, Gerspacher-Lara R, Costa
Drummond S, Antunes CM, Nobre V, Rayes A: Hepatosplenic
schistosomiasis in field-based studies: a combined clinical and
sonographic definition. Mem Inst Oswaldo Cruz 2001, 96(Suppl):147-150.
19. Coulibaly G, Diallo M, Madsen H, Dabo A, Traore M, Keita S: Comparison of
schistosome transmission in a single- and a double-cropped area in the
rice irrigation scheme ‘Office du Niger’, Mali. Acta Trop 2004, 91(1):15-25.
20. Dabo A, Diop S, Doumbo O: [Distribution of intermediate mollusc hosts
in human schistosomiasis in the Office of Niger (Mali). II. Role of
different habitats in the transmission]. Bull Soc Pathol Exot (1990) 1994,
87(3):164-169.
Koukounari et al. BMC Infectious Diseases 2010, 10:227
http://www.biomedcentral.com/1471-2334/10/227
Page 13 of 14
21. Dabo A, Sacko M, Toure K, Doumbo O, Dialo A: [Epidemiology of
schistosomiasis in a suburban school area of Bamako (Republic of Mali)].
Bull Soc Pathol Exot (1990) 1995, 88(1):29-34.
22. Dabo A, Traore HA, Diakite M, Kouriba B, Camara F, Coulibaly CO, Sacko M,
Doumbo O: [Echographic morbidity due to Schistosoma haematobium
in a peripheral district of Bamako in Mali Missabougou]. Bull Soc Pathol
Exot (1990) 1995, 88(1):11-14.
23. De Clercq D, Rollinson D, Diarra A, Sacko M, Coulibaly G, Landoure A,
Traore M, Southgate VR, Kaukas A, Vercruysse J: Schistosomiasis in Dogon
country Mali: identification and prevalence of the species responsible
for infection in the local community. Trans R Soc Trop Med Hyg 1994,
88(6):653-656.
24. Kardorff R, Traore M, Diarra A, Sacko M, Maiga M, Franke D, Vester U,
Hansen U, Traore HA, Fongoro S, et al: Lack of ultrasonographic evidence
for severe hepatosplenic morbidity in schistosomiasis mansoni in Mali.
Am J Trop Med Hyg 1994, 51(2):190-197.
25. Traore M, Maude GH, Bradley DJ: Schistosomiasis haematobia in Mali:
prevalence rate in school-age children as index of endemicity in the
community. Trop Med Int Health 1998, 3(3):214-221.
26. van der Werf MJ, de Vlas SJ, Landoure A, Bosompem KM, Habbema JD:
Measuring schistosomiasis case management of the health services in
Ghana and Mali. Trop Med Int Health 2004, 9(1):149-157.
27. Werler C: Efficiency of focal molluscicide treatment against
schistosomiasis reinfection in an irrigation scheme and in a small dams
area in Mali. Preliminary communication. Trop Med Parasitol 1989,
40(2):234-236.
28. Lyke KE, Dicko A, Dabo A, Sangare L, Kone A, Coulibaly D, Guindo A,
Traore K, Daou M, Diarra I, et al: Association of Schistosoma haematobium
infection with protection against acute Plasmodium falciparum malaria
in Malian children. Am J Trop Med Hyg 2005, 73(6):1124-1130.
29. Friis H, Ndhlovu P, Kaondera K, Franke D, Vennervald BJ, Christensen NO,
Doehring E: Ultrasonographic assessment of Schistosoma mansoni and S.
haematobium morbidity in Zimbabwean schoolchildren. Am J Trop Med
Hyg 1996, 55(3):290-294.
30. El-Khoby T, Galal N, Fenwick A, Barakat R, El-Hawey A, Nooman Z, Habib M,
Abdel-Wahab F, Gabr NS, Hammam HM, et al: The epidemiology of
schistosomiasis in Egypt: summary findings in nine governorates. Am J
Trop Med Hyg 2000, 62(2 Suppl):88-99.
31. Medhat A, Nafeh M, Swifee Y, Helmy A, Zaki S, Shehata M, Ibrahim S,
Abdel-Kader DA, Strickland GT: Ultrasound-detected hepatic periportal
thickening in patients with prolonged pyrexia. Am J Trop Med Hyg 1998,
59(1):45-48.
32. Wilson RA: The saga of schistosome migration and attrition. Parasitology
2009, 136(12):1581-1592.
33. Abdel-Wahab MF, Esmat G, Ramzy I, Fouad R, Abdel-Rahman M, Yosery A,
Narooz S, Strickland GT: Schistosoma haematobium infection in Egyptian
schoolchildren: demonstration of both hepatic and urinary tract
morbidity by ultrasonography. Trans R Soc Trop Med Hyg 1992,
86(4):406-409.
34. Levin BR: The evolution and maintenance of virulence in microparasites.
Emerg Infect Dis 1996, 2(2):93-102.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2334/10/227/prepub
doi:10.1186/1471-2334-10-227
Cite this article as: Koukounari et al.: The impact of single versus mixed
schistosome species infections on liver, spleen and bladder morbidity
within Malian children pre- and post-praziquantel treatment. BMC
Infectious Diseases 2010 10:227.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Koukounari et al. BMC Infectious Diseases 2010, 10:227
http://www.biomedcentral.com/1471-2334/10/227
Page 14 of 14
